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1. INTRODUCTION 
1.1 INTRODUCTION TO ANALYTICAL CHEMISTRY  
(Fifeld F.W and Kealey D. 2006)                                                       
Analytical chemistry is a metrological discipline that develops, optimizes and applied 
measurement processes intended to derive quality (bio) chemical information of global and 
partial type from natural and artificial objects or systems in order to solve analytical problems 
derived from information needs. 
1.2 Aims and Objectives 
 Thus, Analytical chemistry has two main aims are Qualitative (intrinsic) and 
Quantitative (Extrinsic). The Qualitative aim is the achievement of metrological quality, i.e. 
ensuring full consistency between the analytical results delivered and the actual value of the 
measured parameters; in metrological terms, this translates into producing high traceable 
results subject to very little uncertainty. The Quantitative aim is solving the analytical 
problems derived from the (bio) chemical information needs posed by a variety of “clients”.  
1.3 ANALYTICAL METHOD                                  (Douglas A. Skoog, et al., 2006) 
The analytical method maybe 
1) Qualitative analysis 
2) Quantitative analysis 
Qualitative analysis was performed to establish composition of natural/synthetic 
substances. These tests were performed to indicate whether the substance or compound is 
present in the sample or not. Various qualitative tests are detection of evolved gas, formation 
of precipitates, limit tests, colour change reactions, melting point and boiling point test etc. 
Quantitative analysis techniques are mainly used to quantify any compound or 
substance in the sample. These techniques are based in  
(a) The quantitative performance of suitable chemical reaction and either measuring 
the amount of reagent added to complete the reaction or measuring the amount of reaction 
product obtained,  
(b) The characteristic movement of a substance through a defined medium under 
controlled conditions, 
(c) Electrical measurement  
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(d) Measurement of some spectroscopic properties of the compound.  
The analytical methods are two types 
 Classical methods  
 Instrumental methods 
In classical methods, for qualitative analysis, the analyte was extracted and treated 
with the reagent specific for a functional group to give a coloured reaction. In quantitative 
analysis, the amount of the analyte in determined by titrimetric method or by gravimetric 
method. 
The instrumental methods are based on the physical properties of the analyte such as 
the light absorption or emission, conductivity, mass to charge ratio, fluorescence, adsorption 
and partition etc. The instrumental methods are basically categorised as follows 
1.4 ANALYTICAL TECHNIQUES                       (Fifeld F.W and Kealey D. 2006) 
A wide variety of parameters may be measured by using following techniques. 
S.No  Group  Property measured 
1 Gravimetric Weight of pure analyte or of a stoichiometric compound 
containing it. 
2 Spectrometric Intensity of electromagnetic radiation emitted or absorbed by the 
analyte. 
3 Electrochemical Electrical properties of analyte  solutions 
4 Radiochemical Intensity nuclear radiations emitted by the analyte. 
5 Mass spectrometric Abundance of molecular fragments derived from the analyte. 
6 Chromatographic Physio- chemical properties of individual analyte after separation. 
 
1.5 SPECTROSCOPIC METHODS 
                        (Gurudeep R. Chatwal, et al., 2008; Beckett and Stenlake, et al., 2007) 
Spectroscopy deals with the interaction of an analyte with electromagnetic radiation. 
The interaction of the electromagnetic radiation results in absorption or emission radiations. 
Based on the absorption or emission the spectroscopy is classified into, absorption 
spectroscopy and emission spectroscopy. 
1.5.1 Absorption Spectroscopy  
 When a beam of electromagnetic radiation is passed through an analyte, certain 
amount of the radiation is absorbed into the matter. The analyte after absorbing the radiation 
goes from the ground state to the excited state giving the absorption spectra. The various  
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absorption spectroscopies include the UV-Visible absorption, X-ray absorption, infrared 
absorption, microwave absorption, radio frequency absorption and atomic absorption, etc. 
1.5.1.1 Atomic Absorption 
In the atomic absorption spectra the electrons are excited from the lower energy state 
to a higher energy state by absorption of electromagnetic radiation. The atom absorbs the 
electromagnetic radiation of energy corresponding to the difference in energy between the 
higher and lower energy states of the absorbing atom. UV-Visible radiation can excite only 
the electrons in the outer most orbital, whereas the X-ray has the capacity to excite the 
electrons located in the inner shell near to the nuclei. 
1.5.1.2 Molecular Absorption 
The molecular absorption spectra of polyatomic molecules are more complex than the 
atomic absorption spectra since the number of energy states are higher. The energies 
associated with a molecule are rotational energy, vibrational energy and electronic energy.  
   E = Eelectronic + Evibrational +Erotational 
The molecule absorbs electromagnetic radiation of energy corresponding to the difference in 
the energy of the ground state molecule and the excited state molecule. The difference in 
energy ∆E is given by, 
 ∆E = (Eelectronic + Evibrational +Erotational) excited – (Eelectronic + Evibrational +Erotational) ground 
The UV-Visible radiations and X-rays have the energy to induce the transition from the 
ground state to the excited state. 
1.5.2 Emission Spectroscopy 
Emission spectroscopy is the technique in which the wavelength of the photons 
emitted by an analyte due to the transition from higher energy level to lower energy on 
exposure to an electromagnetic radiation was studied. Each analyte emits a specific 
wavelength of radiation corresponding to the composition of the sample. The energy of the 
photons emitted is given by 
    Ephoton = hυ 
Where E is the energy of the photon, ν is the frequency and h is the Planck‟s constant. 
The various instrumental techniques which are based on the measurement of the emitted 
radiation include flame photometry, fluorimetry, radiochemical methods. 
1.5.2.1. Atomic Emission 
When an analyte is heated, it emits light characteristic of the atom present in it. For 
example, sodium when heated emits yellow light and potassium emits lilac light. When a 
metal is heated, the electrons in the outer orbital absorb the heat and goes to a higher energy 
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state. The atom then comes back to the ground state by emitting the photons of light which 
has energy equal to the difference between the higher energy state and the lower energy 
 state. The instrumental analytical technique, such as the flame emission spectroscopy 
works on the principle of measuring the photons of energy emitted by a thermally excited 
atom. 
1.5.2.2. Molecular Emission 
When a beam of electromagnetic radiation falls on a molecular species, it absorbs the 
radiation and gets excited. The excited molecules are short lived and it fall back to the ground 
state immediately. The molecules in the excited sate have higher vibrational energy than that 
of the ground state. They emit the absorbed energy by the following ways, fluorescence and 
phosphorescence.The difference in the energy levels of the absorbed radiation, fluorescence 
and phosphorescence are as below 
   ∆Eabsorption > ∆Efluorescence > ∆Ephosphorescence 
 The analytical techniques spectrofluorimetry and phosphorimetry involves the 
principle of molecular emission. 
1.5.3. UV Spectroscopy               
UV-visible spectroscopic methods are based on the type of chromospheres/functional 
group present in the drug moiety. Multi component systems are also easily analysed by 
means of spectral isolation. Spectroscopic methods are widely used as tools for quantitative 
analysis, characterization and quality control in the pharmaceutical, agricultural and 
biomedical fields 
The UV spectroscopy is one of the most widely used instrumental analytical 
techniques for the analysis of pharmaceuticals. The UV region extends from 190 nm to 380 
nm. The instrument used to measure the intensity of the UV radiation absorbed or transmitted 
is known as the UV - Visible spectrophotometers. A molecule can absorb the UV radiation 
only when the energy of the radiation matches the energy that was required to induce 
electronic transition in the molecule. 
1.5.3.1 Laws of Absorption 
When a beam of UV light is allowed to pass through a substance which absorbs the 
UV light, the intensity of the transmitted light was lesser than the incident light. The 
reduction of the intensity is may be due to reflections on the surface of the cell, scattering of 
light by macro molecules and absorption. 
The two important laws which govern the UV spectroscopy are the Lambert‟s law and 
Beer‟s law. Lambert‟s law states that the intensity of the light decreases exponentially with 
decrease in the thickness of the medium through which it passes. Beer‟s law states that the 
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intensity of the light decreases exponentially with increase in the concentration of the 
absorbing substance. 
The two laws where combined to form the Beer-Lambert‟s law, which is given by the 
equation 
    A = abc 
Where, A is the absorbance 
 a is the absorptivity 
 b is the path length 
 c is the concentration. 
 The absorptivity is defined as, the absorbance of a substance at a specific wavelength 
of 1 g/100 ml solution in a 1cm cell. 
1.5.3.2 Beer - Lambert’s Law  
 When light is incident upon a homogeneous medium, a part of incident light is 
reflected, a part is absorbed by the medium and the remainder is allowed to transmit as such. 
I0 = Ia + It + Ir 
 
 Where,   
  I0 = Incident light 
  Ia = Absorbed light 
  It = Transmitted light 
  Ir = Reflected light 
Lambert‟s Law states “when a beam of light is allowed to pass through a transparent medium, 
the rate of decrease of intensity with the thickness of the medium is directly proportional to 
the intensity of the light”. 
-  
  It = I0 e
-kt
       ---------- (1) 
(or) 
 
Beer‟s Law states “The intensity of a beam of monochromatic light decreases exponentially 
with the increase in concentration of the absorbing substance”. 
     -  
  It = I0 e
-k‟c
      ----------- (2) 
(or) 
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By solving equations 1 and 2, on changing equations from natural logarithm, 
   It = I0. 10
-0.4343kt
 = I0 10
-kt
   ----------- (3) 
   It = I0. 10
-0.4343 k‟c
 = I0
-k‟c       
----------- (4) 
On combining equations 3 and 4, 
It = I0 10
-act
 
 
Where k and k' are constants, C is the concentration of the absorbing substance and          
denotes thickness of the medium. 
1.5.3.2.1 Limitations of Beer’s law 
 The linearity of the Beer-Lambert law is limited by chemical and instrumental factors. 
Causes of nonlinearity include:  
 deviations in absorptivity coefficients at high concentrations (>0.01M) due to 
electrostatic interactions between molecules in close proximity  
 scattering of light due to particulates in the sample  
 fluorescence or phosphorescence of the sample  
 changes in refractive index at high analyte concentration  
 shifts in chemical equilibria as a function of concentration  
 non-monochromatic radiation, deviations can be minimized by using a relatively flat 
part of the absorption spectrum such as the maximum of an absorption band  
 stray light  
 1.5.3.2.2 Deviations from Beer’s law 
 According to Beer‟s law, a straight line passing through the origin should be obtained, 
when a graph is plotted between absorbance and concentration. But there is always a 
deviation from linear relationship between absorbance and concentration and intact the shape 
of an absorption curve usually changes with changes in concentration of solution and unless 
precautions are observed. Deviations from the law may be positive or negative according to 
whether the resulting curve is concave upward or concave downward.                
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The latter two are generally known as instrumental deviation and chemical deviation. 
a. Instrumental deviations 
 Stray radiation, Improper slit width, Fluctuation in single beam. 
b.  Chemical deviations 
 Hydrolysis, Association, Polymerization, Ionization and Hydrogen bonding 
1.5.3.2.3 Deviations from Beer’s law can arise due to the following factors 
1. Beer‟s law will hold over a wide range of concentration provided the structure of 
coloured ion or of the coloured non electrolyte in the dissolved state does not 
change with concentration. If a coloured solution is having a foreign substance 
whose ions do not react chemically with the coloured components, its small 
concentration does not affect the light absorption and may also alter the value of 
extinction co - efficient. 
2. Deviations may also occur if the coloured solute ions dissociates or associates. 
3. Deviations may also occur due to the presence of impurities that fluorescence or 
absorb at absorption wavelength. 
4. Deviations may occur if monochromatic light is not used. 
5. Deviations may occur if the width of slit is not proper and therefore it allows 
undesirable radiations to fall on the detector. 
6. Deviations may occur if the solution undergoes polymerization. 
7. Beer‟s law cannot apply to suspensions but the latter can estimated 
calorimetrically after preparing a reference curve with known concentrations. 
1.5.3.3 Transitions in Organic Molecules                  (Gurdeep R. Chatwal, et al., 2008) 
The absorption in the ultraviolet region results in the transition of the valence electron 
form the ground level to the excited level. The three types of electrons involved in the 
transition are 
σ-electrons: These are involved in the formation of saturated bonds. The energy required for 
the excitation of the electrons is more than that of the UV radiations. Hence these electrons 
do not absorb near UV radiation. 
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π-electrons: These are involved in the formation of unsaturated bonds. 
Example: Dienes, trienes and aromatic compounds. It absorbs radiation in near UV region. 
n-electrons: These are the lone pair of electrons present in atoms such as oxygen, nitrogen 
etc., in a molecule. They can be excited by both UV and Visible radiations. 
The various types of transitions are 
σ →σ* 
 n→σ* 
π → π * 
  n→π* 
 
           σ* -------------------------------------------- Anti bonding 
 π* -------------------------------------------- Anti bonding 
 n   ---------- --------------------------------- Non-bonding 
 π   --------------------------------------------- Bonding 
 σ   --------------------------------------------- Bonding 
 Figure: Electronic Transitions 
The energy required for the various types of transitions are  
σ→σ* > n→σ* > π → π * > n→ π *  
1.5.3.3.1 σ→σ* transitions 
These transitions occur in saturated hydrocarbons with single bonds and no lone pair 
of electrons. The energy required for this type of transition is very high because of the strong 
sigma bond formed by the valence electrons. Thus, the transitions occur at very short 
wavelength. The saturated hydrocarbons such as methane, ethane, propane etc. absorbs at    
126 -135 nm region of the UV region. Hence these compounds are used as solvents in UV 
spectroscopy. 
1.5.3.3.2 n → σ* transitions 
Saturated compounds with lone pair of electrons show n→σ* transitions in addition to 
σ→σ* transitions. The energy required for the n→σ* transition is lesser than the energy 
required for σ→σ* transitions. The energy required for n→σ* transition, in alkyl halides, 
decreases with increase in the size of the halogen atom. Alcohols and amines forms hydrogen 
bonding with the solvent hence require higher energy for the transitions. 
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1.5.3.3.3 π → π * transitions 
These transitions occur in unsaturated compounds containing double or triple bonds 
and also in aromatic compounds. Lower energy is required for these transitions and hence a 
longer wavelength causes the excitation of the molecule. 
1.5.3.3.4 n→ π* transitions 
These transitions occur in compound which contains oxygen, nitrogen, sulphur and 
halogens because of the presence of free lone pair of electrons. These transitions require least 
amount of energy and hence they occur in UV and Visible region. Saturated carbonyl 
compounds shows two types of transitions, low energy n→ π* transitions occurring at longer 
wavelength and high energy n→ π* transitions occurring at lower wavelength. The shifts in 
the absorption of the carbonyl compounds are due to the polarity of the solvent. 
1.5.3.4 Transition Probability (Gurudeep R. Chatwal, et al., 2008) 
It is not essential that, when a compound is exposed to UV light, transition of the 
electron should take place. The probability that an electronic transition should take place 
depends on the value of extinction coefficient. The transitions are classified as allowed 
transition and forbidden transition. 
1.5.3.4.1 Allowed Transitions 
The transitions having εmax value greater than 10
4
 are called allowed transitions. They 
generally arise due to the π → π * transitions. For example, 1, 3 – butadiene exhibits 
absorption maximum at 217 nm and has εmax value of 21000 represents allowed transitions. 
1.5.3.4.2 Forbidden Transitions 
These transitions have εmax value less than 10
4. They occur due to n→ π* transitions. 
Example, saturated carbonyl compound (R-C=O) shows absorption near 290 nm and εmax 
value less than 100 represent forbidden transitions. 
1.5.3.5 Chromophore 
These are groups or structure which is responsible to impart colour to the compound. 
The presence of chromophore is responsible for the absorption of UV radiation by any 
compound. The groups include nitro group, amine groups, double bonds, triple bonds, etc.  
There are two types of chromophore 
 Groups containing π electrons and undergoes π → π * transitions. Example: ethylene, 
acetylenes 
 Groups containing π electrons and n electrons. They undergo two types of transition 
like π → π * transitions and n→ π* transitions. Example:- carbonyls, nitriles, azo 
compounds etc. 
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1.5.3.6 Auxochrome 
 Any groups which do not itself act as a chromophore but its presence brings a shift in 
the position of absorption maximum. Chromophores are unsaturated whereas the 
auxochromes are covalently saturated. The auxochromes are of two types 
Co-ordinately unsaturated- (NH2, -S- groups containing lone pair of electrons). 
Co-ordinately saturated- (NH3+ groups). 
1.5.3.7 Absorption and Intensity shifts 
1.5.3.7.1 Bathochromic shift or Red shift 
The shift in the absorption maximum of a compound, due to the presence of  
certain auxochromes, towards longer wavelength is called as the bathochromic shift. 
1.5.3.7.2 Hypsochromic shift or Blue shift 
The shift in the absorption maximum to shorter wavelength is called Hypsochromic 
shift. The shift is due to solvent effect or removal of conjugation in a molecule. 
1.5.3.7.3 Hyperchromic effect 
The increase in intensity of absorption by inclusion of an auxochrome to a system is 
hyperchromic shift. 
1.5.3.7.4 Hypochromic shift 
The decrease in the intensity of absorption is due to the distortion of the geometry of 
the molecule. 
1.5.3.8 Solvent Effect 
The solvent used for the spectral analysis should not interfere in the absorbance of the 
analyte. It means that the solvent should not have any absorbance in the region under 
investigation. Based on the polarity of the solvent used the intensity of the absorption 
changes for a particular analyte. The α, β – unsaturated carbonyl compounds shows two 
different types of transitions 
n→ π* transition  
The increase in polarity moves the absorption maximum to a shorter wavelength. The 
ground state is more polar when compared to the excited state. 
π → π * transitions 
The increase in polarity moves the absorption maximum to longer wavelength. Only 
lesser energy is required for this transition and hence shows red shift. 
1.5.3.9 Choice of Solvent 
There are two important requirements a solvent must satisfy to be used as a solvent in 
UV spectroscopy.  
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They are  
 It should be transparent throughout the region of UV under investigation 
 It should not interact with the solute molecules and should be less polar. 
1.5.3.9.1. Solvents used in UV spectroscopy 
S.No. Solvent Cut-off  (nm) 
1. Ethanol 205 
2. Methanol 210 
3. Acetonitrile 210 
4. Hexane 210 
5. Cyclo hexane 210 
6. Diethyl ether 220 
7. Chloroform 245 
8. Carbon tetrachloride 265 
9. Toluene 280 
 
1.5.3.10 Instrumentation                         (Gurudeep R. Chatwal et al., 2008) 
 All photometers, colorimeters and spectrophotometers have the following basic 
components 
1.5.3.10.1 Radiation source  
i) It must be stable. 
ii) It must be of sufficient intensity for the transmitted energy to be detected at  
the end of the optical path. 
iii) It must supply continuous radiation over the entire wavelength region in which it 
is used. 
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1.5.3.10.2 UV region  
  Hydrogen discharge lamp, Deuterium discharge lamp, Xenon arc Lamp 
1.5.3.10.3 Visible region 
 The tungsten lamp and tungsten halogen lamp are the most common source of visible 
radiation. 
1.5.3.10.4 Filters and monochromators 
 The filters and monochromators are used to disperse the radiation according to the 
wavelength.  
1.5.3.10.4.1 Filters  
 A light filter is a device that allows light of the required wavelength to pass but 
absorbs light of other wavelengths wholly or partially. Thus, a suitable filter can be selecting 
a desired wavelength band. It means that a particular filter may be used for a specific 
analysis. If analysis is carried out for several species, a large number of filters have to be used 
and interchanged. This method is very useful for routine analysis. 
Types of filters 
 Filters are two types, 
 i) Absorption filters 
ii) Interference filters 
 Absorption filters work by selective absorption of unwanted wavelengths and are 
made up of solid sheet of glass, coloured by a pigment or dispersed in glass and dyed gelatin. 
Interference filters work by selective transmission of selected wavelengths and they are made 
up of semitransparent metal film deposited on a glass plate and coated with dielectric material 
(MgF2). 
1.5.3.10.4.2. Monochromators  
 Monochromators successfully isolates band of wavelengths usually much more than a 
narrower filter. The essential elements of a monochromator are an entrance slit, a dispersing 
element (prim or gratings) and an exit slit. The entrance slit sharply defines the incoming 
beam of heterochromatic radiation. The dispersing element disperses the heterochromatic 
radiation into its component wavelengths where as exit slit allows the nominal wavelength 
together with a band of wavelength on either side of it. The position of the dispersing element 
is always adjusted by rotating it to vary the nominal wavelength passing through the exit slit. 
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Types of monochromator 
 1) Prisms 
 2) Gratings  
 A prism is made up of quartz (for UV region), glass (for visual range) and alkali 
halides (for IR). The main advantage of prisms is that they undergo dispersion giving 
wavelengths which do not overlap, but the main disadvantage is that they give non – linear 
dispersion.  A grating consists of large number of parallel lines ruled on a highly polished 
surface like alumina. Generally, gratings are difficult to prepare therefore, replica gratings are 
prepared from an original grating. This is done by coating the original grating with a film of 
an epoxy resin which after setting is removed to yield replica. Then replica is made reflective 
by aluminizing its surface. Gratings give linear dispersion but they suffer from an overlap of 
spectral orders. 
1.5.3.10.5 Sample cells 
These are containers for holding the sample and reference solutions and must be 
transparent to the radiation passing through generally with a thickness of 1 Cm. The choice of 
a sample cells are based on transmission characteristics at desired wave lengths, the path 
length, shape, size and the relative expense. The transmission characteristics are based on the 
construction materials. For UV region, the cells made up of quartz and for visible region, the 
cells are made of glass. 
1.5.3.10.6 Detectors 
Detectors used in UV-Visible spectrophotometers can be called as photometric 
detectors. In these detectors the light energy is converted to electrical signal which can be 
recorded. The types of detectors used are Barrier Layer cell (or) Photo Voltaic cell, Photo 
tubes (or) Photo emissive tubes, Photomultiplier tubes and Photo diode. 
1.5.7.10.6. Recorders 
 Detectors transmits the amount of light absorbed by a particular chemical species and 
only by that species is desired and by correcting the absorbance of solvent and other species 
in the solution. The recorders record the spectrum without any interferences compared with 
blank and they are user friendly. 
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Figure: Double Beam UV - Spectrophotometer 
1.5.4. Quantitative Analysis  (Beckett and Stenlake, et al., 2007) 
1.5.4.1. Quantitative Analysis of Single Component  
The assay of an analyte is done by dissolving the analyte in a suitable solvent and measuring 
the absorbance of the solution at the required wavelength. The selected wavelength is the 
absorbance maximum of the analyte in that particular solvent. The concentration of the 
analyte can be determined by 
 Use of absorptivity value 
 Use of calibration graph 
 Single or double point standardization 
1.5.4.1.1. Absorptivity Value Method 
 This method is usually followed in official books such as Indian Pharmacopoeia, 
British Pharmacopoeia etc. The advantage of the method is, the preparation of standard 
solutions of reference substance is not required for the calculation of the concentration of the 
analyte. 
1.5.4.1.2 Calibration Graph Method 
 In this method, a series of linear concentration solutions of the reference solutions are 
prepared and the value of absorbance is plotted against the concentration of the reference 
solution. From the graph the absorbance of the sample solution is plotted and the 
concentration is found. 
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1.5.4.1.3 Single Point or Double Point Standardization 
 In single point standardization, the standard and the sample solutions are prepared 
under same identical condition. Also, the standard and the sample concentration are almost 
equal. Then after the measurement of absorbance the following formula is applied to find the 
unknown sample concentration 
 
 Double point standardization is used when there is a linear but non proportional 
relationship between concentration and absorbance. The concentration of one of the standard 
is higher and the concentration of other is lower than that of the standard. 
 
1.5.4.2. Assay of Substance in Multi Component Samples 
 The spectrophotometric assay of drugs rarely involves the measurement of absorbance 
of sample containing only one absorbing component. The pharmaceutical analyst frequently 
encounters the situation where the concentration of one or more substances is required in 
samples known to contain other absorbing substances which potentially interfere in the assay. 
Alternatively, interference which is difficult to quantify may arise in the analysis of 
formulations from manufacturing impurities, decomposition products and formulation 
excipients. Unwanted absorption from these sources is termed irrelevant absorption and, if 
not removed, imparts a systematic error to the assay of the drug in the sample. 
 The basis of all the spectrophotometric techniques for multi component sample is the 
property that at all wavelengths; 
 The absorbance of a solution is the sum of absorbance‟s of the individual 
components; or 
 The measured absorbance is the difference between the total absorbance of the solution 
in the sample cell and that of the solution in the reference cell. 
  Multi component analysis is done when the sample contains more than one analyte to 
be quantified in the sample. In such methods one of the analyte may be taken as interferent 
and the absorbance of the interferent reduced to find the true absorbance of the analyte. 
Similarly the absorbance of the other analyte is found by taking the first analyte as the 
interferent. The various methods used are as follows. 
 Simultaneous equation method 
 Absorption ratio method 
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 Geometric correction method 
 Orthogonal polynomial method 
 Difference spectroscopy 
 Area under curve method  
 Absorbance ratio method 
 Derivative spectrophotometry 
1.5.4.2.1 Simultaneous equations method 
 If a sample contains two absorbing drugs (X and Y) each of which absorbs at the 
max of the other, it may be possible to determine both drugs by the technique of 
simultaneous equations (Vierodt‟s method) 
 
  
The information required is: 
a. The absorptivities of X at 1 and 2, ax1 and ax2 respectively. 
b. The absorptivities of Y at 1 and 2, ay1 and ay2 respectively. 
c. The absorbances of the diluted sample at 1 and 2, A1 and A2 respectively. 
Let Cx and Cy be the concentrations of X and Y respectively for diluted sample. 
 Two equations are constructed based upon the fact that at 1 and 2 the absorbance of 
the mixture is the sum of individual absorbances of X and Y. 
At 1 
A1 = ax1bcx + ay1bcy    (1) 
At 2 
A1 = ax2bcx + ay2bcy    (2) 
For measurements in 1 cm cells, b = 1 
Rearrange eq. (2) 
 
Substituting for cy in eq. (1) and rearranging gives 
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And 
 
 As an exercise you should derive modified equations containing a symbol (b) for path 
length, for application in situations where A1 and A2 are measured in cells other than 1 cm 
path length. 
Criteria for obtaining maximum precision, based upon absorbance ratios, have been 
suggested that place limits on the relative concentrations of the components of the mixture.  
The criteria are that the ratios 
 
should lie outside the range 0.1 - 2.0 for the precise determination of Y and X respectively, 
these criteria are satisfied only when the max of the two components are reasonably 
dissimilar. An additional criterion is that the two components do not interact chemically, 
thereby negating the initial assumption that the total absorbance is the sum of the individual 
absorbance. The additivity of the absorbance should always be confirmed in the development 
of a new application of this technique. 
1.5.4.2.2 Absorbance Ratio Method 
 The absorbance ratio method is a modification of the simultaneous equations 
procedure.  It depends on the property that, for a substance which obeys Beer‟s Law at all 
wavelengths, the ratio of absorbances at any two wavelengths is a constant value independent 
of concentration or path length.  For example, two different dilutions of the same substance 
give the same absorbance ratio A1/A2, 2.0.  In the USP, this ratio is referred to as a Q value.  
The British Pharmacopoeia also uses a ratio of absorbance at specified wavelengths in certain 
confirmatory tests of identity.  
 In the quantitative assay of two components in admixture by the absorbance ratio 
method, absorbances are measured at two wavelengths one being the max of one of the 
components ( 2) and the other being a wavelength of equal absorptivity of the two 
components ( 1), i.e., an iso-absorptive point. Two equations are constructed as described  
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above for the method of simultaneous equation (eq. (1) and eq. (2)). Their treatment is 
somewhat different, however, and uses the relationship ax = ay1 at ( 1).  
Assume b = 1 cm. 
A1 = ax1cx + ax1cY    (5) 
 
Divide each term by cx + cy and let Fx = cx/(cx + cy) and Fy = cy/(cx + cy) i.e. Fx and Fy are the 
fractions of X and Y respectively in the mixture: 
 
But Fy = 1 – Fx‟ 
 
 
 
 
QM = Fx(Qx – Qy) + Qy 
   (6) 
 Equation 6 gives the fraction, rather than the concentration of X (and consequently of 
Y) in the mixture in terms of absorbance ratios. As these are independent of concentration, 
only approximate, rather than accurate, dilutions of X, Y and the sample mixture are required 
to determine Qx, Qy and QM respectively. 
A1 = ax1 + ( cx + cY) 
 
From eq. (6) 
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                               (7) 
 
Equation 7, gives the concentration of X in terms of absorbance ratios, the absorbance of the 
mixture and the absorptivity of the compounds at the iso-absorptive wavelength.  Accurate 
dilutions of the sample solution and of the standard solutions of X and Y are necessary for the 
accurate measurement of A1 and ax1 respectively. 
1.5.4.2.3 Geometric Correction Method 
 A number of mathematical correction procedures have been developed which reduce 
or eliminate the background irrelevant absorption that may be present in samples of 
biological origin. The simplest of these procedures is the three-point geometric procedure, 
which may be applied if the irrelevant absorption is linear at the three wavelengths selected. 
Corrected absorbance, D =  
 
1.5.4.2.4 Orthogonal Polynomial Method 
 The technique of orthogonal polynomials is another mathematical correction 
procedure which involves more complex calculations than the three-point correction 
procedure.  The basis of the method is that an absorption spectrum may be represented in 
terms of orthogonal functions as follows 
A( ) = p0P0( ) + p1P1( ) + p2P2( )….pnPn ( ) 
Where, A = Absorbance  
   = Wave length 
  Po ( ), P1 ( ), P2 ( )….Pn ( ) represent the polynomial coefficient 
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Each coefficient is proportional to each other. These polynomials represent a series of 
fundamental shapes and the contribution that each shape, e.g.P2 makes to the absorption 
spectrum is defined by the appropriate coefficient, e.g. p2 for P2.  The coefficients are 
proportional to the concentration of the absorbing analyte, and a modified Beer – Lambert 
equation may be constructed: 
pj = jbc 
  For example, when b is 1 cm and concentration of the analyte (c), is in g/ dl. When 
irrelevant absorption so, present in a sample solution, the calculated coefficient (pi) comprises 
the coefficients of the analyte and of the irrelevant absorption (Z).  
  Thus, 
Pj = αjc + pj(Z) 
 Where, 
  Pj = polynomial coefficient 
  aj = proportionality constant 
  b = path length 
  c = concentration 
With the correct choice of polynomial, number of wavelengths and the wavelength interval, 
the contribution from the irrelevant absorption may be negligible. In general, a quadratic (P2) 
polynomial eliminates linear or almost linear irrelevant absorption and a cubic (P3) 
polynomial eliminates parabolic irrelevant absorption. 
 The segment of the spectrum of the drug between 1and 8 shows a minimum around 
3 and a maximum around 5. Its shape may therefore be represented by a cubic polynomial. 
The irrelevant absorption is a simple parabolic curve which does not contain a cubic 
contribution. The coefficient (P3) of the polynomial for each set of eight absorbances 
(A1……..A8) is calculated from: 
P 3 = [(-7) A1 + (+5) A2 + (+7) A3 + (+3) A4 + (-3) A5 + (-7) A6 + (-5) A7 + (+7) A8] 
Where the factors are those of an eight –point cubic polynomial obtained from standard texts 
of numerical analysis (e.g. Fischer and Yates, 1953). The contribution of the irrelevant 
absorption to the coefficient of the polynomial of the sample is eliminated  by the selection of 
these parameters, and the concentration of the drug in the sample may be calculate with 
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reference to a standard solution of the drug, from the proportional relationship that exists 
between the calculated P3 value and concentration. 
 The accuracy of the orthogonal functions procedure depends on the correct choice of 
polynomial order and set of wavelengths. Usually, quadratic or cubic polynomials are 
selected depending on the shape of the absorption spectra of the drug and the irrelevant 
absorption. The set of wavelengths is defined by the number of wavelengths, the interval, and 
the mean wavelength of the set ( max). approximately linear irrelevant absorption is  
normally eliminated using six to eight wavelengths, although many more, up to 20, 
wavelengths may be required if the irrelevant absorption contains high frequency 
components. The wavelength interval and m are best obtained from convoluted absorption 
curve. This is a plot of the coefficient (Pj) for a specified order of polynomial, a specified 
number of wavelengths and a specified wavelength interval (on the ordinate) against the m 
of the set of wavelengths. The optimum set of wavelengths corresponds with a maximum or 
minimum in the convoluted curve of the analyte and with a coefficient of zero in the 
convoluted curve of the irrelevant absorption. In favourable circumstances the concentration 
of an absorbing drug in admixture with another may be calculated if the correct choice of 
polynomial parameters is made, thereby eliminating the contribution of one drug from 
polynomial of the mixture. For, example, the selective assay phenobarbitone, combined with 
phenytoin in a capsule formulation using a six-point quadratic polynomial, has been reported. 
 The determination of the optimum set of wavelengths is readily accomplished with 
the aid of a microcomputer. A suitable exercise is to write a program to compute and plot the 
data for convoluted spectrum.  
1.5.4.2.5 Difference Spectrophotometry 
 The selectivity and accuracy of spectrophotometric analysis of samples containing 
absorbing interferants may be markedly improved by the technique of difference 
spectrophotometry. The essential feature of a difference spectrophotometric assay is that the 
measured value is the difference absorbance ( A) between two equimolar solutions of the 
analyte in different chemical forms which exhibit different spectral characteristics. 
The criteria for applying difference spectrophotometry to the assay of a substance in the 
presence of other absorbing substances are that: 
a. reproducible changes may be induced in the spectrum of the analyte by the addition of one 
or more reagents 
b. the absorbance of the interfering substances is not altered by the reagents. 
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 The simplest and most commonly employed technique for altering the spectral 
properties of the analyte is the adjustment of the pH by means of aqueous solutions of acid, 
alkali or buffers.  The ultraviolet-visible absorption spectra of many substances containing 
ionisable functional groups, e.g. phenols, aromatic carboxylic acids and amines, are 
dependent on the state of ionization of the functional groups and consequently on the pH of 
the solution. 
 The absorption spectra of equimolar solutions of Phenylephrine, a phenolic 
sympathomimetic agent, in both 0.1M hydrochloric acid (pH 1) and 0.1M sodium hydroxide 
(pH 13) are shown in figure.  The ionization of the phenolic group in alkaline solution 
generates an additional n (non-bonded) electron that interacts with the with the ring π 
electrons to produce a bathochromic shift of the max from 271nm in acidic solution to 291 
nm and an increase in absorbance at the max (hyperchromic effect).  The difference 
absorption spectrum is a plot of the difference in absorbance between the solution at pH 13 
and that at pH 1 against wavelength. It may be generated automatically using a double-beam 
recording spectrophotometer with the solution at pH 13 in the sample cell and the solution at 
pH 1 in the reference cell. At 257 and 278 nm both solutions have identical absorbance and 
consequently exhibit zero difference absorbance. Such wavelengths of equal absorptivity of 
the two species are called isobestic or iso-absorptive points. Above 278 nm the alkaline 
solution absorbs more intensely than the acidic solution and the A is therefore positive. 
Between 257 and 278 nm it has a negative value. The measure value in a quantitative 
difference spectrophotometric assay is the A at any suitable wavelength measured to the 
baseline, e.g. A1 at 1 or amplitude between an adjacent maximum and minimum, e.g. A1 
at 2 and 1. 
At 1 A = Aalk – Aacid 
 Where Aalk and Aacid are the individual absorbances in 0.1M sodium hydroxide and 
0.1M hydrochloric acid solution respectively. If the individual absorbance, and are 
proportional to the concentration of the analyte and path length, the also obeys the     Beer – 
Lambert‟s law and a modified equation may be derived. Where A is the difference 
absorptivity of the substance at the wavelength of measurement. 
 If one or more other absorbing substances are present in the sample which at the 
analytical wavelength has identical absorbance in the alkaline and acidic solutions, its 
interference in the spectrophotometric measurement is eliminated. The selectivity of the A 
procedure depends on the correct choice of the pH values to induce the spectral change of the 
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analyte without altering the absorbance of the interfering components of the sample. The use 
of 0.1M sodium hydrochloric acid to induce the A of the analyte is convenient and 
satisfactory when the irrelevant absorption arises from pH intensive substances.  
 
1.5.4.2.6 Area under the curve method 
 From the spectra obtained for calculating the simultaneous equation, the area under 
the curve were selected at a particular wavelength range for both the drugs were each drug  
have its absorption. The “X” values of the drugs were determined at the selected AUC range. 
The “X” value is the ratio of area under the curve at the selected wavelength range with the 
concentration of the component in mg/ml. These “X” values were the mean of six 
independent determinations. A set of two simultaneous equations were obtained by using 
mean “X” values. And further calculations are carried out to obtain the concentration of each 
drug present in the sample. 
1.5.4.2.7 Absorbance correction method 
 The method can be used to calculate the concentration of component of interest found 
in a mixture containing it along some unwanted interfering component. The absorption 
different between two points on the mixture spectra is directly proportional to the 
concentration of the component to be determined irrespective of the interfering component. If 
the identity, concentration and absorptivity of the absorbing interferences are known, it is 
possible to calculate their contribution to the total absorbance of a mixture. The concentration 
of the absorbing component of interest is then calculated from the corrected absorbance (total 
absorbance minus the absorbance of the interfering substance) in a usual way. The data 
required for the construction of absorbance corrected for interference are 
i. The max of the drugs should be found out by using reference standards of the 
drugs. 
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ii. The calibration curve is plotted for each drug and linearity range should be found 
out. 
iii. At one wavelength, one of the drugs shows no absorbance. Hence the other drug 
was calculated without any interference. 
iv. The absorbance values of every drug at the two wave lengths should be measured 
and the absorptivity values should be calculated. 
v. In another wavelength, the absorbance corrected for another drug and the first 
drug was determined. 
1.5.4.2.8 Derivative spectrophotometry 
 Derivative spectrophotometry involves the conversion of a normal spectrum to its 
first, second or higher derivative spectrum. The transformations that occur in the derivative 
spectra are understood by reference to a Gaussian band which represents an ideal absorption 
band. In the context of derivative spectrophotometry, the normal absorption spectrum is 
referred to as the fundamental, Zeroth order or D° spectrum. The first derivative (D
1
) 
spectrum is a plot of the ratio of change of absorbance   with wavelength against wavelength, 
i.e. a plot of the slope of the fundamental spectrum against wavelength or a plot of dA/dλ Vs 
λ. At λ2 and λ4, the maximum positive and maximum negative slope respectively in the D°. 
Spectrums correspond with maximum and a minimum respectively in the D
1
 spectrum. The 
λmax at λ3 is a wavelength of zero slope and gives dA/dλ = 0, i.e. a cross-over point, in the 
D
1
Spectrum. 
 
Figure: The zeroth (a), first (b) and second (c) derivative spectra of a Gaussian band 
The second derivative (D
2
) spectrum is a plot of the curvature of the D° spectrum  
against wavelength or a plot of d
2A/dλ2 Vs λ. The maximum negative curvature at λ3 in the 
D° spectrum gives a minimum in the D
2
 spectrum, and at λ1 and λ5 the maximum positive 
curvature in the D° spectrum gives two small maxima called „satellite‟ bands in the D2  
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spectrum. At λ2 and λ4 the wavelengths of maximum slope and zero curvature in the D° 
spectrum correspond with cross-over points in the D
2
 spectrum. 
In summary, the first derivative spectrum of an absorption band is characterized by a 
maximum, a minimum, and a cross-over point at the λmax of the absorption band. The-second 
derivative spectrum is characterized by two satellite maxima and an inverted band of which 
the minimum corresponds to the λmax of the fundamental band. As an exercise, you should 
construct third and fourth derivative spectra (i.e. plots of d
3A/d λ3 and d4A/d λ4 respectively 
against wavelength) of the fundamental spectrum. 
These spectral transformations confer two principal advantages on derivative 
spectrophotometry. Firstly, an even order spectrum is of narrower spectral bandwidth than its 
fundamental spectrum. A derivative spectrum therefore shows better resolution of 
overlapping bands than the fundamental spectrum and may permit the accurate determination 
of the λmax of the individual bands. Secondly, derivative spectrophotometry discriminates in 
favors of substances of narrow spectral bandwidth against broad bandwidth substances. This 
is because „the derivative amplitude (D), i.e. the distance from a maximum to a minimum, is 
inversely proportional to the fundamental spectral bandwidth (14‟) raised to the power (n) of 
the derivative order.  
Thus,                         D α (1/W)n 
Consequently, substances of narrow spectral bandwidth display larger derivative 
amplitudes than those of broad bandwidth substances. 
(a) The individual spectra of two components X and Y in admixture and their 
combined spectrum (b) The second derivative spectrum of the mixture showing improved 
resolution of the individual bands. 
These advantages of derivative spectrophotometry, enhanced resolution and 
bandwidth discrimination, permit the selective determination of certain absorbing substances 
in samples in which non-specific interference may prohibit the application of simple 
Spectrophotometric methods. For example, benzenoid drugs such as Ephedrine 
Hydrochloride, displaying fine structure of narrow spectral bandwidth in the region     240 - 
270 nm, are both weakly absorbing (A about 15) and formulated at a relatively low dose in 
solid dosage preparations (typically 1 - 50 mg/ unit dose). The high excepients/drug ratio and 
high sample weight required for the assay may introduce into simple Spectrophotometric 
procedures serious irrelevant absorption from the formulation excepients. Second derivative 
spectrophotometry discriminates in favour of the narrow bands of the fine structure of the 
benzenoid drugs and eliminates the broad band absorption of the excepients. All the 
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amplitudes in the derivative spectrum are proportional to the concentration of the analyte, 
provided that Beer‟s Law is obeyed by the fundamental spectrum. The measured value in a 
quantitative assay is the largest amplitude that is unaffected by the presence of other, 
absorbing components of the sample spectrophotometric methods. The enhanced resolution 
and bandwidth discrimination, increases with increasing derivative order. However, it is also 
found that the concomitant increase in electronic noise. Inherent in the generation of the 
higher order spectra, the consequent reduction of the signal-to-noise ratio, place serious 
practical limitations on the higher order spectra. 
 
Figure: (a) The individual spectra of two components X and Y in admixture and 
their combined spectrum (b) The second derivative spectrum of the mixture showing 
improved resolution of the individual bands. 
1.6. CHROMATOGRAPHY 
1.6.1. INTRODUCTION TO CHROMATOGRAPHY   (Gurudeep R. Chatwal et al, 2008) 
Chromatography (Greek words Chroma - colour, Graphos - writing) 
 Chromatography is a non- destructive procedure for resolving a multi component 
mixture of trace, minor, major constituents into its individual fractions. Different variation 
may be applied to solid, liquids, and gases. While chromatography may be applied both 
quantitatively, it is a primarily a separation tool. Chromatography is relative new techniques 
which was first invented by M.Tswett a botanist in 1906 in warsaw. Advances have since 
been made and the method is used to separate colored as well as colourless substances. 
Chromatography may be regarded as a method of separation of solutes occurs between a 
stationary phase and mobile phase. Chromatography is probably the most important signal  
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analytical techniques used today and will probably continue to be so far the foreseeable 
future.   
1.6.2. Definition of Chromatography  
 Chromatography maybe defined as a method of separating a mixture of components 
into individual components through equilibrium distribution between two phases. 
Essentially, the technique of chromatography of separation in general involves the 
rate at which the components of a mixture move through a porous medium (called mobile 
phase) under the influence of some solvent or gas (called moving phase). 
The chromatography method of separation of separation in general, involves the following 
steps 
1. Adsorption or retention of a substance or substances on the stationary phase 
2. Separation of adsorbed substances by the mobile phase 
3. Recovery of the separate substances by a continuous flow of the mobile phase; the method 
being called elution. 
4. Qualitative and quantitative analysis of the eluted substances.  
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1.6.3.TYPES OF CHROMATOGRAPHY 
 
Chromatography techniques are roughly classified on the basis of purpose for which 
they are used and method developed. The different types of laboratory techniques used in the 
separation of mixtures are grouped under an umbrella term, chromatography. The process 
through which constituents of a mixture are separated and analyzed by physical means is 
referred to as chromatography. Apart from the different criteria of classification of 
chromatography discussed below, the basic criterion is the purpose for which this process is 
carried out. On the basis of this criterion, the process of chromatography is classified into 
analytical and preparative. The former is carried out for the purpose of measuring the amount 
of an analyte present in a mixture. On the other hand, preparative chromatography is used for 
separating the components of a mixture for their further use. Depending on the techniques 
used in chromatography, the process is broadly classified as adsorption and partition 
chromatography. An attempt to explain the different types of chromatography is made 
through this article. Let us find more about the different procedures. 
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1.6.3.1. Adsorption Chromatography 
In this form of chromatography, the chemical mixtures in question are passed over an 
adsorbent bed. Different compounds present in the mixture get adsorbed on the bed at 
different rates. This process is mostly carried out for analytical separation. Adsorption 
chromatography is further divided into 'affinity' and 'ion-exchange' chromatography. 
1.6.3.2. Ion-exchange Chromatography 
The mechanism of ion-exchange which is used in this form of chromatography allows 
carrying out the segregation of analytes. This kind of segregation/separation can be 
performed in 2 different modes, i.e. planar and column. Separation of charged compounds 
like peptides, amino acids, proteins, etc. takes place through a charged stationary phase. 
1.6.3.3.Column Chromatography 
The column chromatography technique uses a set-up in which the stationary phase is 
placed in a column. There are two ways through which the stationary phase is positioned in a 
column: either it entirely fills the column or lines the walls of the column. 
1.6.3.4. Planar Chromatography 
The stationary phase is placed on a plane surface. The set-up is unlike the one used in 
column chromatography where stationary phase is placed in a column. Here, a plane surface 
is used. The plane surface could be anything from paper to glass. 
1.6.3.5. Affinity Chromatography 
The non-covalent interaction which takes place between the analyte in question and 
certain molecules is the basis of working of affinity chromatography. Purification of proteins 
bound to tags is conducted with this technique. 
1.6.3.6. Partition Chromatography 
In this separation technique, components of the given mixture are separated through 
the use of partition of a solute between two solvents. In the process, one of the solvents is 
immobilized by means of a substance present in the filter paper or column. 
1.6.3.7. Gel Filtration Chromatography 
This technique is also known as gel permeation or size exclusion chromatography. 
Molecules of the mixture in question are separated on the basis of their size. Technically 
speaking, the process of separation is carried out on the basis of hydrodynamic diameter  
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(size) of molecules. Larger molecules of the mixture are unable to enter the pores of media; 
therefore, molecules are washed out quickly. On the other hand, smaller molecules take more 
time to elute because they are able to enter the pores of media. 
1.6.3.8. High Performance Liquid Chromatography 
In this type of chromatography, separation of compounds is carried out on the basis of 
their idiosyncratic polarities. Interaction of these compounds with the stationary phase of the 
column too is considered. Equipment needed for carrying out high performance liquid 
chromatography includes a pump (used for moving the mobile phase and analyte through the 
column), stationary phase and a detector. Retention time for the analyte is also provided by 
the detector. Depending on the strength of interactions taking place between the analyte and 
stationary phase, retention time can vary. 
1.6.3.9. Gas Chromatography 
This form of chromatography uses cylinders wherein gas is stored under pressure. 
These gases do the work of carrying the solute. The carrier gas that is commonly used in this 
chromatography is helium. Flame ionization detectors and thermal conductivity are used in 
gas chromatography. There are three sub-types of gas chromatography which include the 
following: gas-liquid chromatography, gas adsorption chromatography and capillary gas 
chromatography. In gas-liquid chromatography, an inert porous solid is used as the stationary 
phase. The stationary phase used in gas chromatography is a bed formed by an adsorbent. In 
capillary gas chromatography, the adsorbents form a layer on fused silica or glass which line 
the capillary walls. 
1.6.3.10. Pyrolysis Gas Chromatography 
This method of chromatography makes use of pyrolysis i.e. decomposition of the 
sample with the help of thermal power. The process of pyrolysis is followed by the regular 
procedure of gas chromatography. Resistive heating, inductive heating and heating in 
isothermal furnace are the three methods used for carrying out pyrolysis in this technique. 
The volatile fragments formed by heating (at a temperature of 600-1000 °C) are separated by 
means of gas chromatography. 
1.6.3.11. Reverse-phase Chromatography 
This technique employs a method which is just opposite to that of normal phase 
chromatography. In reverse-phase chromatography, the stationary phase is made up of  
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hydrophobic compounds; they attract the hydrophobic compounds present in the mobile 
phase. Here, the polarity of mobile phase is reduced in order to allow the hydrophobic 
molecule to elute. The technique of chromatography which is meant for separation of 
compounds from mixtures thus, holds immense importance in fields like biochemistry, 
biotechnology and many others. An attempt to list as many types of chromatography as 
possible is made in this write-up. 
1.6.4. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY                                       
         (Sharma B.K., 2006) 
The high performance liquid chromatography is thus a method of separation in which 
the stationary phase is contained in a column, one end which is attached to a source of 
pressurized liquid eluent (mobile phase). 
The choice of mobile phase is very important in HPLC and the eluting power of the 
mobile phase is determined by it‟s over all polarity of the stationary phase and the nature of 
sample components. For normal phase separations the eluting power increases with 
increasing polarity of the solvent, but for reversed phase separations, eluting power decreases 
with increasing solvent polarity. 
1.6.4.1. Elution techniques    (Sharma B.K., 2006) 
Two types of elution techniques generally used. They are, 
i) Isocratic elution 
One particle solvent or mixture is pumped through the whole analysis. 
ii) Gradient elution 
            For some determinations the solvent composition may be altered gradually 
gradient elution system can be classified as low pressure and high pressure system. In low 
pressure gradient elution system the eluent components are miner proportion varying with 
time at low pressure and the mixture is pumped in order to be delivered at high pressure to 
the column. In high pressure gradient elution system components or mixtures of fixed 
composition are each pumped by separate pump and then mixed at high pressure in a ratio 
varying with time. 
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1.6.4.2. HPLC SEPARATION MODES  
Chromatographic 
Mode 
Abrv. Column Type Mobile Phase Application 
Reverse-phase 
chromatography 
RPC Non-polar (e.g. 
C18) 
Polar mixture of water and 
organic solvent (e.g. 
acetonitrile) 
Water-soluble 
samples 
Normal-phase 
chromatography 
NPC Polar ( e.g. 
unbonded 
silica) 
Less-polar (than stationary 
phase) mixture of organic 
solvents (e.g. hexane, ethyl 
ether, chloroform, 
methylene chloride) 
Water-insoluble 
samples, isomer 
separation, and 
preparative HPLC 
Non-aqueous 
reverse-phase 
chromatography 
NARP Non-polar (e.g. 
C18) 
Mixture of organic solvents 
(e.g. ACN + methylene 
chloride) 
Very hydrophobic 
samples 
Hydrophilic 
interaction 
chromatography 
HILIC Polar (e.g. 
silica or amide-
bonded) 
Mixture of water organic 
solvents (e.g. ACN + H2O 
Highly polar 
samples that are 
poorly retained by 
reverse-phase mode 
Ion-exchange 
chromatography 
IEC Usually an 
organic resin 
that has 
charged groups 
able to bind 
ions of 
opposite charge 
Aqueous solution of a salt 
with buffer. 
Separating 
ionizable samples, 
large biomolecules 
(e.g. proteins, 
carbohydrates) 
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Chromatographic 
Mode 
Abrv. Column Type Mobile Phase Application 
Ion-pair 
chromatography 
IPC Non-polar (e.g. 
C18) 
Polar mixture of water and 
organic solvent (e.g. ACN) 
w/ an ion-pairing reagent 
(e.g. alkylsulfonates, 
trifluoroacetic acid) that 
interacts w/ sample ions of 
oposite charge 
Acids and bases 
that are weekly 
retained by reverse-
phase 
Size-exclusion 
chromatography 
SEC Inert Aqueous or organic Large 
biomolecules, 
polymers. 
Separates by 
molecular weight. 
(http://www.justchromatography.com/chromatography/hplc-separation-modes) 
 
1.6.4.3. HPLC stationary phases                                         (Robert D. Braun, 1986) 
HPLC can be performed by using the stationary phases. Generally the stationary 
phases are packed into a stainless steel column of 10-, 15-, 25-, 50-, 100-cm length with a 
diameter which is usually between 2 and 6 mm for analytical columns. Alumina is solid 
adsorbent which is widely used as a column packing material because alumina is basic it 
retains acidic compounds. Silica gel is also used as a packing material in the form of pure 
particles and as a pellicle on a solid support. A pellicle is a thin layer or coating on a surface 
generally the pellicles used for HPLC have thickness about 1µm on glass beds which have 
diameter about 40mm. 
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1.6.4.4. Mobile phases 
In HPLC, for solid adsorbent and liquid stationary phases (both normal and reverse 
phase) mixed solvents are used as the mobile phase .Generally the mobile phase consists of a 
mixture of polar solvents such as alcohol and non-polar solvents such as hydro carbons. 
The mobile phase must be chosen so as not to interfere with the measurement by the 
detector. For example, if an UV absorption detector is used the solvent cannot absorb UV 
radiation. Mixtures of methanol, ethanol or propanol with heptane and of chloroform with 
heptane are popular choices of HPLC mobile phase. 
1.6.5. INSTRUMENTATION         (Willard et al., 1986) 
The general instrumentation for HPLC incorporates the following components:  
i. Mobile phase reservoir pump   ii. Injector 
iii. Column  iv. Detector and Data system 
 
1.6.5.1. Mobile phase reservoir pump                                                   
The mobile phase must be delivered to the column over a wide range of flow rates and 
pressures to permit the use a wide variety of organic and inorganic solvents. The pump it 
seals and all connections must be made of materials chemically resistant to the mobile phase. 
A degasser is needed to remove the dissolved air and other gases from the solvent. Another 
desirable feature is the solvent delivery system is the capability for generating a solvent 
gradient. In HPLC pump should be able to operate to at least 100atm (1500 psi). A pressure 
suited to less expensive chromatographs however, 400atm (6000psi) is a more desirable 
pressure limit.  
 
HPLC basic instrumentation (www.chromotech.com/ab/in/tech) 
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Standard HPLC pump requirements are, 
a. Flow rate range 0.01 to 100 ml/ min.  
b. Pressure range: 1 to 5000 psi. 
c. Flow rate stability not more than 1% 
d. Pressure pulsations less than 1% 
The types of pumps used are, 
1.  Reciprocating Piston Pumps 
2.  Syringe-Type Pumps 
3.  Constant-Pressure Pumps 
The common problems in pumping liquids are,  
a. Solvent degassing  
b. Corrosion 
c. Compressibility  
 1.6.5.2. Injectors                                                                               
In liquid chromatography, liquid samples may be injected directly and solid samples 
need only be dissolved in an appropriate solvent. The solvent need not be the mobile phase, 
but frequently it is judiciously chosen to avoid detector interference, column/component 
interference and loss in efficiency or all of these. It is always best to remove particles from 
the sample by filtering or centrifuging since continuous injections of particulate material will 
eventually cause blockage of injection devices or columns. Standard HPLC injector should be 
accurate in injecting volume in the range of 0.1 to 100 ml with high reproducibility and under 
high pressure (up to the 4000 psi) and should produce minimum band broadening and should 
minimize possible flow disturbances. 
 1.6.5.3. HPLC Columns 
HPLC columns are packed with very fine particles (usually a few microns in 
diameter). The very fine particles are required to attain the low dispersion that give the high 
plate counts expected of modern HPLC. Plate counts in excess of 25,000 plates per column 
are possible with modern columns because of the dispersion associated with injection valves, 
detectors, data acquisition systems and the dispersion due to the higher molecular weight of 
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real samples as opposed to the common test samples. LC columns, achieve their separation 
by exploiting the different intermolecular forces between the solute and the stationary phase 
and those between the solute and the mobile phase. The column will retain those substances 
that interact more strongly with the stationary phase than those that interact more strongly 
with the mobile phase. The main consideration with HPLC is the much wider variety of 
solvents and packing materials that can be utilized because of the much lower quantities of 
both which are required. In particular, very expensive optically pure compounds can be used 
to make chiral HPLC stationary phases and may even be used as (disposable) HPLC solvents.   
Different types of columns are used. They are, 
1.  Analytical column 
2.  Short column 
3.  Narrow bore column 
4.  Guard column 
5.  Inline filters 
Analytical column variables are as follows: 
a. Length (10-30 cm) 
b. ID (4-10 mm) 
c. Packing (many kinds) 
d. Particles sizes (3-10 μm) 
e. Most common columns 250mmx4.6mm i.e. with 5μm particle size.
 
(http://www.waters.com/webassets/cms/category/media/other_images/primer_M-
1_Columnexamples.jpg) 
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1.6.5.4. Detectors 
Optical detectors are most frequently used. Current LC detectors have wide dynamic 
range normally allowing both analytical and preparative scale runs on the same instrument. 
Basic detector requirements 
An ideal LC detector should have the following properties: 
1. Low drift and noise level (particularly crucial in trace analysis). 
2. High sensitivity. 
3. Fast response. 
4. Wide linear dynamic range (this simplifies quantification). 
5. Low dead volume (minimal peak broadening). 
6. Cell design which eliminates remixing of the separated bands. 
7. Insensitivity to changes in type of solvent, flow rate, and temperature. 
8. Operational simplicity and reliability. 
9. It should be tunable so that detection can be optimized for different compounds. 
1.6.5.4.1. On-line detectors 
A. Refractive index. 
B. UV/Visible Fixed wavelength. 
C. UV/Visible Variable wavelength. 
D. UV/Visible Diode array. 
E. Fluorescence. 
F. Conductivity. 
G. Mass-spectrometric (LC/MS). 
1.6.5.4.2. Off-line detector 
A. FTIR spiral disk monitor. 
1.6.5.6. Noise and drift 
The problem is to distinguish between the actual component and artifact caused by the 
pressure fluctuation, bubble, compositional fluctuation, etc. If the peaks are fairly large, one 
has no problem in distinguishing them. However, the smaller the peak, the more important is 
that the baseline be smooth, free of noise and drift. Baseline noise is the short time variation 
of the baseline from a straight line. Noise is normally measured "peak-to-peak": i.e., the 
distance from the top of one such small peak to the bottom of the next. Noise is the factor 
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which limits detector sensitivity. In trace analysis, the operator must be able to distinguish 
between noise spikes and component peaks. The baseline should deviate as little as possible 
from a horizontal line. It is usually measured for a specified time, e.g., 1/2 hour or one hour 
and called drift. Drift usually associated to the detector heat-up in the first hour after power-
on. 
1.6.5.7. Data systems 
The main goal in using electronic data systems is to increase analysis accuracy and 
precision while reducing operator attention. In routine analysis, where no automation is 
needed, a pre-programmed computing integrator may be sufficient. For higher control levels, 
a more intelligent device is necessary, such as a data station or minicomputer. 
The advantages of intelligent processors in chromatographs are, 
 Additional automation options become easier to implement. 
 Complex data analysis becomes more feasible. 
 Software safeguards can be designed to reduce accidental misuse of the system. 
1.6.5.8. Summary of HPLC operation                                        
1.  Filter and degas mobile phase. 
2. Prime pump, rinse column with strong solvents and equilibrate column. 
3. Purge injection and make sure there are no air bubbles in the sample syringe. 
4. Perform system suitability test. 
5. Analyze sample. 
6. Process and report data. 
7. Rinse column and shut down pump and lamps. 
1.6.7. HPLC method development     
The wide variety of equipment, columns, eluent and operational parameters involved 
makes high performance liquid chromatography (HPLC) method development seem 
complex. The process is influenced by the nature of the analytes. The different stages in 
method development was given in the following flow chart 
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HPLC Method development flow chart 
Selection of the HPLC method and initial system 
 
Selection of initial conditions 
 
Selectivity optimization 
 
System optimization 
 
Method validation 
1.6.6 Checking for problems                                                   (Lloyd et al., 1997) 
As method development proceeds, various problems can arise, some of which are 
listed below. 
Prolems Comments 
Low plate numbers Poor choice of column, poor peak shape effect. 
Column variability Poor choice of column, secondary retention effect. 
Short column life Poor choice of column, need for sample pretreatment. 
Retention drift Insufficient column equilibration, need for sample 
pre-treatment, loss of bonded phase. 
Poor quantitative 
precision 
Need for better calibration. 
1.6.8. QUANTITATIVE ANALYSIS 
          The four primary techniques for quantitation are 
a. Normalized peak area 
b. External standard calibration method 
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c. Internal standard calibration method  
d. method of standard addition 
1.6.8.1. Normalized peak area  
After completion of a run and the integration of all significant peaks in the 
chromatogram, the total peak area can then be calculated. The area percent of any individual 
peak is referred to as the normalized peak area. The technique of normalized peak area is 
actually not a calibration method per se, since there is no comparison to a known amount for 
any peak in the chromatogram. However, this technique is widely used to estimate the 
relative amounts of small impurities or degradation compounds in a purified material.  
1.6.8.2. External standard calibration method 
The most general method for determining the concentration of an unknown sample is 
to construct a calibration plot using external standards. Standards solutions are prepared at 
known concentrations. A fixed volume of each standard solution is injected and analyzed, 
and the peak responses are plotted Vs concentration. The standard solutions are referred to as 
external standards, since they are prepared and analyzed in separate chromatograms from 
those of the unknown samples. Unknown samples are then prepared, injected and analyzed 
exactly in the same manner. 
1.6.8.3. Internal standard calibration method 
 Another technique for calibration involves the addition of an internal standard to the 
calibration solutions and samples. The internal standard is a different compound form the 
analyte, but one that is well resolved in the separation. The internal standard can compensate 
for changes in sample size or concentration to instrumental variations. With the internal 
standard method, a calibration plot is produced by preparing and analyzing calibration 
solutions containing different concentration of the compound of interest with a fixed 
concentration of the internal added. 
The Internal standard comply the following requirements: 
i. Well resolved from the compound of interest and other peaks. 
ii. Similar retention (k) to the analyte. 
iii. Should not be in the original sample. 
iv. Should mimic the analyte in any sample preparation steps. 
v. Does not have to be chemically similar to analyte. 
vi. Commercially available in high purity. 
vii. Stable and unreactive with sample or mobile phase. 
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viii. Should have similar detector response to the analyte for the concentration used 
ix. It must be separated from all compounds of interest in the separation. 
1.6.8.4. Method of standard addition 
 A calibration standard ideally should be prepared in a blank matrix of drug 
formulation components without the drug substance or an animal without added compound 
usually can be used for standard calibration solutions. The method of standard addition is 
most often used in trace analysis. In this approach, different weights of analyte(s) are added 
to the sample matrix, which initially contains an unknown concentration of the analyte. 
Extrapolation of a plot of response found for the standard addition calibration concentration 
to zero concentration defines the original concentration in the unspiked sample. 
1.6.9. System Suitability Parameters (Lloyd, 1997; Beckett and Stenlake, 2007) 
System suitability testing is an integral part of many analytical procedures. The tests 
are based on the concept that the equipment, electronics, analytical operations, and samples to 
be analyzed constitute an integral system that can be evaluated as such. System suitability test 
parameters to be established for a particular procedure depend on the type of procedure being 
validated.  
The parameters that are affected by the changes in chromatographic conditions are, 
 
 
 Column capacity factor (KA) 
 Resolution (Rs) 
 Selectivity ( ) 
 Column efficiency (N) and 
 Peak asymmetry factor (As) 
 Tailing factor (T) 
 1.6.9.1. Column capacity factor (KA) 
The retention of a drug with a given packing material and eluent can be expressed as 
retention time or retention volume, but both of these are dependent on flow rate, column 
length and column diameter. The retention is best described as a column capacity ratio (K), 
which is independent of these factors. The column capacity ratio of a compound (A) is 
defined as  
0
0A
0
0A
A
t
tt
V
VV
K  
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Where, 
VA = Elution volume of A 
V0 = Elution volume of a non-retained compound (void volume) 
At constant flow rate, retention times (tA and to) can be used instead of retention 
volumes. Retention data is sometimes expressed, relative to a known internal standard (B). 
The ratio of retention times (tA/tB) can be used, but the ratio of adjusted retention times  
oB
oA
tt
tt
 is better when data need to be transferred between different chromatographs. 
The values of „k‟ of individual bands are increase or decrease with changes in solvent 
strength. In reversed phase HPLC, solvent strength increases with the increase in the volume 
of organic phase in the water / organic mobile phase. Typically an increase in percentage of 
the organic phase by 10 % by volume will decrease k‟ of the bands by a factor of 2-3.  
 
 1.6.9.2. Resolution (Rs) 
The resolution, Rs of two neighbouring peaks is defined by the ratio of the distance 
between the two peak maxima. It is the difference between the retention times of two solutes 
divided by their average peak width. For baseline separation, the ideal value of Rs is 2.0. It is 
calculated by using the formula, 
)WW(5.0
RtRt
R
21
12
f  
Where,  
Rt1 and Rt2 are the retention times of components 1 and 2  
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W1 and W2 are peak widths of components 1 and 2. 
 
 1.6.9.3. Selectivity ( ) 
The selectivity (or separation factor), , is a measure of relative retention of two 
components in a mixture. The ideal value of selectivity is 2. It can be calculated by using the 
formula,   
01
02
VV
VV
 
Where, V0 is the void volume of the column and V2 and V1 are the retention    
volumes of the second and the first peak, respectively. 
 
1.6.9.4. Column efficiency 
Efficiency, N, of a column is measured by the number of theoretical plates per meter. 
It is a measure of band spreading of a peak. Smaller the band spread, higher is the number of 
theoretical plates, indicating good column and system performance. Columns with N ranging 
from 5,000 to 100,000 plates/meter are ideal for a good system. Efficiency is calculated by 
using the formula, 
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2
16
W
Rt
N  
Where, 
Rt is the retention time and W is the peak width. 
  
1.6.9.5. Peak asymmetry factor (As) 
Peak asymmetry factor, Ascan be used as a criterion of column performance. The peak 
half width b of a peak at 10 % of the peak height, divided by the corresponding front half 
width a gives the asymmetry factor. 
a
b
AS  
1.6.9.6. Tailing factor (T) 
The tailing factor T, a measure of peak symmetry, is unity for perfectly symmetrical 
peaks and its value increases as tailing becomes more pronounced. 
In some cases, values less than unity may be observed. As peak asymmetry increases, 
integration, and hence precision becomes less reliable. 
 
Where, 
            W0.05 = width of peak at 5% height 
f = Distance from the peak maximum to the leading edge of the peak, the distance 
being measured at a point 5% of the peak height from the baseline. Limit:  ≤ 2 is 
preferable.  
1.6.9.7. Height Equivalent to a Theoretical Plate (HETP) 
A theoretical plate can be of any height, which decides the efficiency of separation. If 
HETP is less the column is more efficient. If HETP is more, the column is less efficient. The 
height equivalent to a theoretical plate (HETP) is given by 
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1.6.10. High Performance Thin Layer Chromatography (Sethi, et al., 1996)                                                                                                                                                                                                                                                                                                                                            
High Performance Thin Layer Chromatography is a versatile separation technique and 
is official in most of the Pharmacopoeias for determining content uniformity, purity profile, 
assay value and dissolution rates in unlimited number of monographs. It is precisely for these 
reasons that almost every laboratory today is equipped HPLC system. 
However, it cannot be denied that more than often, the systems are working beyond 
their capacities and mostly dedicated who would like to change a well running stabilized 
column and prepare fresh solutions only because few assorted samples even though urgent 
are required to be analyzed.  
1.6.10.1. Various Steps Involved in HPTLC 
 Selection of HPTLC plates and sorbent.  
 Samples preparation including any clean up and  
 Pre-chromatographic derivatization. 
 Application of sample.  
 Development. 
 Detection including post-chromatographic derivatization.  
 Quantification. 
 Documentation.      
1.6.10.2. Criteria for Identification of an Analyte by HPTLC 
 Rf value of an analyte should agree ± 3 % compared to standard material used under 
similar conditions. 
 Visual appearance of the analyte should be indistinguishable from that of standard 
material.  
 Centre of the spot nearest to that due to analyte should be separated from it by at least 
half the sum of analyte spot diameter. 
 For conforming the identity, co-chromatography is mandatory, as a result, only the 
spot supposed to be due to analyte should be visible and no additional spot appear. 
 Whenever spectrum detection is used, maximum absorption wavelength of the sample and 
standard should be same within limits of resolution of detection system and UV spectra 
should not be visibly different from that of the standard material. 
1.6.10.3. HPTLC Method Development 
 
Method Development for HPTLC 
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         Selection and Optimization of            Selection of Stationary Phase;  
                  Mobile phase                                   Prewashing of Layer 
 
          In situ Pre Chromatographic           Pre Conditioning /saturation of                  
                       Derivatization                                           Layer  
 
 
 
 
 
      UV-Visible /Fluorescent              Post Chromatographic  
                           Detection                                Derivatization  
 
 
 
  1.6.10.4. Factors Influencing the HPTLC Separation and Resolution of Spots 
 Type of stationary phase, its particle size and activity  
 Type of plates   
 Layer thickness 
 pH of the layer 
 Binder in the layer 
 Mobile phase 
 Solvent purity 
 Type and size of developing chamber  
 Degree of chamber saturation  
 Solvent for the sample preparation  
 Sample volume spotted 
 Size of initial spot and gradient  
 Temperature and relative humidity  
1.7. ANALYTICAL VALIDATION (PD Sethi et al., 1996) 
 Analytical validation of a pharmaceutical product or of specific ingredients within the 
product is necessary to ensure its safety/efficacy throughout all phases of its shelf life. Such 
Sample Preparation 
Application of Sample 
Development of Chromatogram 
Detection of Analyte 
Quantitative Evaluation 
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monitoring is in accordance with the specifications elaborated/validated during the product 
development. 
 Analytical method validation is the process to confirm that the analytical procedure 
employed for a specific test is suitable for its intended use. Method validation is the 
documented successful evaluation of an analytical method that provides a high level of 
assurance that such method will consistently yield result that are accurate with in previously 
established specification. 
 Analytical testing of a pharmaceutical product is necessary to ensure its purity, 
stability, safety and efficacy. Analytical method validation is an integral part of the quality 
control system.  
 Although a thorough validation cannot rule out all potential problems, the process of 
method development and validation should address the most common ones.  Analytical 
method validation ensures that the selective analytical method will give reproducible and 
reliable results adequate for intended purpose.  
1.7.1. INTRDUCTION TO VALIDATION 
The word Validation means “Assessment” of validity or action of proving 
effectiveness. Various standardizing authorities defined the term validation as follows. 
FDA defines validation as “establish the documented evidence which provides a high 
degree of assurance that a specific process will consistently produce a product of 
predetermined specifications and quantity attributes”. 
EUGMP define validation as “action of proving in accordance with the principle of 
Good manufacturing practice (GMP), that any material, activity or system actually lead to 
expected result”. 
Australian GMP defines validation as “the action of proving that any material, 
process, activity, procedure, system, equipment or mechanism used in manufacture or control 
can and will be reliable and achieve the desire and intended result”. 
The objectives of the validation are, 
 The primary objective of validation is to form a basis for written procedure for 
production and process control which are designed to assure that the drug products 
have the identity, quality, and purity they purport or are represented to possess. 
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 Assurance of Quantity. 
 Government Regulation. 
The validation is divided into different types. They are, 
1. Prospective validation 
This method is employed when historical data of the Product is not available or is not 
sufficient and in process and finished product testing is not adequate to ensure reproducibility 
or high degree of compliance to product likely attributes. 
2. Retrospective validation 
This provides trend of comparative result (i.e.) review and evaluation of existing 
information for comparison when historical data is sufficient and readily available. 
3. Concurrent validation 
Based on information generated during implementation of a system for this extensive 
testing and monitoring are performed as part of initial run of the method. 
4. Re-validation 
Revalidation provides the evidence that changes in a process and are the process 
environment, introduced either intentionally or unintentionally, do not adversely affect 
process characteristic and product quality. There are two basic categories of revalidation. 
Revalidation in case of known change. Periodic revalidation carried out at scheduled 
intervals. 
1.7.2. Analytical Parameters used in Assay Validation as per ICH Guidelines               
(Code Q2A; Q2B, ICH Guidelines 1994 and 1996; USP, 1995) 
The objective of validation of an analytical procedure is to demonstrate that it is suitable for 
its intended purpose. A tabular summation of the characteristics applicable to identification, 
control of impurities and assay procedures is included. 
 
1.7.3. Types of Analytical Procedures to be validated 
 The discussion of the validation of analytical procedures is directed to the four most 
common types of analytical procedures, 
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1.7.3.1. Identification Tests 
 Quantitative tests for impurities content. 
 Limit tests for the control of impurities. 
 Quantitative tests of the active moiety in samples of drug substance or drug product or 
other selected component(s) in the drug product. 
 A brief description of the types of tests considered in this document is provided 
below. 
 Identification tests are intended to ensure the identity of an analyte in a sample this is 
normally achieved by comparison of a property of the sample (example spectrum, 
chromatographic behaviour, chemical reactivity etc.) to that of a reference standard. 
1.7.3.2. Accuracy 
 The word accuracy refers to term trueness. It expresses the closeness between the true 
value or the reference value and the value found in the analysis. True value is the accepted 
value of the reference value. The accuracy is determined by the recovery studies. 
1.7.3.3. Precision 
 Precision expresses the degree of scatter between a series of measurement made in 
multiple sampling from the same homogenous sample. It may be considered fewer than three 
levels 
 Repeatability 
 Intermediate precision 
 Reproducibility 
The precision is expressed as Variance, standard deviation and coefficient of variation 
for a series of measurements. 
The repeatability is confirmed by a minimum of 6 estimations at 100% of test 
concentrations. The standard deviations should be less than 2. 
The intermediate precision is confirmed by inter day and intraday analysis, different 
instruments and different analyst.  
1.7.3.4. Specificity 
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 Specificity refers to the ability of the method to assess the analyte in the presence of 
other components like impurities, matrix or degradants, etc. The implications of specificity 
are 
 
Identification: To ensure identity 
Purity tests: To determine the content of impurity 
Assay: Content of the analyte in the sample 
1.7.3.5. Limit of Detection 
 It is the lowest amount of an analyte that can be detected by the analytical procedure 
but cannot be quantified exactly. 
The LOD is performed based on the following parameters 
 Based on visual examination 
 Based on signal to noise ratio 
 Based on the standard deviation and slope value. 
The visual examination is done by analysing the sample with known quantity of 
standard and by establishing the minimum level at which the analyte can be detected. 
A signal to noise ratio of 3 o 2.1 is considered as acceptable value for calculating the 
detection limit. 
Based on slope and standard deviation values, Detection limit can be calculated by 
using the formula, 
 
Where, 
 σ = the standard deviation of the response 
S = the slope of the calibration curve (of the analyte) 
1.7.3.6. Limit of Quantitation 
 The lowest amount of the analyte which can be quantified by an analytical method 
with precision and accuracy is the limit of quantification. 
Three approaches are made for determining the quantification limit. They are similar to that 
of determining the detection limit.  
 Based on visual examination 
 Based on signal to noise ratio 
 Based on slope and standard deviation value 
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Where, 
 σ = the standard deviation of the response. 
 S = the slope of the calibration curve (of the analyte). 
1.7.3.7. Linearity 
 Linearity is the ability of an analytical method to obtain results which are directly 
proportional to the analyte concentration within a given range. The linearity is evaluated as a 
plot of signals as a function of analyte concentration. The statistical parameters such as the 
slope, intercept, regression equation and correlation coefficient are calculated. For 
establishing of linearity, a minimum of 5 concentrations is required. 
1.7.3.8. Range 
 It is the interval between the lower and upper limit of concentration in a sample for 
which the analytical method has suitable precision, accuracy and linearity. The minimum 
range considered for the assay of drug or finished product is form 80 to 120 percent of the 
test concentration. 
1.7.3.9. Robustness 
 It is the ability of an analytical method to remain unaltered by small but deliberate 
variations in various parameters of the method and indicate its reliability. The typical 
variation includes stability of analytical solutions and extraction time. In case of HPLC, the 
change in the ratio of mobile phase, flow rate, variation of pH of the solution are done for 
determining the robustness of the method. 
1.7.4. Complete Method Development and Validation Parameters 
 
 
52 
 
Acceptance criteria of validation 
 
S.No. Characteristics Acceptance Criteria 
1 
Accuracy Recovery 98-102% with 80,100,120% spiked sample. 
2 Precision RSD < 2% 
2a Repeatability RSD < 2% 
2b 
Intermediate Precision RSD < 2% 
3 
Specificity/ Selectivity No interference 
4 Detection Limit S/N > 2 or 3 
5 
Quantification  Limit S/N > 10 
6 Linearity r > 0.999 
7 Range 80-120% 
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1.8. BASIC STATISTICAL PARAMETERS  
 (Gupta, et al., 1995; Bolton, et al.,2004; Mendham, et al., 1994)   
 Statistical techniques have been widely used in many diverse areas of scientific 
investigation. Statistical applications have been recognized as crucial to quality control 
procedure, test, specification and definitions. Principle of modern analytical techniques and 
skill in their application are necessary attribute of the successful pharmaceutical analyst, thus 
does not ensure the satisfactory solution of all the problem that may encountered. Some 
auxiliary knowledge methods those can aid the analyst in designing experiment, collecting 
data, and interpreting the result. 
1.8.1 Linear Regression 
 Linear regression is a statistical technique that defines the functional relationship 
between two variables by best-fitting straight line.  Once a linear relationship has been shown 
to have a high probability by the value of the correlation coefficient „r‟, then the best straight 
line through the data points has to be estimated. This can often be done be done by visual 
inspection of the calibration graph, but in many cases it is far more sensible to evaluate the 
best straight line by linear regression (the method of least squares). 
The equation of straight line is  
y = mx + c 
Where, y the dependent variable is plotted as result of changing x, the independent variable. 
         To obtain the regression line „y on x‟ the slope „m‟ of the line and the intercept „c‟ on 
the y axis are given by the following equation. 
        and       
1.8.2 Correlation Coefficient (r) 
         It is a procedure commonly used to characterize quantitatively the relationship between 
variable. Correlation is related to linear regression.  To establish whether there is a linear 
relationship between two variables x1 and y1, use Pearson‟s correlation coefficient r. 
 
  Where n is the number of data points. 
 The value of r must lie between +1 and -1, the nearer it is to +1, the greater the 
probability that a definite linear relationship exists between the variables x and y, values 
close to +1 indicate positive correlation and values close to -1 indicate negative correlation 
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values of „r‟ that tend towards zero indicate that x and y are not linearly related (they made be 
related in a non-linear fashion). 
1.8.3 Standard Deviation (SD) 
          It is commonly used in statistics as a measure of precision statistics as a measure of 
precision and is more meaningful than is the average deviation. It may be thought of as a 
root-mean-square deviation of values from their average and is expressed mathematically as 
                                             1N
xx
S
ni
1i
i
 
Where, 
S is standard deviation. 
If N is large (50 or more) then of course it is immaterial whether the term in the 
denomination is N -1 or N  
Σ       = sum 
x       = Mean or arithmetic average. 
x -x  = deviation of a value from the mean. 
N      = Number of observations. 
1.8.4 Percentage Relative Standard Deviation (%RSD) 
 It is also known as coefficient of variation (CV). It is defined as the standard deviation 
(SD) expressed as the percentage of mean. 
                                         C 100
x
S.D
RSD  %or  V
 
          Where,  
SD   = the standard deviation, 
x       = Mean or arithmetic average. 
 The variance is defined as S
2
 and is more important in statistics than S itself.  
However, the latter is much more commonly used with chemical data. 
1.8.5 Standard Error of Mean (SE) 
 Standard error of mean can be defined as the value obtained by division of standard 
deviation by square root of number of observations. It is mathematically expressed as  
n
S.D.
S.E.  
   Where, 
            SD = Standard deviation. 
                           n = number of observation 
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1.8.6 Confidence Interval (CI) 
 A confidence interval gives an estimated range of values which is likely to include a 
unknown population parameter, the estimated range being calculated from a given set of 
sample data. A confidence interval with a particular confidence level (95% selected by the 
user) is intended to give the assurance that, if the statistical model is correct then the interval 
could deliver the true value. 
Confidence interval for a normal population, 
   
Where  
     = Sample mean 
            = upper  critical value of standard normal distribution 
    N = Size of sample  
    σ = Standard deviation 
1.9. QUALITY AND THE ANALYTICAL PROBLEM 
 The general approach to quality encompasses both the basic and the practical side and 
their mutual complementary relationships. Analytical chemical quality has two additional 
components namely: (i) Metrological features, which include capital (accuracy, traceability, 
uncertainty) and basic analytical properties (precision, sensitivity, selectivity); and (ii) the 
analytical problem- solving process, which is related to capital and basic properties, and also 
to productivity- related properties (expeditiousness, cost- effectiveness, personnel-related 
factors). The basic and applied sides of quality in general and the analytical problem in 
particular are mutually related. 
 Properly solving analytical problems in order to ensure client satisfaction is thus an 
essential ingredient of analytical quality. At present, analytical quality is frequently identified 
almost soley with the metrological side. It is widely accepted that “no quality is to be 
expected unless the objectives are properly defined”; in fact, the analytical problem provides 
analytical chemists with such objectives. Also, “quality is the concern of us all rather than a 
few”. It is therefore essential to have analytical laboratories systematically plan and solve 
analytical problems if integral analytical quality is to be achieved; this entails breaking some 
traditional barriers of analytical chemistry. 
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Five General Steps Involving in Planning and Solving Analytical Problems 
1.10.  ANALYTICAL ERRORS (Kellner et al., 2004) 
 Analytical information can be classified in to three major groups according to its 
nearness to the true value. Further classification allows one to establish the so-called 
“Chemical metrological hierarchy” 
 Analytical errors can be defined as alterations of the analytical information delivered, 
i.e. as differences between the true values or held as true and the parameters on the other 
levels of the metrological hierarchy, and also as differences between results. An analytical 
error can arise both from an analytical result and analytical process. It can be expressed in 
absolute or relative terms. There are three main types of analytical errors are random error, 
systemic error and gross error. 
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1.10.1. Types of Analytical Errors 
Differences between types 
of errors 
Types of Errors 
Random Systematic Gross 
Source Indeterminate Determinate (well defined) 
References for definition 
Means of a set 
( , ‟) 
True value (xˆ) 
value held as true (xˆ) 
 
Sign 
Unpredictable   
(+) and (-) 
Unique                                               
(+) or ( -) 
Relative Magnitude (in 
general terms) 
Small Small Large 
Analytical properties 
involved 
Precision 
Accuracy 
Uncertainty (traceability) 
 
 
 
 
 
 
 
 
 
 
 
 
 
LITERATURE  
REVIEW
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2. LITERATURE REVIEW 
2.1 DRUG PROFILE 
2.1.1 Telmisartan 
 (BP,2009; The Merck Index, 2006; Clarks Analysis of Drugs and Poisons, 2004;              
www.rx list.com; www.caymanchem.com/catalog/11615, www.guidechem.com) 
Molecular Structure  
                           
Chemical Name 
 4 -[(1,4 -Dimethyl-2-propyl[2,6 -bi-1H-benzemidazole]-1 -yl)methyl]-[1,1 -biphenyl]-
2-carboxylic acid. 
Molecular Formula 
 C33H30N4O2 
Molecular Weight  
 514.6 
Category 
 Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of 
hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to 
the angiotensin II (AT1) receptors with high affinity, causing inhibition of the action of 
angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood 
pressure. 
Description 
 White or slightly yellowish, crystalline powder. 
Solubility 
  Soluble in strong base, sparingly soluble in strong acid (except hydrochloric acid), 
sparingly soluble in methylene chloride, slightly soluble in methanol, practically insoluble in 
water.  
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Identification 
1. Melting Point 
Standard Value Observed Value* 
261º - 263ºC 262.3ºC 
(*Average of six observations) 
2. IR spectrum was recorded and shown in figure 1 
Storage 
 Stored in cool dry place (25
0 
C), the bottles should be tightly closed 
pKa value 
 3.83 
Pharmacology Description 
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of 
hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to 
the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action 
of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial 
blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma 
agonistic properties that could potentially confer beneficial metabolic effects. 
Mechanism of Action 
Telmisartan interferes with the binding of angiotensin II to the angiotensin II AT1-
receptor by binding reversibly and selectively to the receptors in vascular smooth muscle and 
the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis 
and release of aldosterone, blockage of its effects results in decreases in systemic vascular 
resistance. Telmisartan does not inhibit the angiotensin converting enzyme, other hormone 
receptors, or ion channels. Studies also suggest that telmisartan is a partial agonist of PPARγ, 
which is an established target for antidiabetic drugs. This suggests that telmisartan can 
improve carbohydrate and lipid metabolism, as well as control insulin resistance without 
causing the side effects that are associated with full PPARγ activators.  
Pharmacodynamic 
Telmisartan is an orally active nonpeptide angiotensin II antagonist that acts on the 
AT1 receptor subtype. It has the highest affinity for the AT1 receptor among commercially 
available ARBS and has minimal affinity for the AT2 receptor. New studies suggest that 
telmisartan may also have PPARγ agonistic properties that could potentially confer beneficial 
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metabolic effects, as PPARγ is a nuclear receptor that regulates specific gene transcription, 
and whose target genes are involved in the regulation of glucose and lipid metabolism, as 
well as anti-inflammatory responses. This observation is currently being explored in clinical 
trials. Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-
converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the 
renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis 
and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium. Telmisartan 
works by blocking the vasoconstrictor and aldosterone secretory effects of    angiotensin II. 
Pharmacokinetics 
Absorbtion 
Absolute bioavailability depends on dosage. Food slightly decreases the 
bioavailability (a decrease of about 6% is seen when the 40-mg dose is administered with 
food). Rapidly absorbed. Dose dependent bioavailability 42% (after 40 mg dose); 58% (after 
160-mg dose). Peak plasma concentrations: 0.5-1 hours. 
Distribution 
Telmisartan is more than 99.5% protein bound.  
Metabolism 
Minimally metabolized by conjugation to form a pharmacologically inactive 
acylglucuronide; the glucuronide of the parent compound is the only metabolite that has been 
identified in human plasma and urine. The cytochrome P450 isoenzymes are not involved in 
the metabolism of telmisartan. 
Elimination 
 Either intravenous or oral administration of telmisartan, most of the administered dose 
(>97%) was eliminated unchanged in feces via biliary excretion; only minute amounts were 
found in the urine (0.91% and 0.49% of total radioactivity, respectively). 
Adverse Effects 
 Upper respiratory track infection, dizziness, back pain, sinusitis, pharyngitis and 
diarrhoea. Slight elevations in liver enzymes. 
Potentially Fatal: Rarely angioedema, rash, pruritus and urticaria. 
Drug Interactions 
Acetyl salicylic acid, amiloride, celecoxib, diclofenac, diflunisal, fenoprofen, 
drospirenone, flurbiprofen, ketoprofen above the drugs interacts with telmisartan, may 
increase the risk of acute renal failure and hyperkalemia.  
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Toxicity 
Intravenous LD50 in rats is 150-200 mg/kg in males and 200 to 250 mg/kg in females. 
Acute oral toxicity is low: no deaths and no changes occurred in rats or dogs at 2000 mg/kg, 
the highest dose tested. Limited data are available with regard to overdosage in humans. The 
most likely manifestations of overdosage with telmisartan would be hypotension, dizziness 
and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation. 
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2.1.2 CHLORTHALIDNE  
 (BP, 2009; USP, 2009; Martindale The Extra Pharmacopeia, 1993; The Merck Index, 2006. 
Analytical Profile of Drug Substance, 2005.) 
 Molecular Structure 
                       
Chemical Name 
 2-chloro - 5 (2, 3, dihydro,-1-hydroxy-3-oxo-1H-isoindol-1-yl) benzene 
sulphonamide. 
Molecular Formulae 
 C14H11Cl N2O4S 
Molecular Weight 
 338.77 g/ mol 
Category 
          Chlorthalidone is diuretic, it indicated in the management of hypertension as sole 
therapeutic agent or in combination with other antihypertensive drugs. It is used as adjunctive 
therapy in the treatment of edema associated with heart failure, hepatic cirrhosis. It has also 
been found useful in the edema due to various forms of renal dysfunction such as nephrotic 
syndrome. 
             Chlorthalidone has been used in the treatment of premenstrual tension if there is 
evidence of fluid retention. It may prevent renal calculus formation in patients with 
hypercalciuria. 
Description 
 White or yellowish-white crystalline powder. 
Solubility 
 Practically insoluble in water, in ether, and in chloroform; slightly soluble in in 
alcohol; soluble in methyl alcohol and in acetone; soluble in solutions of alkali hydroxides. 
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Identification 
1. Melting Point 
 
 
 
(* Average of six observations) 
2. IR spectrum was recorded and shown in figure.2 
Storage 
Stored in well closed container below 40
 
C   
pKa value 
 9.4 
Mechanism of Action 
Chlorthalidone inhibits sodium ion transport across the renal tubular epithelium in the 
cortical diluting segment of the ascending limb of the loop of Henle. By increasing the 
delivery of sodium to the distal renal tubule, Chlorthalidone indirectly increases potassium 
excretion via the sodium-potassium exchange mechanism. 
Pharmacodynamics 
             The diuretic effect of the drug occurs within two hours after an oral dose and 
continues for up to 72 hours. It produces copious loss of electrolytes, and consequently, of 
water. The site of action is the distal renal tubul. The hypotensive effect is also due to a 
reduction in peripheral resistance observed mainly in chronic use. 
Pharmacokinetics 
Absorbtion 
 Chlorthalidone is erratically absorbed from the gastrointestinal tract.  Bioavailability 
after oral administration is approximately 65% peak blood concentrations being attained after 
8 to 12 hours. Chlorthalidone crosses the placental barrier and passes into breast milk 
Distribution  
  The volume of distribution of chlorthalidone is 3.9 ± 0.8 l/ kg About 75% is bound 
to plasma protein and the blood-to-plasma ratio is 72.5%. And crosses the placenta. 
 Metabolism 
Metabolized in Liver  
 
 
 
 
Standard Value Observed Value* 
218
o
-220ºC 218ºC 
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  Elimination 
 During long-term administration, 30 to 60% has been reported to be excreted 
unchanged in the urine. The urinary excretion after 50 and 100 mg doses.  The clearance of 
chlorthalidone is 1.6 ± 0.3 ml/ min/ kg, and decreases with age and at greater doses.   
       Chlorthalidone is excreted in breast milk.   
   Adverse Effects 
Hypotension, Vasculitis, Electrolytes abnormal, Hyperglycemia, Hyperuricemia, 
Diarrhea, Loss of appetite, Nausea, Vomiting, Dizziness, Headache, Paresthesia, Cardiac 
dysrhythmia (rare), Pulmonary edema (rare). 
Drug interactions 
Deslanoside, diazoxide, digitoxin, digoxin, dofetilide, lithium, tenoxicam, trandolapril, 
treprostinil 
Toxicity 
Symptoms of overdose include nausea, weakness, dizziness and disturbances of 
electrolyte balance. 
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2.2. REPORTED METHODS 
1. AjitPandeyet al., (2011), reported “UV- Spectrophotometric method for estimation of 
Telmisartan in bulk and tablet dosage form”. UV Spectrophotometric method has been 
developed and validated for the estimation of Telmisartan in bulk and tablet dosage form.  
The zero order spectra of telmisartan in 0.1 M sodium hydroxide shows λmax at 234.0 nm 
calibration graph was found to be linear over the concentration range 4-24μg/ ml. 
2. AkifulHaque.Met al., (2012), reported “Simultaneous Estimation of Atenolol and 
Chlorthalidone as Bulk and in Tablet dosage Form Using UV-spectrophotometry”. UV 
Spectrophotometric method has been developed for the simultaneous estimation of atenolol 
and Chlorthalidone in bulk and its combined tablet dosage form. The stock solutions were 
prepared in methanol followed by further required dilution with methanol. The absorbance 
maxima of atenolol and Chlorthalidone were found to be 225 nm and 284 nm respectively. 
Beer law obeyed the concentration range of atenolol is 10-60 μg/ ml  and chlorthalidone is 
30-140 μg/ ml . 
3. AshaB.Thomaset al., (2010), reported “SimultaneousSpectrohotometric Estimation of 
Amlodipine Besylate and Telmisartan in Tablet Dosage Form”.First method involves 
determination using the simultaneous equation method, the sampling wavelength selected are 
364.5 nm and 252.5 nm over the concentration range of 1-50 μg/ ml  and 10-50 μg/ ml  for 
Amlodipine besylate and Telmisartan, respectively. The second method is the Area under 
Curve method, the sampling wavelength range selected are 366.5-362.5 nm and              
256.5-252.5 nm with the linearity concentration range of 1-50 μg/ ml and 10-80 μg/ ml for 
Amlodipine besylate and Telmisartan respectively. The third method using the 
multicomponent mode method, the sampling wavelength selected are 364.5nm and 254.5 nm 
over the concentration range of 1-0 μg/ ml and 10-80 μg/ ml for Amlodipine besylate and 
Telmisartan respectively.  
4. Bankey S et al., (2009), reported “Simultaneous Determinaton of 
RamiprilHydrochlorthizide and Telmisartan by Spectrophotometry”.The 
multicomponent mode analysis method has been developed for simultaneous determination 
of ramipril,hydrochlorothiazide and telmisartan in tablet formulation. The wavelength 
selected for these drugs were 218 nm, 271 nm, and 296 nm, respectively using methanol as 
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solvent.the linearity for these drug at all the selected wavelength lies between 0.5-3.5 μg/ ml 
for Ramipril, 1.25-8.75 μg/ ml  for Hydrochlorthiazide and 4-28 μg/ ml for Telmisartan. 
5. BhaskaraRajuet al., (2011), reported “Novel HPLC Method Development Validation 
and Estimation of Telmisartan in Bulk and Its Pharmaceutical Formulation”. Separation 
of drug was achieved on reverse phase C8 column using acetonitrile and phosphate buffer  
(pH 3.0) as mobile phase in the ratio of 60:40 v/v, with the flow rate of 0.9 ml/ min at 229 nm 
as detection wavelength the linearity was observed in the range of 20-60 μg/ ml with 
correlation coefficient of 0.9996. 
6. Bhatia NM.et al., (2010), reported “Development and Validation of Spectrophotometric 
and Ion Pair Chromatographic Techniques for Estimation of Telmisartan and 
Hydrochlorothiazide”. The first method involves multiwavelength spectrophotometric 
estimation where interference due to hydrochlorothiazide at 286 nm (wavelength for the 
estimation of telmisartan) and 308 nm whereas interference of telmisartan at 262 nm 
(wavelength for the estimation of hydrochlorothiazide) was removed by recording absorbance 
difference at 262 nm and 282 nm. Linearity of the response was demonstrated by telmisartan 
in the concentration range of 5-35 μg/ ml and the concentration range of 3-21 μg/ ml for 
hydrochlorothiazide with correlation coefficient of 0.9995 and 0.9992 for telmisartan and 
chlorothiazide. The second method utilize ion pair chromatography on a HIQ Sil ODS 
column, using mobile phase as Methanol: 0.0025M orthophosphoric acid in the ratio        
70:30 v/v at  pH 4.6 containing 0.1% 1- hexane Sulphonic acid monohydrate sodium salt as 
mobile phase with UV detection at 259 nm over a concentration range of 20-120 μg/ ml for 
telmisartan and 12.5-75 μg/ ml for hydrochlorothiazide, Losartan  Potassium was used as the 
internal standard.  
7.Brijesh Singhet al., (2009), reported “A Reversed- Phase High Performance Liquid 
Chromatographic Method for Determination of Chlorthalidone in Pharmaceutical 
Formulation”. The method was carried out on reverse phase C18 column using mixture of 
Acetonitrile, Methanol, and 50mM dihydrogenphosphate in the ratio of 05:30:70 v/v, pH 
adjustedto 3.5 with orthophosphoric acid as mobile phase. Hydrochlorothiazide was used as 
international standard. The detection was carried out by UV- Detector at 220 nm. The 
calibration was found tobe linear in the range of 0.1to3.2 μg/ ml.   
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8. Elshanawane AAet al., (2009), reported “Development and Validation of a Reversed –
Phase High-Performance liquid chromatographic method for the simultaneous 
determination of amiloride hydrochloride, atenolol, hydrochlorothiazide and 
chlorthalidone in their combined mixtures”. The method was developed for the 
simultaneous determination of 2 ternary mixtures containing amiloride hydrochloride, 
atenolol, hydrochlorothiazide and chlorthalidone usingCyanopropyl column, the mobile 
phase consisted of 10mM KH2PO4 Buffer pH 4.5 and Methanol in the ratio of 75:25 % v/v, at 
the flow rate 1 ml/min. Uv detector was operate 275 nm. Calibration graphs were linear in the 
concentration ranges of 2-10μg/ml, 20-200 μg/ ml, 10-100 μg/ ml and 5-50 μg/ ml for 
amiloride hydrochloride, atenolol, hydrochlorothiazide and chlorthalidone, respectively.   
9.Faimida Jahan et al., (2012), reported “Simultaneous Estimation of Telmisartan and 
Cilinidipine in solid dosage form”. Spectrophotometric method (Vierodts method), was 
developed and validated for the determination of cilinidipine and telmisartan in tablet dosage 
form. In developed method cilinidipine and telmisartan were quantified using their 
absorptivity values at selected wavelength,viz., 350 nm and 294 nm respectively.   
10.Jat R.K. et al., (2012), reported “Quantitative Estimation of Telmisartan in Bulk Drug 
and Tablets by UV Spectroscopy”.Spectrophotometer method has been developed for the 
assay of  Telmisartan in bulk drugs and tablets. Telmisartan shows maximum absorbance at 
216 nm. Beer‟s law was obeyed in the concentration range of 5-25 μg / ml. With correlation 
coefficient of 0.999.  
11. Kalyan Kumar B. et al., (2011), reported “Development and Validation of RP-HPLC 
Method for Simultaneous Estimation of Ramipril, Telmisartan and 
Hydrochlorothiazide in Pharmaceutical dosage Forms”. Isocratic high performance liquid 
chromatographic method was developed and validated for the determination of 
Hydrochlorothiazide, Ramipril and Telmisartan in tablet formulation. The method employs 
waters HPLC system on XTerra RP8 column and flow rate 0.8 ml/ min with load of 20 μl. 
Acetonitrile and Phosphate buffer (pH 3.0) was used as mobile phase in the composition 
45:55 the detection was carried out at 215 nm. Linearity ranges for Hydrochlorothiazide, 
Ramipril and Telmisartan were 12.5-22.5 μg /ml, 5-9 μg/ ml, and 40-72 μg / ml respectively. 
Retention time of Hydrochlorothiazide, Ramipril, Telmisartan were found to be 2.83, 3.65 
and 5.03min, respectively. 
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12.Kondawar M.S. et al.,(2011), reported “UV Spectrophotometric Estimation of 
Amlodipine besylate and Telmisartan in Bulk Drug and Dosage Form by 
Multiwavelength Analysis”. The Spectrophotometric method has been developed for the 
simultaneous estimation amlodipine besylate and telmisartan in combined table dosage 
forms. The tablet is determined by the multi-wavelength technique at the wavelength of      
360 nm and 298 nm over the concentration ranges of 15-75 μg/ ml and 1-10 μg/ ml using 
methanol as solvent. 
 
13. Kumbhar S.T. et al., (2011), reported “Visible Spectrophotometric Determination of 
Telmisartan from Urine”. This method can find application in clinical studies and 
therapeutic drug monitoring. This method of colorimetric estimation of yellow coloured 
chromogen when its react with alizarin in presence of thionyl chloride. The concentration of 
telmisartan over a range of 10-60 μg/ ml. The yellow coloured complex has absorption 
maxima at 427 nm.   
14. Kumar G.S. et al., (2012), reported “Development and Validation of RP-HPLC 
method for Simultaneous Estimation of Atenolol and Chlorthalidone from 
Pharmaceutical Formulation”. A HPLC method has been developed and validated for the 
simultaneous estimation of Atenolol and Chlorthalidone in marketed formulation. The 
determination was carried out on an XTerra RP column using a mobile phase of containing 
Methanol: Potassium dihydrogen Phosphate buffer (50:50v/v adjusted to pH 3.4) with flow 
rate 0.5ml/ min UV detection at 240 nm. The retention time for Atenolol was 3.2 min and for 
Chlorthalidone 5.0 min. Atenolol and Chlorthalidone showed a linear response in the 
concentration range of 50-150 μg/ ml. The correlation coefficient for Atenolol and 
Chlorthalidone was 0.9996.   
24. Kurade V.P. et al., (2009), reported “RP-HPLC Estimation of Ramipril and 
Telmisartan in Tablets”. The separation was achieved by Genesis C18 column having 
dimensions of 4.6×250 mm and particle size of 5 μm in isocratic mode, with mobile phase 
containing a mixture of 0.01 M potassium dihydrogen phosphate buffer (adjusted to pH 3.4 
using ortho phosphoric acid): methanol : acetonitrile (15:15:70 v/v/v) was used. The mobile 
phase was pumped at a flow rate of 1.0 ml/ min and the eluents were monitored at 210 nm. 
The selected chromatographic conditions were found to effectively separate Ramipril          
(Rt: 3.68 min) and Telmisartan (Rt: 4.98 min) having a resolution of 3.84.   
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16. Lakshmi KSet al., (2010), reported “Design and Optimization of a Chemometric-
Assisted Spectrophotometric Determination of Telmisartan and Hydrochlorothiazide in 
Pharmaceutical Dosage Form”. The chemometric methods applied were principle 
component regression and partial least square. These approaches successfully applied to 
quantity the two drugs in the mixture using the information include in the UV absorption 
spectra of appropriate solution in the range of 200 – 350 nm.  
17. Leena R. Bhatet al., (2007), reported “Validated RP-HPLC Method for the 
Simultaneous Determination of Telmisartan and Hydrochlorothiazide in 
Pharmaceutical Formulation”. The mobile phase consisted of Acetonitrile: Methanol 
(30:70 v/v) at flow rate 1ml/ min and wavelength detection was 270 nm. Rabeprazole was 
used as an internal standard. The retention time for telmisartan, hydrochlorthiazide and 
rabeprazole were 1.79, 2.80 and 3.19 minutes, respectively.  
18. Luz Luis M. et al.,(1999),reported “Simultaneous Determination of Chlorthalidone 
and Spironolactone with Univariate and Multivariate Calibration: Wavelength Range 
Selection ”.Univariate Calibration was performed by the Zero-crossing and Derivative ratio 
spectrum methods. Extensive spectral overlap and the Scarcityo of wavelength in derivative 
spectra allowing one analyte to be distinguished and quantitated in the presence of the other 
gave rise to poor results that called for multivariate calibration. 
19.MadhuBabuKasimala. et al., (2012), reported “Reverse Phase –HPLC Method 
Development and Validation for the  Simultaneous Estimation of Azilsartanmedoxomil 
and chlorthalidone in pharmaceutical Dosage Forms”.The method is isocratic elution at 
flow rate of 0.9ml/ min was employed on a summary C18 column at ambient temperature. The 
mobile phase consisted acetonitrile; methanol: water: 0.1% orthophosphoric acid at the ratio 
of 15:30:15:5 (v/v/v/v). The UV detection wavelength was 251nm. The retention time for 
Chlorthalidone was 3.923 min and Azilsartanmedoxomil was 7.208 min. 
20. Mayurmodi.et al., (2012), reported “Development and Validation of 
Spectrophotometric Methods for simultaneous Estimation of Metoprolol succinate and 
Telmisartan in Combined Pharmaceutical Formulation”. Four spectrophotometric 
methods have been developed for simultaneous analysis of Metoprolol succinate and 
Telmisartan in Combined Pharmaceutical Formulation. Simultaneous equation method 
employs using two wavelengths 230.2 nm for metoprolol succinate, 237 nm for telmisartan.  
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First derivative Q-absorbance equation method. It involves, formation of Q-absorbance 
equation at 231.8 nm is absorptive point, 231.8 nm for Telmisartan in first derivative method. 
Absorbance correction method, involves measurement of corrected absorbance at 296.6 nm 
for Telmisartan and measurement of corrected absorbance at 223 nm for metoprolol 
succinate. Combination of first derivative dual wavelength, which uses the difference in 
absorbance at 282.4 nm 284.6 nm for estimation of Metoprolol succinate for zero crossing 
and 330 nm for estimation of Telmisartan in first derivative spectra. The calibration graph 
follows beer‟s law in the range of 3-20 µg/ ml for Metoprolol succinate and 4-16 µg/ ml for 
Telmisartan with R square value greater than 0.999. 
21. Mhaske R A et al., (2012), reported “RP-HPLC Method for Simultaneous 
Determination of Amlodipine , Valsartan, Telmisartan, Hydrochlorothiazide and 
Chlorthalidone: Application to Commercially available Drug Products ”. The separation 
was achieved on Cosmosil PAQ 4.6×150 mm and particle size of 5 μmcolumn with gradient 
flow.The mobile phase at a flow rate of 1ml /min consisted of 0.05M Sodium dihydrogen 
phosphate buffer and acetonitrile (gradient ratio) The UV detection was carried out at 220nm.  
22. Mhaske R A et al., (2012), reported “RP-HPLC Method for Simultaneous 
Determination of Atrovastatin Calcium, olmisartan medoxomil, Candesartan, 
Hydrochlorthiazide and Chlorthalidone : Application to Commercially available Drug 
Products ”. The separation was achieved on Cosmosil PAQ 4.6×150 mm and particle size of 
5 μm column with gradient flow. The mobile phase at a flow rate of 1ml /min consisted of 
0.05M Sodium dihydrogen phosphate buffer and acetonitrile (gradient ratio) The UV 
detection was carried out at 220 nm.  
23. Niranjan D. Chivateet al., (2012), reported “Development of UV Spectrophotometric 
Method for Estimation and Validation of Telmisartan as a Pure API”. The 
spectrophotometric method wavelength was selected 240 nm by using 60% ethanol (95%) 
and 40% of 0.1M NaHCO3 as a solvent for Telmisartan. The linearity for this drug lies 
between 2-24 µg / ml. 
25. Palled M S et al., (2006), reported “Difference spectrophotometric Determination of 
Telmisartan in Tablet dosage Forms”. Spectrophotometric method was developed. 
Telmisartan exist in two different forms in acidic and basic medium that differ in their UV  
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spectra. Difference spectrum, obtained by keeping Telmisartan in 0.01N NaOH in reference 
cell and Telmisartan in 0.01N HNO3 in sample cell, showed two characteristic peaks at       
295 nm and 327 nm with positive negative absorbance respectively. The method was linear in 
the range of 2 -12 µg/ ml. 
26. Prajakta S. Nawaleet al., (2012), reported “Normal and RP-HPTLC Methods for 
Simultaneous Estimation of Telmisartan and Metoprolol Succinate in Pharmaceutical 
Formulation”. Method I was developed with aluminium plates precoated with silica gel      
60 F254S, and toluene: propanol: methanol: triethylamine (8:1:1: 0.5 v/v) was used as as 
mobile phase. Method II was carried out using aluminium coated with RP18 silica gel            
60 F254S HPTLC plates using methanol : water : triethylamine (6 : 4 : 0.5 v/v) as mobile 
phase. Both analyses were scanned with a densitometer at 242 nm. In Method I, good 
separation and resolution of drugs were achieved with Rf values 0.45 ± 0.02 (Telmisartan) 
and 0.70 ± 0.02 (Metoprolol), while in Method II, Telmisartan and Metoprolol showed Rf 
values 0.55 ± 0.02 and 0.41 ± 0.02, respectively. 
27. Patil U P et al., (2009), reported “Simultaneous Determination of Atrovastatin 
Calcium and Telmisartan in Tablet Dosage form by Spectrophotometry”. Three 
Spectrophotometric methods were developed. Absorbance correction method employs 
wavelength 328 nm for direct estimation of Telmisartan where Atrovastatin nil absorbance. 
Estimation of Atrovastatin is carried out after correction for absorbance of Telmisartan at 
241nm.  Second method is based on First order derivative spectroscopy wavelengths 297 nm 
and 241.8 nm were selected for the estimation of atrovastatin calcium and telmisartan. Third 
method is based on dual wavelength method Atrovastatin calcium was determined by plotting 
difference in absorbance at 258 nm and 291nm (difference in zero for Telmisartan). Similarly 
Telmisartan the difference absorbance at 225 nm add 252 nm (Difference is zero for 
Atrovastatin calcium). Both the drug obeys beer‟s law in the concentration range                   
5-30 µg / ml. 
28. Popat B Mohiteet al., (2010), reported “Simultaneous Estimation of Ramipril and 
Telmisartan in Tablet Dosage Form by Spectrophotometry”. The multicomponent 
method it involves absorbance measurement at 205 nm and 291 nm for Ramipril and 
Telmisartan in 0.2M H2SO4. Beers law obeys the concentration range of 5-40 µg/ ml for 
Ramipril and 2-20 µg/ ml for Telmisartan. Graphical absorbance which is based on  
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measurement of absorbance of ramipril and telmisartanat 222 nm (isoabsorptive point of 
Ramipril and Telmisartan) and 291 nm.  
29.   Pratap Y Pawaret al., (2012), reported “Simultaneous Spectrophotometry Estimation 
of Amlodipine Besylate and Telmisartan in Tablet Dosage Form”. The Simultaneous 
equation method is based on measurement of absorbance at 367 nm and 292 nm as two 
wavelengths selected for quantification of Amlodipine Besylate and Telmisartan. The First 
order derivative based on the measurement of absorbance at 270 nm and 295 nm as two 
wavelengths selected for quantification of Amlidipine Besylate and Telmisartan. Both 
method obey Beer‟s law in the concentration range of 20-100 µg/ ml for A and 5-30 µg /ml 
for Telmisartan.   
30.    Ramesh L Sawant et al., (2012), reported “Validated Spectrophotometric Method for 
Simultaneous Estimation of Telmisartan and indapamide in pharmaceutical Dosage 
Form”. The absorption maxima were found to be at 296 nm and 242 nm in methanol for 
telmisartan and intapamide respectively. Beer‟s law obey in the concentration range of         
5-25 µg/ ml for Telmisartan and  10-30 µg/ ml for indapamide with correlation coefficient 
within the range of 0.996-0.998 for both drug. The simultaneous equation method is based on 
the multi component analysis involves recording absorbance of standard solution at 296 nm 
and 242 nm. 
31.  Ridhdhi S Sinojiya et al., (2012), reported “Development and Validation of RP-HPLC 
Method for the Simultaneous Determination of Telmisartan, Amlodipine Besylate and  
Hydrochlorothiazide in a Tablet Dosage Form”.Separation of Chromatographic method by 
using RP-C18 (Hypercil, 250× 4.6 mm), mobile phase Acetonitrile  : 1% triethlyamine in ratio 
of 50 : 50 (pH adjusted to 3.5 with orthophosphoric acid) with flow rate of 1.2ml /min, 
injection volume 20 µL. Isocratic elution with total run time 8 min. detection of multi 
component was carried out at 237 nm. Retention time for Amlodipine, Hydrochlorothiazide, 
and Telmisartan was found to be 2.323, 2.810 and 5.527 min respectively. The calibration 
curve concentration range of 2-22.5 µg/ ml for Amlodipine, 6.25-56.25 µg/ ml for           
Hydrochlorothiazide and 20-180 µg/ ml Telmisartan. had regression coefficient greater than 
0.999 for the all drugs. 
32.    Sagar Tatane., (2011), reported “Development of UV Spectrophotometric Method of 
Telmisartan in Tablet Formulation”.  The wavelength selected for the telmisartan was     
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230 nm. The linearity for the drug at the selected wavelength is lies between 1-8 µg/ ml, 
correlation coefficient - 0.999. 
33.     Santhos V Gandhi et al., (2011), reported “A Validated Reverse Phase HPLC 
Method for Simultaneous Determination of Telmisartan and Ramipril as Bulk Drug 
and in Tablet dosage Form”.Separation of drug was carried out with HiQ-Sil C8 column 
(250 mm × 4.6 mm) using Acetonitril:0.01 M Heptane sulphonic acid sodium salt (pH 2.8) 
(60:40 v/v) as mobile phase. The method was development using Phenylpropanolamine 
hydrochloric acid as internal standard. Detection at 216 nm. Beer‟s law obeyed the 
concentration range of 10-50 µg/ ml and 2.5-12.5 µg/ ml for Telmisartan and Ramipril 
respectively. 
 
34.     SubhakarNandipati et al., (2012), reported “Development and Validation of RP-
HPLC Method for Estimation of Telmisartan in Bulk and Tablet Dosage Form”. 
Separation of drug was carried out with C18 sun fire column (250 mm × 4.6 mm) 5µm. 
Mobile phase Acetonitril: Potassium di hydrogen phosphate (60:40 v/v)  pH adjust with ortho 
phosphoric acid. Flow rate was 1ml/ min, Retention time was 3.4 for Telmisartan. 
 
35.    Sunil Jawla et al., (2010), reported “Development and Validation of Simultaneous 
HPLC Method for Estimation of Telmisartan and Ramipril in Pharmaceutical 
Formulations”. Separation of drugs were carried out with ODS C18 column (250 mm × 4.6 
mm) 5µm. using a mobile phase consisting of Acetonitrile:Potassium dihydrogen phosphate 
buffer having pH 2.8 in the ratio of 40: 60 v/v with the flow rate 1.5ml/ min using PDA 
detection at 210 nm. The linear response was observed over the concentration range of        
2.5-25.5 ppm and 3.0-7.25 ppm for assay of  Telmisartan and Ramipril respectively.                 
The retention time for Telmisartan and Ramipril 5.7 min and 10.8 min respectively. 
 
36. Sunil Singh., (2012), reported “Simultaneous Eestimation of Telmisartan and 
Ramipril in Combined Dosage Form by using HPTLC”. The method was carried out in 
TLC Precoated silica gel on aluminum plate 60 F 254, (10 cm ×10 cm, prewashed by 
methanol and activated at 60° C for 5 min prior to chromatography). The solvent system was 
Acetone: Benzene: Ethyl acetate: Glacial acetic acid in the proportion of 6:4:1:0.05, (v/v/v/v) 
with Rf value for telmisartan and ramipril was0.673 and 0.353 respectively. The linearity 
regression analysis for calibration showed 0.999 and 0.998 for telmisartan and ramipril with 
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respect to peak area and height in the concentration range of 150- 1700 ng/spot and            
300-1900 ng/ spot respectively. 
 
36.     Vijayamirthraj R et al., (2010), reported “Development and Validation of RP-HPLC 
Method for Simultaneous Estimation of Telmisartan and Atrovastatin Calcium inTablet 
Dosage Form”. Separation of drugs were carried out with Phenomenex C18 column (250 mm 
× 4.6 mm) 5µm. using a mobile phase consisting of Acetonitrile: Potassium dihydrogen 
phosphate buffer (0.01 M) having pH 4 (adjusted with orthophosphoric acid) in the ratio of 
65 : 35 v/v with the flow rate 2.0 ml/ min using PDA at 250nm. 
37.    Vijaya Kumar G et al., (2011), reported “Validated of RP-HPLC Method for the 
Estimation of Telmisartanin Serum Samples”. Isocratic elution at a flow rate of 1.0 ml/ 
min was employed on a Equsil, 250×4.6mm, 5µ. The mobile consist of Acetonitrile: buffer       
(65: 35) v/v. the detection wavelength 282 nm and  Retension time for telmisartan was        
3.32 min. 
38.   Yogesh Gupta et al., (2009), reported “Isocratic RP-HPLC-UV Method Development 
and Validation for the simultaneous Estimation of Ramipril and Telmisartan in Tablet 
Dosage Form”. Separation was carried out by using mobile phase Acetonitrle: Buffer 
(65:35) at pH 4.5 the flow rate 1.0ml/ min, Detection at 210 nm and Retention time for 
Ramipril and Telmisartan were4.25 min and 7.99 min respectively. 
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3. AIM AND PLAN OF WORK 
3.1 AIM OF WORK 
 Hypertension is a chronic disorder very commonly seen among people. Current 
hypertension treatment guidelines recommend a goal of <140/90 mmHg for population with 
uncomplicated hypertension and goals are even lower (< 130/80 mmHg) for patients with 
diabetes or renal disease. These recommendations are supported by long-term trials 
suggesting that the greater reduction in blood Pressure, the greater reduction in risk of 
cardiovascular events. Major clinical studies have shown that most patients require two or 
more drugs to achieve their blood pressure goals. Combination therapy should be used as 
initial treatment for patients in whom the probability of achieving BP control with 
monotherapy is low. Given the number of antihypertensive agents available, the number of 
potential combinations is large. However, rational choices should be based on some 
requirements. 
The prevalence of cardiovascular disease will undoubtedly increase as the mean age 
of the populations throughout the world increases. Heart disease is generally complex and 
multi factorial. Despite considerable advances in therapy, the underlying mechanisms are still 
rather poor. Efforts are directed towards the development of new drugs through the 
modification of the physicochemical properties of drug molecule, and the design and 
synthesis of new drugs with particular emphasis on drug delivery systems, pharmaceutical 
materials research, controlled drug release and targeting of drugs to the site of action to 
enhance the therapeutic effects. The perspective of the user enables the pharmacist and 
clinicians in understanding the factors leading to the suboptimal use of drugs in society. 
Identifying, solving and preventing drug-related problems in order to improve health and 
quality of life through pharmaceutical care in the community are therefore also important. 
Equally, the optimal utilization of pharmacist and clinician know – how will bring 
tremendous benefits to the patients from the viewpoint of social pharmacy in the promotion 
of safe and efficient use of drugs. 
The use of combination drug therapy for cardiovascular (CV) disease risk reduction is 
the established approach to multiple risk factor reduction. The spectrum of rational 
combination products in cardiovascular disease prevention and treatment alone is extremely 
broad. Development of fixed-dose combination drug products requires information beyond 
that needed for approval of single active ingredient products. Establishing the rationale and 
target populations for novel combinations, as well as the contributions of the component 
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drugs to the claimed effects, and characterizing the pharmacokinetics, the 
pharmacodynamics, and clinical safety and efficacy of the combination are all necessary to 
support approval. 
Nowadays, Telmisartan and Chlorthalidone are used for treatment of hypertension. 
The combined dosage form used for the treatment of prolonging hypertension and improve 
the quality of life. There are several methods were reported for the estimation of Telmisartan 
and Chlorthalidone individually or combination with other drugs. But there are no methods 
were reported for estimation of these drugs in combined dosage form without prior 
separation. 
The non- availability of any UV-spectroscopy, HPLC and HPTLC until now for the 
simultaneous analysis of the combination made it a worth-while objective to pursue the 
present work. 
Hence the present work was aimed to develop simple, precise and accurate methods 
for the estimation of Telmisartan and Chlorthalidone in bulk and in combined pharmaceutical 
dosage form and to validate the developed methods by UV-Spectrophotometry, HPLC and 
HPTLC. 
3.2 PLAN OF WORK 
3.2.1 Survey on Literature 
 A complete literature survey was made on the drugs of Telmisartan and 
Chlorthalidone for the various physicochemical properties such as solubility, melting point, 
storage conditions, etc. This survey gives some basic information of the drugs and the 
reported analytical methods of these drugs which help in the process of analytical method 
development. 
3.2.2 Procurement of Raw Material and Formulation 
 The standard raw materials drugs of Telmisartan and Chlorthalidone  were obtained as 
the gift samples from ERIS Pharmaceuticals, Gujarat, India. Eritel-CH-40, containing 
Telmisartan 40 mg and Chlorthalidone 12.5 mg was procured from local pharmacy, 
Melmaruvathur. 
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3.2.3 Method Development 
 The solubility of individual drugs was checked and from the list of solvents the 
common and stable solvent for the two drugs was selected. The solvent selected for both UV 
spectroscopy, HPLC and HPTLC must be cheap and readily available. 
The various steps involved in the method development as follows, 
UV Spectroscopy 
   Selection of appropriate analytical wavelength and selection of suitable                  
     method 
   Determination of working concentration range 
   Analysis of synthetic mixture 
   Simultaneous analysis of the formulation by using the developed method 
HPLC Method 
   Optimization of chromatographic conditions 
   Analysis of formulation 
   System suitability testing 
HPTLC Method 
   Optimization of chromatographic conditions 
   Analysis of formulation 
   System suitability testing 
3.2.4 Validation 
 The method to be developed should be validated as per ICH and USFDA guidelines. 
The various parameters of validation are Linearity, Range, Precision, Accuracy, LOD, LOQ 
and Ruggedness.  
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4. MATERIALS AND METHODS 
4.1 MATERIALS 
4.1.1 Drug substance 
 The standard raw materials drugs of Telmisartan and Chlorthalidone  were obtained as 
the gift samples from ERIS Pharmaceuticals, Gujarat, India.  
4.1.2 Formulation Used 
 Eritel-CH-40, containing Telmisartan 40 mg and Chlorthalidone 12.5 mg was 
procured from local pharmacy, Melmaruvathur. 
 4.1.3 Chemicals and Solvents Used  
 Methanol (HPLC grade), Acetonitrile (HPLC grade), Water for HPLC,             
Toluene (AR grade), 2- Propanol (AR grade), Ammonia (AR grade) and Sodium hydroxide 
(AR grade)  were purchased from Qualigens India Pvt. Limited, Mumbai and Loba Chemie 
India Limited, Mumbai. Distilled water was obtained from Double distillation unit in our 
laboratory. 
4.1.4 Instruments Used  
Different instruments used to carry out the work are, 
 Shimadzu AUX- 220 Digital balance. 
 Shimadzu- 1700 Double Beam UV-Visible Spectrophotometer with a pair of 10 mm 
matched quartz cells. 
 ELICO SL-210 Double Beam UV- Visible Spectrophotometer with pair of   
10 mm matched quartz cells. 
 Soltec - Sonica Ultrsonic Cleaner - Model 2200 MH. 
 Remi Centrifuge Apparatus 
 Cyberlab Micropipette. 
 HPLC  
  Shimadzu SPD – 20A UV – Visible detector.  
   Shimadzu LC – 20 AD solvent delivery module   
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4.1.5 Specifications of Instruments 
4.1.5.1. Double beam UV-Visible Spectrophotometer (Shimadzu Instruction Manual) 
Model: Shimadzu, UV-1700; Cuvetts: 1 cm matched quartz cells. 
SPECIFICATIONS 
Light source 
20 W halogen lamp, Deuterium lamp. 
Light source position automatic adjustment mechanism 
Monochromators 
Aberration- correcting concave blazed holographic 
grating 
Detector Silicon photodiode 
Stray Light 
0.04% or less (220 nm: NaI 10 g/lt) 
0.04% or less (340 nm: NaNO2 50 g/lt) 
Measurement wavelength range 190 ~ 1100 nm 
Spectral band width 1nm or less (190 to 900 nm) 
Wavelength accuracy 
±0.5 nm on board automatic wavelength calibration 
mechanism 
Recording range 
Absorbance: -3.99~3.99 Abs 
Transmittance: -3.99~3.99 Abs 
Photometric accuracy ±0.004 Abs (at 1.0 Abs), ±0.002 Abs (at 0.5 Abs) 
Operating temperature/ humidity 
Temperature range: 15 to 35° C 
Humidity range: 35 to 80% (15 to below 30° C) 
35 to 70% (30 to below 35° C) 
 
4.1.5.2. Shimadzu AUX- 220 digital balance (Shimadzu instruction manual) 
SPECIFICATIONS 
Weighing capacity 200 gms 
Minimum display 0.1 mg 
Standard deviation ≤ 0.1 mg 
Operating temperature range 5 to 40° C 
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4.1.5.3. Elico - SL 210 Double Beams UV- Visible Spectrophotometer 
(Elico Instruction Manual) 
SPECIFICATIONS 
Light source 
Tungsten halogen lamp (W), Deuterium lamp (D2).  
Light source positions automatic adjustment 
mechanism 
Monochromators Concave holographic grating with 1200 lines/mm 
Detector Photodiode 
Stray light <0,05%T at 220 nm with NaI 10 g/lt 
Measurement Wavelength range 190 to 1100 nm 
Spectral Band Width 1.8 nm 
Wavelength Accuracy ±0.5 nm 
Spectral repeatability ±0.2 nm 
Spectral readability 0.1 nm 
Recording range ±3.0000 Abs 
Photometric accuracy ±0.005 Abs (at 1.0 Abs), ± 0.010 Abs (at 1.5 abs) 
Operating temperature/ Humidity 
Temperature range: 15 to 35º C 
Humidity range: 35 to 80% (15 to below 30º C) 
 35 to 70% (30 to below 35º C) 
 
 
C) Shimadzu HPLC(Shimadzu Instruction Manual) 
Detector Specifications 
Light source Deuterium arc lamp 
Wavelength range 190 to 700 nm 
Spectral Band Width 5 nm 
Wavelength Accuracy  1 nm 
Cell path length 10 nm 
Cell volume 20 l 
Operating temperature range 4 to 40 C (39 to 104 F) 
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Recording range 0.0001 to 4.000 AUFS 
Operating Temperature/ Humidity 4 to35 C/ 75 % 
Pump Specifications 
Pump type Double reciprocating plunger pump 
Pumping methods Constant flow delivery and constant pressure delivery 
Suction filter 45 m  
Line filter 5 m mesh 
Operating temperature 4 to 40 C 
 
4.1.5.4. CAMAG Automatic TLC Sampler 4 (ATS4) 
APPLICATOR SPECIFICATIONS 
 
Spray gas 
Nitrogen 
Sample solvent type 
 
Methanol 
Spray gas temperature Unheated 
Syringe size 25 μl 
Number of tracks 15 
Application type Band 
Band length 8 mm 
 
 
 
4.1.5.5. CAMAG TLC Scanner 3 
SPECIFICATIONS 
Lamp D2 and W lamp 
Scanning Speed 20 mm/ sec 
Data Resolution 100 μm/ step 
Measurement Type Remission 
Measurement Mode Absorption 
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Optical Filter Second Order 
Detector Mode Automatic 
 
4.2 METHODS 
An effort was made to develop and validate simple, accurate and precise methods for 
the simultaneous analysis of Telmisartan and Chlorthalidone in bulk and in pharmaceutical 
dosage form by 
1. UV Spectrophotometry 
First order derivative spectrophotometry 
2. HPLC method 
3. HPTLC method. 
 
4.2.1 UV Spectrosphotometry 
4.2.1.1 First Order Derivative Spectrophotometry 
Derivative spectrophotometry involves the conversion of a normal spectrum to its 
first, second or higher derivative spectrum. The transformations that occur in the derivative 
spectra are understood by reference to a Gaussian band which represents an ideal absorption 
band. In the context of derivative spectrophotometry, the normal absorption spectrum is 
referred to as the fundamental, zero order or D° spectrum. The first derivative (D1) spectrum 
is a plot of the ratio of change of absorbance with wavelength against wavelength.  
4.2.1.1.2 Selection of Solvent 
 The solubility of drugs was determined in a variety of polar and non-polar solvents as 
per IP specification. The common and stable solvent was found to be  0.l M Sodium 
Hydroxide and dilutions were made with same 0.1 M Sodium Hydroxide for the analysis of 
Telmisartan and Chlorthalidone for the proposed method. 
 
 
4.2.1.1.3 Preparation of Standard Stock Solutions 
 50 mg and 40 mg of Telmisartan and Chlorthalidone were weighed accurately and 
transferred in to 100 ml volumetric flasks. Dissolved with 0.1 M Sodium Hydroxide and 
made up to the volume with same 0.1 M Sodium Hydroxide. The stock solution contains       
500 µg/ ml and 400 µg/ ml of Telmisartan and Chlorthalidone Respectively. 
4.2.1.1.4 Selection of Wavelength  
 10 µg/ ml concentration solutions of Telmisartan and Chlorthalidone were prepared 
from the stock solution and the spectra were recorded between   200 nm - 400 nm by using 
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0.1 M sodium Hydroxide as blank. The zero order spectra were derivitized to first order and 
the spectra were overlain. From the overlain spectra, the wavelength selected for the analysis 
was 251 nm and 311 nm for Chlorthalidone and Telmisartan respectively. 
 
4.2.1.1.5 Stability Studies 
 The stability of Telmisartan and Chlorthalidone were checked using 10 µg/ ml 
solutions at the selected wavelengths in different time intervals. It was found that Telmisartan 
was stable more than 5 hours, and Chlorthalidone  was stable up to 4 hours 30 minutes. 
4.2.1.1.6 Linearity and Calibration 
 From the stock solution Telmisartan, 1 – 8 ml was transferred in to a series of 100 ml 
volumetric flasks and made up to the volume with 0.1M Sodium hydroxide to get 
concentrations of 5 to 40 µg/ ml of Telmisartan. From the stock solution of Chlorthalidone, 
0.5 – 6 ml were transferred in to series of 100 ml volumetric flask individually and made up 
to the volume with 0.1 M Sodium hydroxide to get the concentrations of 2– 24 µg/ ml of 
Chlorthalidone. The absorbance of the solutions was measured and the calibration graph was 
constructed 
4.2.1.1.7 Synthetic Mixture 
 1 to 7 ml and 0.5 to 6 ml were pipetted out from Telmisartan and Chlorthalidone stock 
solutions, respectively into a series of six 100 ml volumetric flasks and made up to 100 ml 
with 0.1M sodium Hydroxide and to get a mixture of Telmisartan and Chlorthalidone in the 
concentration range of 5 to 35 µg/ ml and 2 to 24 µg/ ml, respectively. The absorbances of 
the prepared synthetic mixtures were measured at the selected wavelengths. The amount of 
drugs in the prepared synthetic mixture was calculated. 
 4.2.1.1.8 Quantification of Formulation  
 Twenty Tablets of (Eritel-CH 40, containing Telmisartan 40 mg and Chlorthalidone 
12.5mg) were accurately weighed and the average weight was calculated. The tablets were 
crushed and made in to a fine powder. The tablet powder equivalent to 80 mg of Telmisartan 
was accurately weighed and transferred into 100 ml volumetric flasks. Dissolved with         
0.1 M sodium hydroxide and shaken upto15 minutes. The volume was made up to 100 ml 
with 0.1 M sodium hydroxide. The solution was filtered through Whatmann filter paper 
No.41. From the stock solution, 2 ml was pipetted out and further diluted to 100 ml with      
0.1 M Sodium hydroxide to get the theoretical concentrations of 16 µg/ ml and 5 µg/ ml of  
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Telmisartan and Chlorthalidone, respectively. The absorbances of solutions were measured at 
251 nm and 311 nm. The procedure was repeated for six times. The amounts of these drugs 
were calculated. 
4.2.1.1.9 Recovery Studies 
4.2.1.1.9.1 Preparation of Raw Material Standard Stock Solutions  
 320 mg of Telmisartan raw material was weighed accurately in to a 10 ml volumetric 
flask, dissolved with 0.1M Sodium hydroxide and made up to 10 ml with 0.1 M Sodium 
hydroxide to get a concentration of 32 mg/ ml of Telmisartan. Similarly 100 mg of 
Chlorthalidone raw material were weighed accurately and transferred into 10 ml volumetric 
flasks, dissolved with 0.1M Sodium hydroxide and made up to 10 ml with 0.1 M Sodium 
hydroxide to get concentrations of 10 mg/ ml of Chlorthalidone. 
4.2.1.1.9.2 Recovery Procedure 
 The recovery study was done by adding a specified quantity of raw material was 
added in to the pre analysed formulation. The tablet powder equivalent to 80 mg of 
Telmisartan was weighed accurately and added 2 ml, 2.5 ml, and 3.0 ml of  raw standard 
stock solutions of Telmisartan and Chlorthalidone into three separate 100 ml volumetric 
flasks. Dissolved in 0.1M sodium hydroxide and shaken up to 15 minutes and made up to 100 
ml with 0.1M sodium hydroxide. The solutions were filtered through Whatmann filter paper 
No.41. From  these solutions, 2 ml was transferred into six 100 ml volumetric flasks 
separately and made up to the volume with 0.1M sodium hydroxide. The absorbances of the 
solutions were measured at 251 nm and 311 nm. The amount of drug recovered was 
calculated. The procedure was repeated three times for each concentration. 
4.2.1.1.10 Validation of Developed Methods 
4.2.1.1.10.1. Linearity 
 A calibration curve was plotted with concentration versus the absorbance value. The 
linearity was checked for Telmisartan in the concentration range of 5 to 40 µg/ ml, 
Chlorthalidone in the concentration range of 2 to 24µg/ ml. The drugs were found to be linear 
in the specified concentration ranges. 
4.2.1.1.10.2. Precision 
 The repeatability of the method was confirmed by repeated analysis of the 
formulation for six times with the same concentration. The amount of drug present in the 
formulation was calculated. The percentage RSD value was calculated. Confidence Interval 
(95%) was also calculated. 
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 The intermediate precision was confirmed by  intraday and interday analysis i.e. the 
analysis was performed three times on the same day and on three successive days. The 
amount of drug present in the formulation was calculated. The percentage RSD values were  
calculated.  
4.2.1.1.10.3. Ruggedness 
 Ruggedness of the method was confirmed by the analysis of formulation in different 
analyst. The amount of drug was calculated and the percentage RSD values were also 
calculated.  
 
4.2.1.1.10.4. Accuracy 
 Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation a known quantity of the standard drug solutions were added and the amount of 
drugs recovered were calculated. The percentages RSD values were calculated. Confidence 
Interval (95%) was also calculated. 
4.2.1.1.10.5. LOD and LOQ 
 The linearity study was carried out for six times. The LOD and LOQ were calculated 
based up on the calibration curve method. The LOD and LOQ were calculated using the 
average of slope and standard deviation of intercept. 
 
4.2.2. REVERSE PHASE – HPLC METHOD 
            In RP – HPLC, the retention of a compound is determined by its polarity, pKa value, 
molecular weight, experimental conditions, mobile phase, column and temperature. The 
column (typically octyl (C8) and octadecyl (C18) bonded phase) is less polar than the        
water – organic phase, usually an almost or entirely mobile phase. Sample molecules 
partition between the polar mobile phase and non – polar C8 and C18 stationary phase and 
more hydrophobic (non - polar) compounds are retained more strongly. Polar compounds are 
less strongly held and elute from the column first and vice versa. Usually the lower the 
polarity of the mobile phase, higher in its elution strength. RP – HPLC columns are efficient, 
stable and reproducible because of the solvents used. Generally gradient and isocratic elution 
techniques used for elution and an isocratic elution technique employed for resolution of 
compounds in present study. 
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4.2.2.1. METHOD DEVELOPMENT AND OPTIMIZATION OF 
CROMATOGRAPHIC CONDITIONS 
4.2.2.1.1. Selection of mobile phase and max 
 Solutions of Telmisartan and Chlorthalidone (10 g/ ml) were prepared in the mobile 
phase and scanned in the UV region of 200 – 400 nm and recorded the spectrums. It was 
found that these two drugs have marked absorbance at 229 nm and can be effectively used for 
estimation of these drugs without interference. Therefore 229 nm was selected as detection 
wavelength for the estimation of Telmisartan and Chlorthalidone by RP – HPLC with an 
isocratic elution technique. 
 
4.2.2.1.2. Stability of sample solutions  
 Solutions of Telmisartan and Chlorthalidone (10 g/ ml) were prepared and 
absorbance was checked for their stability at 229 nm and it was found that these two drugs 
were stable for 3 hours. 
 
4.2.2.2. OPTIMIZATION OF CHROMATOGRAPHIC CONDITIONS 
4.2.2.2.1. Initial separation conditions  
The following chromatographic conditions were preset initially to get better resolution of 
Telmisartan and Chlorthalidone. 
 
Mode of operation - Isocratic 
Stationary phase - C18 column (150 mm  4.6 mm i.d. 5 ) 
Mobile phase -        Acetonitrile: Methanol  
Proportion of mobile phase - 50: 50% v/v 
Detection wavelength -  229 nm 
Flow rate - 1ml/ min 
Temperature - Ambient 
Sample load - 20 l 
Method  - External Standard Calibration method. 
 
 
 The mobile phase was primarily allowed to run for 30 minutes to recorded a steady 
baseline. Mixture of solutions of Telmisartan and Chlorthalidone were injected and the 
respective chromatogram was recorded. It was found that both Telmisartan and 
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Chlorthalidone were eluted  with broad peak. For this reason, different ratios of mobile phase 
with different solvents were tried to obtain good chromatogram with acceptable system 
suitability parameters. 
 
S.No Mobile phase Observation 
1 Acetonitrile : methanol (50: 50% v/v) 
Telmisartan and Chlorthalidone  were eluted 
with broad peak 
2 Acetonitrile: Methanol (70: 30% v/v) 
Telmisartan and Chlorthalidone  were eluted 
with broad peak and resolution was less. 
3  Acetonitrile: Water  (70: 30% v/v) 
Resolution between Telmisartan and 
Chlorthalidone was not obtained. 
4 Acetonitrile: Water (50:50% v/v) 
Peaks were eluted with better resolution but 
peak shape was not good for Chlorthalidone 
 
4 
Acetonitrile: 10Mm Ammonium 
Acetate Buffer (pH3) adjust with 
triethylamine. 50:50% v/v 
Telmisartan and Chlorthalidone were eluted  as 
broad peak with tailing. 
 
5 
Acetonitrile: 10Mm Ammonium 
Acetate    (pH 7) adjust with tri 
ethylamine     50: 50 %v/v 
Telmisartan and Chlorthalidone were eluted  as 
broad peak with tailing. 
 
6 
Acetonitrile: 10Mm Potassium            
di hydrogen orthophosphate (pH3) 
adjust with orthophosphoric acid 
50:50%v/v 
Telmisartan and Chlorthalidone peaks  were 
merged 
 
   7 
Acetonitrile: Methanol: 10Mm 
potassium dihydrogen ortho phosphate 
buffer 50:20:30 v/v/v 
Telmisartan and Chlorthalidone were eluted 
with good separation but tailing on both peaks 
 
8 
Acetonitrile: Water (50: 50% v/v) with 
0.1 ml of 0.1% Triethylamine 
The peaks were found to be good with better 
resolution  
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 With the above information‟s, Acetonitrile: water with 0.1ml of 0.1% triethylamine 
was selected as mobile phase and further optimization was done with this mobile phase.  
4.2.2.2.2. Effect of ratio of mobile phase 
         With the above selected mobile phase, different composition was tried with  the 
different ratios of Acetonitrile and  Water. The ratios tried were 50:50, 70:30, 30:70 and 
60:40 % v/v.  At 50:50 ratios the peaks obtained were very sharp with better resolution.  
Hence this ratio was selected for further analysis. 
4.2.2.3. Optimized chromatographic conditions 
          The following optimized chromatographic conditions were employed for analysis of 
Telmisartan and Chlorthalidone by isocratic RP – HPLC method. 
Mode of operation -  Isocratic 
Stationary phase -   C18 column (150 mm  4.6 mm i.d. 5 ) 
Mobile phase - Acetonitrile : Water with 0.1 ml of 0.1 % Triethylamine  
Proportion of mobile phase     - 50:50% v/ v 
Detection wavelength    - 229 nm 
Flow rate - 1ml/ min 
Temperature - Ambient 
Sample load - 20 l 
Operating pressure - 140kgf 
Method - External Standard Calibration method. 
 
 
4.2.2.3.1. Preparation of standard Telmisartan solution 
 25 mg of Telmisartan was weighed accurately and transferred into 25 ml volumetric 
flask and dissolved in methanol, after dissolution the volume was made up to the mark with 
methanol (1000 g/ ml). Further dilution was made by pipetting 2.5 ml of mother liquor into 
25 ml with mobile phase to acquire 100 g/ ml solution. 
4.2.2.3.2. Preparation of standard Chlorthalidone solution 
 25 mg of Chlorthalidone was weighed accurately and transferred into 25 ml 
volumetric flask and dissolved in methanol, after dissolution the volume was made up to the 
mark with methanol (1000 g/ ml). Further dilution was made by pipetting 2 ml of mother 
liquor into 25 ml with mobile phase to acquire 80 g/ ml solution. 
4.2.2.3.3. Preparation of Calibration graph 
 In this progression, the aliquots of stock solution of Telmisartan and Chlorthalidone 
(0.5 – 2.5 ml) and (0.5 – 2 ml ) individually were transferred into a series of 10 ml volumetric 
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flasks and made up to the mark with mobile phase. The solutions containing the 
concentrations of    5- 25 g/ ml of Telmisartan and 2 – 16  g/ ml of Chlorthalidone. All the 
solutions were injected and the chromatograms were recorded at 229 nm. The above 
concentration range was found to be linear and obeys Beer‟s law. The procedure was 
repeated for three times. The peak areas were plotted against concentration and the 
calibration curve was constructed. 
 
4.2.2.3.4. Estimation of  Telmisartan and Chlorthalidone in tablet formulation 
 Estimation of Telmisartan and Chlorthalidone in tablet formulation by RP – HPLC 
was carried out using optimized chromatographic conditions. Ten tablets of formulation 
(Eritel-CH 40 containing 40 mg of Telmisartan, 12.5mg of Chlorthalidone) were weighed 
accurately. The average weight of tablets was found and powdered. The tablet powder 
equivalent to  80 mg of  Telmisartan was weighed and transferred into 100 ml volumetric 
flask and added about 80 ml of methanol to dissolve the substance and made up to the 
volume with the same (800 g/  ml). The solution was sonicated for 15 minutes, centrifuged 
at 200 rpm for 15 minutes and filtered through Whatmann filter paper No. 41. From the clear 
solution, further dilutions were made by diluting 1 ml into 10 ml with mobile phase to obtain 
80 g/ ml solution. This solution was used for further analysis. 
4.2.2.3.5. Assay Procedure  
        1ml of test solution was transferred into six 10 ml volumetric flasks individually and 
made up to the mark with mobile phase to obtain 8 g/ ml.  A steady base line was recorded 
with optimized chromatographic conditions. After the stabilization of base line for                   
30 minutes, the test solutions were injected and recorded the chromatograms. The 
concentration of each test solution was determined by using slope and intercept values from 
the calibration graph. 
4.2.2.3.6. Recovery Experiments  
a) Preparation of pre analysed formulation stock solution  
 The powdered tablet equivalent to 80 mg of Telmisartan  was weighed and transferred 
into 100 ml standard flask and added about 80 ml of methanol to dissolve the substance and 
made up to the volume with methanol (800 g/ ml). The solution was sonicated for 15 
minutes, centrifuged at 200 rpm for 15 minutes and filtered through Whatmann filter paper 
No. 41. From the clear solution, further 1ml transferred into 10 ml volumetric flask and 
diluted 10 ml with mobile phase to obtain 80 g/ ml solution. 
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4.2.2.3.7. Procedure 
           Formulation equivalent to 80 mg of Telmisartan and added 64 mg, 80 mg and 96 mg 
raw material of Telmisartan and 20 mg, 25 mg and 30 mg raw material of Chlorthalidone into 
100 ml volumetric flasks separately and made up to the mark with methanol. Further 
procedure was followed as per the analysis of formulation. The solutions were injected and 
the chromatograms were recorded at 229 nm. The quantity of drug recovered was calculated 
by using slope and intercept values from the calibration graph. 
4.2.2.3.8. System suitability studies 
           The system suitability studies conceded as per ICH guidelines and USP. The 
parameters like capacity factor, tailing factor, asymmetry factor, number of theoretical plates 
and resolution were calculated. 
4.2.2.3.9. Validation of Developed Method 
4.2.2.3.9.1. Linearity 
A calibration curve was plotted with concentration versus the peak area. The linearity 
range was checked for in the concentration range of 100 – 800 ng/ µl and 50 – 400 ng/ µl, 
ofTelmisartan and Chlorthalidone respectively. The drugs were found to be linear in the 
specified concentration ranges. 
4.2.2.3.9.2 Precision 
 The repeatability of the method was checked by repeated analysis of the formulation 
for six times with the same concentration. The amount of drug present in the formulation was 
calculated. The percentage RSD value was calculated. Confidence Interval (95%) was also 
calculated. 
 The intermediate precisions were confirmed by the intraday and inter day analysis i.e. 
the analysis was performed three times on the same day and on three successive days. The 
amount of drug present in the formulation was calculated. The percentage RSD values were 
calculated.  
4.2.2.3.9.3. Accuracy   
Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation a known quantity of the standard drug solutions were added and the amount of 
drug recovered was calculated. The percentages RSD values were calculated.  
4.2.2.3.9.4. LOD and LOQ 
 The linearity study was carried out for three times. The LOD and LOQ were 
calculated based up on the calibration curve method. The LOD and LOQ were calculated 
using the average of slope and standard deviation of intercept. 
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4.2.3. HPTLC 
In HPTLC, the separation of the components of a mixture is based on the principle of 
adsorption. The HPTLC differ from the TLC in the size of silica gel used as the stationary 
phase and automated sampling application and detection. In the present study a twin through 
chamber and silica 60 F 254 were used. 
4.2.3.1. Selection of Stationary Phase 
  The resolution of Telmisartan and Chlorthalidone was achieved using TLC plate 
made up of silica gel G60 F 254 coated on an Aluminium support (E.Merck). The size of the 
silica gel particle was 2  and thickness of sorbent layer was 0.2 mm. The plates were 
supplied in 20 × 10 cm size which was cut in to appropriate sizes for method development. 
4.2.3.2. Selection of Mobile Phase 
 The mobile phase system was chosen based on the solubility and polarity of two 
drugs. The solution of drugs was prepared in methanol and used for spotting. Methanol gets 
vaporized soon after application on to the plate under nitrogen stream. After trying different 
mobile phase system an ideal system was chosen based on the resolution between 
compounds. The fixed mobile phase system for the separation of two drugs consisted of 
(mobile phase) with an appropriate Rf values. The drugs were scanned at 224 nm after the 
development. 
The velocity of mobile phase in HPTLC is affected by the nature of the stationary 
phase (porosity, packing, particle size, etc), as well as mobile phase properties (viscosity, 
surface tension, vapour pressure of solvents, etc). Generally the velocity of mobile phase 
decreases during chromatographic development due to higher resistance of stationary phase 
densely packed with fine particles.  
Various mobile phase tried were 
Mobile Phase Ratio 
0.5 M NaCl: Methanol: Acetonitrile: 
Glacial acetic acid 
(10: 4: 6: 0.01% v/v/v/v/v) 
Ethyl Acetate: 1,4- dioxane: Methanol: 
25% ammonia 
(15: 15: 3:1.5 % v/v/v/v/v) 
Ethyl acetate: Methanol: 25% ammonia:  
Glacial Acetic acid 
(7.5: 1.5: 2.0: 1.0: 0.2 % v/v/v/v/v) 
Toluene: Benzene: Methanol (5: 3: 2 % v/v/v) 
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Benzene: Toluene: Diethylamine (5: 3: 2 % v/v/v) 
 
Benzene: Toluene: n-butanol (5: 3: 2% v/v/v) 
 
THF: dichloromethane: Methanol: 25% 
ammonia 
(6: 2: 1: 0.4% v/v/v/v/v) 
 
THF: dichloromethane: Methanol: 25% 
ammonia 
(6: 2: 1: 0.2% v/v/v/v/v) 
 
Toluene: 2-Propanol:25% ammonia (5.5: 4.5: 0.02% v/v) 
Toluene: 2-Propanol:25% ammonia (6.5: 3.5: 0.02% v/v) 
Toluene: 2-Propanol:25% ammonia (4.5: 5.5: 0.02% v/v) 
Toluene: 2-Propanol:25% ammonia (3.5: 6.5: 0.02% v/v) 
 
From the above list of mobile phase the mobile phase Toluene: 2- Propanol: 25% 
ammonia (6.5: 3.5: 0.02% v/v) was found to be an ideal mobile phase with good resolution 
between the spots.  
4.2.3.3. Optimization of Variants in TLC 
 The composition of mobile phase, chamber saturation (equilibration time), plate 
equilibration time, the distance of solvent development and bandwidth of the spot are a few 
variants affect Rf values of drugs. 
4.2.3.4. Chamber Saturation (Equilibration time) 
 Chamber saturation is done so that equilibration is established eventually between the 
components of developing solvents and their vapour phase and the formation of secondary 
solvent fronts could be avoided 
Hence in the current study chamber saturation was taken in to consideration to 
achieve reproducible Rf values and peak area. The mobile phase was placed on one side of 
twin through chamber and shaken well. Different saturation times were maintained for 
different mobile phase. The chamber saturation time for Toluene: 2- Propanol: 25% ammonia 
(6.5: 3.5: 0.02% v/v) was 30 minutes. 
4.2.3.5. Selection of Detection Wavelength 
 By comparing the spectral characters of Telmisartan and Chlorthalidone the detection 
wavelength was selected for the method 229 nm was selected for as the detection wavelength 
with reference to the spectral conformation graph.  
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4.2.3.5.1. Optimized Chromatographic Conditions 
 After conforming with the mobile phase and detection wavelength, the optimized 
conditions for the method was as follows  
Stationary Phase  - Silica Gel 60 F 254 HPTLC Plates  
Mobile Phase   - Toluene: 2- Propanol: 25% ammonia  
Mobile Phase ratio  - (6.5: 3.5: 0.02% v/v) 
Detection   - CAMAG TLC scanner 3, at 229 nm 
Temperature   - Room Temperature 
Chamber   -  Twin through Chamber   
Development Mode  - Ascending Mode  
4.2.3.5.2. Preparation of Standard Stock Solution 
 100 mg of Telmisartan raw material was accurately weighed into 50 ml volumetric 
flask and 100 mg of Chlorthalidone raw material was accurately weighed into 100 ml of 
volumetric flask, dissolved in methanol and made up to the volume with methanol. The 
solution contains 2 mg/ ml of Telmisartan and 1 mg/ml of Chlorthalidone. 
4.2.3.5.3. Linearity and Calibration Curve  
   0.5- 4.0 ml of the standard stock solutions of Telmisartan and Chlorthalidone were 
pipetted out into a serious of 10 ml volumetric flasks and made up to the volume with 
methanol. 1µl solutions were spotted on TLC plates and to get the concentration range of 100 
– 800 ng/ µl, and 50 – 400 ng/ µl of Telmisartan and Chlorthalidone, respectively. 
4.2.3.5.4. Quantification of Formulation 
 Twenty Tablets were weighed accurately and the average weight of each tablet was 
determined. The tablet powder equivalent to 32 mg of Telmisartan into a series of six 100 ml 
volumetric flasks. Dissolved in methanol and sonicated for 15 minutes. The volume was 
made up to 100 ml with methanol and was centrifuged for 15 minutes at 2000 rpm. The 
supernatant solution was filtered through whatmann filter paper No.41. The solution contains 
320 ng/µl, 100 ng/ µl, of Telmisartan and Chlorthalidone, respectively. 1 µl spots were 
placed on the plates and the chromatogram was developed in the twin through chamber. From 
the peak area and amount of drugs were calculated. The procedure was repeated for six times. 
4.2.3.5.5. Recovery Studies 
4.3.3.5.5.1. Procedure 
           To the tablet formulation equivalent to 32 mg of Telmisartan, added 25.6 mg, 32 mg 
and 38.4 mg of raw material of Telmisartan and 8 mg, 10 mg and 12 mg of raw material of 
Chlorthalidone into 100 ml volumetric flasks separately and made up to the mark with 
94 
 
methanol. Further procedure was followed as per the analysis of formulation. The solutions 
were injected and the chromatograms were recorded at 229 nm. The quantity of drug 
recovered was calculated by using slope and intercept values from the calibration graph. 
4.2.3.6 Validation of Developed Method 
4.2.3.6.1. Linearity 
A calibration curve was plotted with concentration versus the peak area. The linearity 
range was checked for in the concentration range of 100 – 800 ng/ µl and 50 – 400 ng/ µl, of 
Telmisartan and Chlorthalidone respectively. The drugs were found to be linear in the 
specified concentration ranges. 
 
 
 
4.2.3.6.2. Precision 
 The repeatability of the method was checked by repeated analysis of the formulation 
for six times with the same concentration. The amount of drug present in the formulation was 
calculated. The percentage RSD value was calculated. 
 The intermediate precisions were confirmed by the intraday and inter day analysis i.e. 
the analysis was performed three times on the same day and on three successive days. The 
amount of drug present in the formulation was calculated. The percentage RSD values were 
calculated.  
4.2.3.6.3. Accuracy   
Accuracy of the method was confirmed by recovery studies. To the pre-analyzed 
formulation a known quantity of the standard drug solutions were added and the amount of 
drug recovered was calculated. The percentages RSD values were calculated.  
4.2.3.6.4. LOD and LOQ 
 The linearity study was carried out for three times. The LOD and LOQ were 
calculated based up on the calibration curve method. The LOD and LOQ were calculated 
using the average of slope and standard deviation of intercept. 
 
 
 
 
 
RESULT 
  AND 
DISCUSSION
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5. RESULTS AND DISSCUSION 
Simultaneous estimation of two drugs in a formulation has more advantages such as 
accurate, less use of reagent and less time requirement for the estimation rather than 
individual estimation of two drugs. The simple, precise and accurate analytical techniques 
were developed for the simultaneous estimation of Telmisartan and Chlorthalidonein bulk 
and in pharmaceutical dosage form. The methods include 
1. UV Spectroscopy 
 First Order Derivative Spectrophotometry 
2. HPLC Method 
3. HPTLC Method 
5.1. UV Spectroscopy 
5.1.1 First Order Derivative Spectrophotometry 
 A simple, precise and accurate first order derivative spectrophotometric method was 
developed and validated for the simultaneous estimation of Telmisartan and Chlorthalidone 
in bulk and in combined dosage form. The drugs were identified by the melting point and IR 
spectrum, the IR spectrum of Telmisartan and Chlorthalidonewere given in figures 1and 2, 
respectively. The solubility of drugs in various polar and non polar solvents checked as per IP 
specifications. All the drugs were exhibited different solubility characters. From the solubility 
data, the common solvents were found to be acetone, acetonitrile, dimethyl formamide, di 
ethylamine, ethanol, methanol, n-butanol, and 0.1M sodium hydroxide. The solvents such as 
acetonitrile, acetone, dimethyl formamide,di ethylamine and n-butanol, were not selected 
because the cut off wavelength of these solutions were above 240 nm and the solvent 
interference should be expected during the analysis.Hence, 0.1M sodium hydroxide was 
selected as the solvent for the analysis of Telmisartan and Chlorthalidone. The solubility 
profile of Telmisartan and Chlorthalidone were given in tables 1 and 2,respectively. 
 10 µg/ ml concentration solutions of Telmisartan and Chlorthalidone were prepared 
and the spectra were recorded. The overlain zero order spectra are shown in figure 3. By 
observing the spectral characters of Telmisartan and Chlorthalidone the methods used for the 
multi component analysis viz. simultaneous equation method, absorption correction method 
and absorption ratio method were not applied, because the interference were more. Hence the 
normal curve was derivitized to first order and overlained as shown in figure 4. From the 
overlain spectra 311nm and 251 nm were selected for the simultaneous estimation of 
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Telmisartan and Chlorthalidone, respectively. At 311 nm, Telmisartan has the absorbance 
where as Chlorthalidone has no absorbance. Hence this wavelength selected for the analysis 
of Telmisartan without the interference of Chlorthalidone. At 251 nm Chlorthalidone has the 
absorbance where as Telmisartan have zero crossing points.Hence this wavelength selected 
for the analysis of Chlorthalidone without the interference of Telmisartan. 
The stability of Telmisartan and chlorthalidone were checked at the selected 
wavelengths using 0.1M sodium hydroxide  as solvent. It was found that Telmisartan was 
stable for more than 5 hours and Chlorthalidone for about 4 hours 30 minutes. 
 
Various aliquots of Telmisartan and Chlorthalidone were prepared in the 
concentration range of 5 - 40 µg/ ml and 2 – 24 µg/ ml,   respectively. The absorbances of 
these solutions were measured at the selected wavelengths. The calibration curve was 
constructed using concentration versus absorbance. The preparation of calibration curve was 
repeated for six times for each drug at their selected wavelengths. The optical parameters like 
Molar absorptivity, Sandell‟s sensitivity,  Correlation coefficient, Slope, Intercept, LOD and 
LOQ were calculated. The correlation coefficient for all the four drugs was found to be above 
0.999. This indicates that all the drugs obey Beer‟s law in the selected concentration ranges. 
Hence the concentrations were found to be linear. The calibration graph for Telmisartan at 
311 nm and for Chlorthalidone at 251 nm are shown in figure 5 and 6, respectively. The 
optical characteristics of the drugs at their selected wavelengths are shown in tables 3 and 4, 
respectively. 
The developed method was applied for the analysis of synthetic mixture to find out 
the developed method was correct or not. The amount of Telmisartan and Chlorthalidone 
were found to be in the range of  99.80-102.07 % and 97.54–99.36%, respectively. The 
results are listed in table 5. The amount found was good agreement with the expected 
concentration. Hence it was planned to apply for the analysis of formulation. 
The tablet formulation Eritel- CH  40 (containing Telmisartan- 40 mg and 
Chlorthalidone) was selected for the analysis. The percentage purity of the drugs in the 
formulation was found to be 100.33 ±0.7993 and 99.99 ± 0.4373 for Telmisartan and 
Chlorthalidone, respectively. The results are listed in table 6. The confidence interval (95%) 
for drugs was found to be in the range of, 99.0142 – 101.6458 and 99.0143 – 100.7098 for 
Telmisartan and Chlorthalidone, respectively. The precision of the method was confirmed by 
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the repeated analysis of formulation for six times. The percentage RSD values were found to 
be 0.7966 and 0.4374 for Telmisartan and Chlorthalidone, respectively. 
Further the precision of the method was confirmed by intraday and inter day analysis. 
Intraday and inter day analysis of formulation was done on three times on same day and one 
time on three consecutive days. The percentage RSD for the intraday and inter day precision 
was found to be 0.9295 and 0.8424 for Telmisartan 1.2105 and 1.1785 for Chlorthalidone, 
respectively. The results are listed in table 7. The low percentage RSD values indicated that 
the precision of the method was confirmed.  
The ruggedness of the method was validated by using different analysts. The 
percentage RSD for analyst 1 were found to be 0.7643 and 0.4279 for Telmisartan and 
Chlorthalidone, respectively. The result shown in table 8. 
The accuracy of the method was confirmed by the recovery studies. To the pre-
analyzed formulation, a known quantity of raw material was added and the percentage 
recovery was calculated. The percentage of raw material added was 80%, 100% and 120% 
for Telmisartan and Chlorthalidone Respectively. The percentage recovery was found to be in 
the range of 99.13- 102.72 % for Telmisartan, 99.98 – 101.52 for Chlorthalidone.  The 
percentage RSD value was found to be 1.7823 for Telmisartan, 1.1152 for Chlorthalidone, 
The low percentage RSD indicated there was no interference due to excipients used in 
formulation. Hence, the accuracy method was conformed. The results are listed in table 9. 
The confidence interval (95%) for drugs was found to be in the range of 100.26 – 102.77, and 
98.85-102.87 for Telmisartan and Chlorthalidone, respectively.   
5.3 RP – HPLC METHOD 
 An effort has been made for a simple, rapid, accurate and precise method for the 
simultaneous estimation of Telmisartanand Chlorthalidone in pure form and in formulation 
by an isocratic RP – HPLC method. 
The solution of 10 µg/ ml of Telmisartan and Chlorthalidone was prepared in the 
mobile phase of Acetonitrile: water with the ratio of 50: 50% v/v. The solutions were scanned 
in the UV range of 200 - 400 nm. It was found that these two drugs have marked absorbance 
at 229 nm and therefore 229 nm was selected as detection wavelength for estimation of two 
drugs by RP – HPLC method with an isocratic elution technique and it was found that these 
two drugs are stable for at least 3 hours. The overlinespectra is shown in figure 7. 
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 The optimization was done by changing the composition of mobile phase, ratio and 
flow rate. The mobile phase consists of Acetonitrile: Methanol (50:50 % v/v) was initially 
tried and chromatogram was recorded. These are shown in Figure 8.  The mobile phase 
consists of Acetonitrile : Ammonium acetate buffer pH 5 (50: 50% v/v) was tried and the 
chromatograms are shown in Figure 9. The mobile phase consists of Acetonitrile: Phosphate 
Buffer (50: 50 % v/v) pH (3.5) and 70:30%  were tried and the chromatograms are shown in 
figures 10 and 11. Finally the mobile phase consists of Acetonitrile: Water with 0.1 ml of 
0.1% triethylamine with the ratio of 50: 50% v/v, was tried. After calculating all system 
suitability parameters Acetonitrile: Water with 0.1 ml of 0.1% Triethylamine in the ratio of 
50: 50 % v/v at flow rate of 1.0 ml/ min was selected and the optimized chromatogram is 
shown in figure 12. The system suitability parameters for optimized chromatogram are shown 
in Table 10. The retention time for Telmisartan and Chlorthalidone was found to be minutes 
2.915 and 4.637 respectively and with a resolution of 9.087 which is better resolution. 
The calibration was done by external standard calibration method. With the optimized 
chromatographic conditions, stock solutions of Telmisartan and Chlorthalidone were 
prepared by using methanol (for first dilution only) and mobile phase and various 
concentrations were prepared in the range of 5-25 g/ ml of Telmisartanand 2 - 16 g/ ml of 
Chlorthalidone, respectively. 20 l of each solution were injected individually and the 
chromatograms were recorded at 229 nm. The chromatograms are shown in                   
figures 13 - 17. The calibration curve was plotted using concentration against peak area. The 
procedure was repeated for three times.  The correlation co - efficient value was found above 
0.999 for two drugs. It indicates that the concentrations of Telmisartan and chlorthalidone 
had good linearity. The calibration graphs are shown in figures 18 and 19. The optical 
characteristics of Telmisartanand Chlorthalidone are shown in Table 11. 
 The tablet dosage form (Eritel-CH 40) was selected for the analysis. The ostensible 
concentration of 8 g/ ml of Telmisartan which is also containing 2.5 g/ ml of 
Chlorthalidonein the mobile phase was prepared. 20 l of each solution was injected and 
chromatograms were recorded. The percentage purity was found to be 101.63 ± 0.7025 and 
101.46 ± 0.4449 for Telmisartan and Chlorthalidone, respectively. The precision of the 
method was confirmed by repeatability of formulation for six times and the chromatograms 
are shown in figures 20 – 25. The percentage RSD was found to be 0.6912 and 0.4329 for 
Telmisartan and Chlorthalidone, respectively. It indicates that the method has good precision. 
The data for the analysis of formulation is shown in Table 12. 
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 The accuracy of the method was performed by recovery studies. To the pre analyzed 
formulation, a known quantity of  Telmisartan and Chlorthalidone raw material solutions 
were added at different levels and injected the solutions. The chromatograms were recorded 
as shown in the Figure 26 - 28. The percentage recovery was found to be in the range 
between 99.45 – 101.76%  for Telmisartan and  99.08 – 102.01% for Chlorthalidone.          
The % RSD was found to be 0.9350 for Telmisartan and 0.3580 for Chlorothalidone 
respectively. The low % RSD values for recovery indicated that the method was found to be 
accurate. The values are given in the table 13. The high percentage recovery revealed that no 
interference produced due to the excipients used in formulation. Therefore, the developed 
method was found to be accurate. 
 
5.2 HPTLC Method  
 An effort was made to develop a simple, precise and accurate method for the 
simultaneous estimation ofTelmisartan and Chlorthalidonein bulk and in pharmaceutical 
dosage form by HPTLC method. 
 The initial separation was based up on the solubility of drugs, the different mobile 
phase were tried to get the better resolution. The different mixtures of the mobile phase tried 
were Ethyl Acetate: 1,4- dioxane: Methanol: 25% ammonia, Ethyl acetate: Methanol: 25% 
ammonia:  Glacial Acetic acid, Toluene: Benzene: Methanol, Benzene: Toluene: 
Diethylamine, THF: dichloromethane: Methanol: 25% ammonia.                                            
InToluene: 2-Propanol:25% ammonia, all the drugs were well separated with good resolution 
when compared to other mobile phases. By altering the composition of Toluene the 
separation was affected more. Hence the chromatograms were recorded by changing the 
concentration of Toluene. In the mobile phase, Toluene: 2-Propanol: 25% ammonia, in the 
ratio of 6.5: 3.5: 0.02%  ammonia, both the drugs were eluted with better resolution. Hence 
this was selected as the mobile phase for the analysis of Telmisartan and Chlorthalidone. 
With the above selected mobile phase the UV spectra of all the drugs were recorded and 
overlained. From the overlain spectra, at 229 nm both the drugs showed marked absorbance. 
Hence this was selected as the detection wavelength. The optimized chromatogram is shown 
in figure 29.  The Rf value for Telmisartan and Chlorthalidone were found to be 0.28 ± 0.01 
and 0.65 ± 0.01 respectively. 
 The linearity range was fixed as 100 – 800 ng/ µl for Telmisartan and  50 – 400 ng/ µl 
for  Chlorthalidone.shown in figures 30 – 37. The calibration graph was recorded using peak 
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area and concentration and these are shown in figures 38 and 39. The correlation coefficients 
were found to be 0.9992 and 0.9989, for Telmisartan and Chlorthalidone, respectively. The 
optical characteristics such as the Correlation coefficient, Slope, Intercept, LOD and LOQ 
and were calculated and shown in tables 14. The correlation coefficient values indicated that 
the selected concentration was linear.  
 The tablet dosage form ERITEL-CH was selected for the analysis. The chromatogram 
for the analysis of formulation was shown in figures 40 – 45. The percentage purity of 
Telmisartan and Chlorthalidone were found to be 101.66 ± 0.7839 and 101.31 ± 0.8343, 
respectively. The results of analysis are shown in table 15. The confidence interval(95%) for 
drugs was found to be in the range of 100.37 – 102.95 and 99.94 – 102.68 for Telmisartan 
and Chlorthalidone, respectively.Precision of the method was confirmed by repeated analysis 
of formulation for six times. The percentage RSD values were found to be 0.7725 and 0.8228 
for Telmisartan and Chlorthalidone, respectively. 
 Further the precision of the method was confirmed by intraday and inter day analysis. 
Intraday and inter day analysis of formulation was done on three times on same day and one 
time on three consecutive days. The percentage RSD values for the intraday and inter day 
precision was found to be less than 2. The low % RSD values indicated that the intermediate 
precision of the method was confirmed. 
 The accuracy of the method was confirmed by the recovery studies. To the pre-
analyzed formulation, a known quantity of raw material was added and the percentage 
recovery was calculated. The percentage of raw material added was 80%, 100% and 120% 
for two drugs. The chromatograms for the recovery analysis are shown in figures 46 – 48. 
The percentage recovery was found to be in the range of  98.99 - 99.23%, for Telmisartan and  
101.16 - 102.38% for Chlorthalidone, The percentage RSD values were found to be 0.1201 
and 0.6319 for Telmisartan and Chlorthalidone respectively. The low percentage RSD value 
indicates that there was no interference due to the excipients used in formulation during the 
analysis. The data of recovery analysis are listed in table 16.  
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6. SUMMARY AND CONCLUSION 
 Three simple, precise and accurate methods were developed for the simultaneous 
estimation of Telmisartan and Chlorthalidone in bulk and in pharmaceutical dosage form. 
 The methods developed were 
1. UV Spectroscopy 
  First Order Derivative Spectrophotometry 
2. HPLC 
3. HPTLC Method 
6.1. UV Spectroscopy  
6.1.1 First Order Derivative Spectrophotometry 
 From the solubility profile, 0.1M Sodium hydroxide was chosen as the common 
solvent for the simultaneous analysis of Telmisartan and Chlorthalidone. The spectra of all 
the drugs recorded and are derivitized to first order. From the overlain first order derivative 
spectra 311 nm and 251nm were selected for the analysis of Telmisartan and Chlorthalidone, 
respectively. 
 Beer‟s law obeyed the concentration range of 5 - 40 µg/ ml, and 2-24 µg / ml,   for 
Telmisartan and Chlorthalidone, respectively. The calibration graphs were plotted. The 
correlation coefficient values for the two drugs were more than 0.999.  The optical 
parameters like the Molar absorptivity, Sandell‟s sensitivity, Correlation coefficient, Slope, 
Intercept, LOD and LOQ, and were calculated. 
The developed method was applied for the analysis of synthetic mixture to find out 
the developed method was correct or not. The amount of Telmisartan and Chlorthalidone 
were found to be in the range of 99.80- 102.07% and 97.54 - 99.36%, respectively. The 
amount found was good agreement with the expected concentration. Hence it was planned to 
apply for the analysis of formulation. 
ERITEL – CH  40  Tablet containing Telmisartan 40 mg and Chlorthalidone 12.5  mg 
and was selected for the analysis. The percentage of drugs in the formulation was found to be 
100.33 ± 0.7993 and 99.90 ± 0.4373 for Telmisartan  and Chlorthalidone respectively. The 
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confidence interval (95%) for drugs was found to be in the range of   99.01-101.64% and     
99.27 - 100.70%   for Telmisartan and chlorthalidone, respectively.   
 The precision of the method was confirmed by the repeatability studies. The 
percentages RSD were found to be 0.7966 and 0.4374 for Telmisartan and Chlorthalidone, 
respectively. 
Further the precision of the method was confirmed by intraday and inter day analysis. 
The percentages RSD values for intraday and inter day were found to be 0.9295 and 0.8424 
for Telmisartan, 1.2105 and 1.1785 for chlorthalidone.  
 The ruggedness of the method was confirmed by performing the analysis with the 
different analysts. The percentage RSD values for different analysts were found to be 0.7643 
and 0.4279 for Telmisartan and chlorthalidone respectively. 
 The accuracy of the method was confirmed by recovery studies. To the pre analysed 
formulation the different amount of raw material were added and the amount of drugs 
recovered were calculated. The percentage recovery was found to be in the range of         
99.13 - 102.72% for Telmisartan 99.98 - 101.52 % for Chlorthalidone, the percentage RSD 
value was found to be 1.7823 for Telmisartan 1.1152 for Chlorthalidone  The confidence 
interval (95%) for drugs was found to be in the range of 100.26 to 102.77 and 98.25 to 101.88 
for Telmisartan and Chlorthalidone, respectively.   
6.2 RP – HPLC METHOD 
         An exertion has been made for a simple, rapid, accurate and precise method for the 
estimation of Telmisartan and Chlorthalidone in pure form and in formulation by an isocratic 
RP – HPLC method. 
   The optimization was done by changing the composition of mobile phase and mobile 
phase ratios. Finally the mobile phase consisting of Acetonitrile and Water with 0.1 ml of 
0.1%Triethylamine was selected. The detection wavelength was 229 nm. The retention time 
ofTelmisartan and Chlorthalidone were found to be  2.915 and 4.637 respectively. The 
resolution between the separated components was 9.187. 
The calibration was done by external standard calibration method. The drug solutions of 
Telmisartan and Chlorthalidone were obyed Beer‟s law in the concentration range of                
5-25 µg/ ml and 2- 16 µg/ ml, respectively. The correlation coefficient was above 0.999 for the 
both the drugs. 
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Eritel-CH 40 tablets containing 40 mg of Telmisartan and 12.5 mg of Chlorthalidone 
was selected for analysis. The percentage label claim present in tablet formulation was found 
to be 101.63 ± 0.7025 and 101.46 ± 0.4449 for Telmisartan and Chlorthalidone, respectively.  
 The accuracy of the method was confirmed by recovery studies. The percentage 
recovery was found to be in the range of 99.45 – 101.76% for Telmisartan and                
99.08 - 102.01% for Chlorthalidone. The % RSD values for Telmisartan and Chlorthalidone 
were found to be 0.9350 and 0.3580 respectively.       
6.3. HPTLC Method 
  The simple, precise and accurate HPTLC method was developed for the simultaneous 
estimation of Telmisartan and Chlorthalidone in bulk and in pharmaceutical dosage form. 
 The mobile phase consists of Toluene: 2-Propanol: 25% ammonia                           
(6.5: 3.5: 0.02% v/v/v/v) was selected for the analysis. From the spectral characteristics, 229 
nm was selected as detection wavelength for the analysis. 
 Beer‟s law obeyed the concentration range of 100 – 800 ng/ µl, 50 – 400 ng/ µl,   for 
Telmisartan and Chlorthalidone, respectively. The calibration graphs were plotted. The 
correlation coefficient values for all the drugs were more than 0.999. The optical parameters 
like the Correlation coefficient, Slope, Intercept, LOD and LOQ were calculated. 
  Eritel-CH 40 containing Telmisartan 40 mg and Chlorthalidone 12.5 mg was selected 
for the analysis. The percentage of drugs in the formulation was found to be 101.66 ± 0.7725, 
101.31 ± 0.8336, for Telmisartan and Chlorthalidone, respectively. The confidence interval 
(95%) for drugs was found to be in the range of 100.36 – 102.95 and 99.94 to 102.68 for 
Telmisartan and Chlorthalidone, respectively. 
Precision of the method was confirmed by repeated analysis of formulation for six 
times. The percentage RSD values were found to be less than 2. The low percentage RSD 
value indicates that the intermediate precision of the method was conformed. 
The accuracy of the method was confirmed by the recovery studies. To the              
pre-analyzed formulation, a known quantity of raw material was added and the percentage 
recovery was calculated. The percentage recovery was found to be in the range of           
98.99 - 99.23%, for Telmisartan and 101.16 – 101.88 for Chlorthalidone. The percentage 
RSD values were found to be 0.1212 and 0.6034 for Telmisartan and Chlorthalidone, 
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respectively. The confidence interval (95%) for drugs was found to be in the range of       
98.90 – 99.29 and    100.68 – 102.77 for Telmisartan and Chlorthalidone, respectively. 
 Three instrumental analytical methods were successfully developed for the 
simultaneous estimation of Telmisartan and Chlorthalidone in bulk and in pharmaceutical 
dosage form. 
The three methods were found to be accurate, precise and rapid for the simultaneous 
estimation of these drugs. This was confirmed by low percentage RSD values. The 
spectrophotometric method is found to be economical when compared to the HPLC and 
HPTLC method. But HPLC and HPTLC is more sensitive than UV spectrophotometric 
method. The low percentage RSD value in the recovery studies suggests that the excipients 
do not interfere in the analysis of formulation and hence all the methods are accurate. HPLC 
and HPTLC are found to be more sensitive than other method. Because the linearity range, 
LOD, LOQ were less in HPLC and HPTLC method than UV spectroscopic method. Hence it 
is suggested that these three methods can be applied successfully for the routine quality 
control analysis for the simultaneous estimation of Telmisartan and Chlorthalidone in bulk 
and in pharmaceutical dosage form and the obtained results will be presented elsewhere.    
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Figure 1 
IR SPECTRUM OF TELMISARTAN
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Figure 2 
IR SPECTRUM OF CHLORTHALIDONE 
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Figure 3 
OVERLAIN ZERO ORDER SPECTRA OF TELMISARTAN AND 
CHLORTHALIDONE 
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Figure 4 
OVERLAIN FIRST ORDER DERIVATIVE SPECTRUM OF TELMISARTAN AND 
CHLORTHALIDONE 
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Figure 5 
CALIBRATION GRAPH FOR TELMISARTAN AT 311 nm 
(FIRST ORDER DERIVATIVE METHOD)
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Figure 6 
CALIBRATION GRAPH FORCHLORTHALIDONE AT 251 nm 
(FIRST ORDER DERIVATIVE METHOD) 
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Figure 7 
OVERLAIN SPECTRA OF TELMISARTAN AND CHLORTHALIDONE BY     
HPLC METHOD 
(DETECTION WAVELENGTH) 
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Figure 8 
INTIAL SEPARATION CONDITIONS IN 
ACETONITRILE: METHANOL (50:50 %v/v) 
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Figure 9 
INTIAL SEPARATION CONDITIONS IN 
ACETONITRILE: AMMONIUM ACETATE BUFFER (pH 5)(50:50 %v/v) 
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Figure 10 
INTIAL SEPARATION CONDITIONS IN 
ACETONITRILE: PHOSPHATE BUFFER (pH 3.5)(50:50 %v/v) 
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Figure 11 
INTIAL SEPARATION CONDITIONS IN 
ACETONITRILE: PHOSPHATE BUFFER (pH 3.5)(70:30 %v/v) 
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Figure 12 
OPTIMIZED CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE 
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FIGURE - 13 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE, (5 and 2 µg/ ml) 
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FIGURE - 14 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE (10, 4µg/ ml) 
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FIGURE - 15 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE (15, 8µg/ ml) 
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FIGURE - 16 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE (20,12µg/ ml) 
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FIGURE - 17 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE (25, 16µg/ ml) 
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FIGURE - 18 
CALIBRATION CURVE FOR TELMISARTAN  BY RP – HPLC 
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FIGURE - 19 
CALIBRATION CURVE FOR CHLORTHALIDONE  BY RP – HPLC 
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FIGURE-20 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION – ERITEL CH 40 
REPEATABILITY – 1 
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FIGURE-21 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION – ERITEL CH 40 
REPEATABILITY –2 
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FIGURE-22 
CHROMATOGRAM FOR ANALYIS OF FORMULATION – ERITEL CH 40 
REPEATABILITY – 3 
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FIGURE-23 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION – ERITEL CH 40 
REPEATABILITY – 4 
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FIGURE-24 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION – ERITEL CH 40 
REPEATABILITY – 5 
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FIGURE-25 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION – ERITEL CH 40 
REPEATABILITY – 6 
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FIGURE-26 
CHROMATOGRAM FOR FIRST RECOVERY OF FORMULATION - 1 
(ERITEL CH- 40 ) 
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FIGURE-27 
CHROMATOGRAM FOR FIRST RECOVERY OF FORMULATION - 2 
(ERITEL CH- 40 ) 
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FIGURE-28 
CHROMATOGRAM FOR FIRST RECOVERY OF FORMULATION - 3 
(ERITEL CH- 40 ) 
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Figure -29  
OPTIMIZED CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE BY HPTLC 
 
 
 
Peak Start Position    Start Height    Max Position     Max Height   Max %   End Position End 
Height Area Area %   Assigned substance 
1  0.26 Rf 6.8 AU 0.29 Rf 29.2 AU 100.00 % 0.34 Rf 
 1.7 AU415.3 AU 100.00 % Telmisartan * 
2  0.62 Rf 0.2 AU 0.65 Rf 61.4 AU 100.00 % 0.69 Rf 
 0.7 AU 792.1 AU 100.00 % Chlorthalidone * 
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FIGURE-30 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE  BY HPTLC 
(100 + 50 ng/ µl) 
 
 
   
 
Peak Start Position    Start Height    Max Position     Max Height   Max %   End Position End 
Height Area Area %   Assigned substance 
1  0.22 Rf 6.0 AU 0.28 Rf 98.4 AU 100.00 % 0.33 Rf 8.0 
AU     213.2 AU 100.00 % Telmisartan * 
2  0.62 Rf 0.1 AU 0.65 Rf 35.1 AU 100.00 % 0.68 Rf 0.0 
AU     507.1 AU 100.00 % Chlorthalidone * 
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FIGURE-31 
LINEARITY CHROMATOGRAM FOR TELMISARTAN AND 
CHLORTHALIDONE  BY HPTLC 
(200 + 100 ng/ µl) 
 
 
 
Peak Start Position    Start Height   Max Position    Max Height  Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.26 Rf 6.8 AU 0.29 Rf 29.2 AU 100.00 % 0.34 Rf    
 1.7 AU    415.3 AU 100.00 % Telmisartan * 
2  0.62 Rf 0.2 AU 0.65 Rf 61.4 AU 100.00 % 0.69 Rf    
 0.7 AU    792.1 AU 100.00 % Chlorthalidone * 
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FIGURE-32 
LINEARITY CHROMATOGRAM FORTELMISARTAN AND CHLORTHALIDONE  
BY HPTLC 
(300 + 150 ng/ µl) 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.22 Rf  3.9 AU   0.27 Rf 81.8 AU 100.00 % 0.31 Rf               
 0.3 AU     584.9 AU 100.00 % Telmisartan* 
2  0.63 Rf             1.4 AU    0.65 Rf 77.9 AU 100.00 % 0.67 Rf  
 0.3 AU  1196.4 AU 100.00 % Chlorthalidone * 
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FIGURE-33 
LINEARITY CHROMATOGRAM FORTELMISARTAN AND CHLORTHALIDONE  
BY HPTLC 
(400 + 200 ng/ µl) 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.24 Rf            6.9 AU       0.28 Rf 19.8 AU 100.00 % 0.34 Rf    0.6 
AU  797.8 AU 100.00 % Telmisartan* 
2  0.62 Rf   2.5 AU      0.64 Rf 110.9 AU 100.00 % 0.69 Rf   10.0 
AU 1471.6  AU 100.00 % Chlorthalidone* 
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FIGURE-34 
LINEARITY CHROMATOGRAM FORTELMISARTAN AND CHLORTHALIDONE  
BY HPTLC 
(500 + 250 ng/ µl) 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.21 Rf 5.4 AU     0.29 Rf 52.8 AU 100.00 % 0.31 Rf 0.5 
AU    1018.9 AU 100.00 % Telmisartan * 
2  0.64 Rf 0.2 AU 0.66 Rf 140.7 AU 100.00 % 0.69 Rf
 18.4 AU   1821.5  AU 100.00 % Chlorthalidone* 
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FIGURE-35 
LINEARITY CHROMATOGRAM FORTELMISARTAN AND CHLORTHALIDONE  
BY HPTLC 
(600 + 300 ng/ µl) 
 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.19 Rf 3.9 AU 0.28 Rf 81.8 AU 100.00 % 0.39 Rf 0.3 
AU   1272.7 AU 100.00 % Telmisartan * 
2  0.63 Rf 1.2 AU 0.65 Rf 174.8 AU 100.00 % 0.67 Rf
 12.6 AU 2197.1 AU 100.00 % Chlorthalidone * 
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FIGURE-36 
LINEARITY CHROMATOGRAM FORTELMISARTAN AND CHLORTHALIDONE  
BY HPTLC 
(700 + 350 ng/ µl) 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.20 Rf 7.4 AU 0.27 Rf 111.7 AU 100.00 % 0.32 Rf 3.1 
AU    1479.6 AU 100.00 % Telmisartan * 
2  0.63 Rf 0.1 AU 0.65 Rf 154.9 AU 100.00 % 0.69 Rf 7.0 
AU    2565.4 AU 100.00 % Chlorthalidone * 
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FIGURE-37 
LINEARITY CHROMATOGRAM FORTELMISARTAN AND CHLORTHALIDONE  
BY HPTLC 
(800 + 400 ng/ µl) 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.20 Rf 8.1 AU 0.27 Rf 122.2 AU 100.00 % 0.36 Rf 2.2 
AU    1690.8 AU 100.00 % Telmisartan * 
2  0.63 Rf 0.3 AU 0.65 Rf 108.9 AU 100.00 % 0.67 Rf 0.0 
AU     2890.6 AU 100.00 % Chlorthalidone * 
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FIGURE-38 
CALIBRATION GRAPH FOR TELMISARTAN  BY HPTLC 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
143 
 
 
FIGURE-39 
CALIBRATION GRAPH FOR CHLORTHALIDONE  BY HPTLC 
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FIGURE-40 
CHROMATAGRAM FOR FORMULATION (ERITEL - CH 40 ) ANALYSIS BY 
HPTLC  
REPEATABILITY 1 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.22 Rf 12.5 AU 0.28 Rf 30.7 AU 91.43 % 0.38 Rf
 9.2 AU    676.13 AU 97.90 % Telmisartan* 
2  0.63 Rf 0.6 AU  0.65 Rf 43.4 AU 98.57 % 0.69 Rf
 1.1 AU     799.7 AU 98.10 % Chlorthalidone * 
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FIGURE-41 
CHROMATAGRAM FOR FORMULATION (ERITEL - CH 40) ANALYSIS BY 
HPTLC  
REPEATABILITY -2 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.22 Rf  3.9 AU   0.27 Rf 81.8 AU 100.00 % 0.31 Rf               
 0.3 AU     666.2  AU 100.00 % Telmisartan* 
2  0.63 Rf             1.4 AU    0.65 Rf 77.9 AU 100.00 % 0.67 Rf  
 0.3 AU  799.2  AU 100.00 % Chlorthalidone * 
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FIGURE-42 
CHROMATAGRAM FOR FORMULATION (ERITEL - CH 40) ANALYSIS BY 
HPTLC  
REPEATABILITY -3 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.24 Rf            6.9 AU       0.28 Rf 19.8 AU 100.00 % 0.34 Rf    0.6 
AU  673.8 AU 100.00 % Telmisartan* 
2  0.62 Rf   2.5 AU      0.64 Rf 110.9 AU 100.00 % 0.69 Rf   10.0 
AU 799.2  AU 100.00 % Chlorthalidone* 
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FIGURE-43 
CHROMATAGRAM FOR FORMULATION (ERITEL - CH 40) ANALYSIS BY 
HPTLC  
REPEATABILITY -4 
 
 
 
 
Peak Start Position    Start Height   Max Position    Max Height  Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.26 Rf 6.8 AU  0.29 Rf 29.2 AU 100.00 % 0.34 Rf    
 1.7 AU    677.4 AU 100.00 % Telmisartan * 
2  0.62 Rf 0.2 AU  0.65 Rf 61.4 AU 100.00 % 0.69 Rf    
 0.7 AU    793.1  AU 100.00 % Chlorthalidone *
149 
 
 
 
 
FIGURE-44 
CHROMATAGRAM FOR FORMULATION (ERITEL - CH 40) ANALYSIS BY 
HPTLC  
REPEATABILITY -5 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.20 Rf 8.1 AU 0.27 Rf 122.2 AU 100.00 % 0.36 Rf 2.2 
AU    675.4 AU 100.00 % Telmisartan * 
2  0.63 Rf 0.3 AU 0.65 Rf 108.9 AU 100.00 % 0.67 Rf 0.0 
AU     785.7 AU 100.00 % Chlorthalidone * 
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FIGURE-45 
CHROMATAGRAM FOR FORMULATION (ERITEL - CH 40) ANALYSIS BY 
HPTLC  
REPEATABILITY -6 
 
Peak Start Position    Start Height    Max Position     Max Height   Max %   End Position End 
Height Area Area %   Assigned substance 
1  0.22 Rf 6.0 AU 0.28 Rf 98.4 AU 100.00 % 0.33 Rf 8.0 
AU     666.5  AU 100.00 % Telmisartan * 
2  0.62 Rf 0.1 AU 0.65 Rf 35.1 AU 100.00 % 0.68 Rf 0.0 
AU     798.2 AU 100.00 % Chlorthalidone * 
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FIGURE-46 
CHROMATOGRAM FOR THE RECOVERY ANALYSIS OF FORMULATION 
(ERITEL – CH 40) BY HPTLC 
RECOVERY 1 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.21 Rf 5.4 AU     0.29 Rf 52.8 AU 100.00 % 0.31 Rf 0.5 
AU    1209.4 AU 100.00 % Telmisartan * 
2  0.64 Rf 0.2 AU 0.66 Rf 140.7 AU 100.00 % 0.69 Rf
 18.4 AU   1374.6  AU 100.00 % Chlorthalidone* 
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FIGURE-47 
CHROMATOGRAM FOR THE RECOVERY ANALYSIS OF FORMULATION 
(ERITEL – CH 40) BY HPTLC 
RECOVERY - 2 
 
Peak Start Position    Start Height   Max Position    Max Height  Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.26 Rf 6.8 AU  0.29 Rf 29.2 AU 100.00 % 0.34 Rf    
 1.7 AU    1344.8 AU 100.00 % Telmisartan * 
2  0.62 Rf 0.2 AU 0.65 Rf 61.4 AU 100.00 % 0.69 Rf    
 0.7 AU    1514.4  AU 100.00 % Chlorthalidone * 
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FIGURE-48 
CHROMATOGRAM FOR THE RECOVERY ANALYSIS OF FORMULATION 
(ERITEL – CH 40) BY HPTLC 
RECOVERY – 3 
 
 
Peak Start Position    Start Height   Max Position    Max Height   Max % End Position End 
Height    Area   Area %   Assigned substance 
1  0.20 Rf 8.1 AU   0.27 Rf 122.2 AU 100.00 % 0.36 Rf 2.2 
AU    1478.3  AU 100.00 % Telmisartan * 
2  0.63 Rf 0.3 AU 0.65 Rf 108.9 AU 100.00 % 0.67 Rf 0.0 
AU     1653.4  AU 100.00 % Chlorthalidone * 
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Table 1 
SOLUBILITY PROFILE OF TELMISARTAN 
S.NO SOLVENT EXTENT OF 
SOLUBILTY 
CATEGORY 
1. Distilled water More than 100 ml Practically insoluble 
2. 0.1 M NaOH 10 mg in 0.25ml Soluble 
3. 0.1 M HCL 10 mg in 0.2 ml Soluble 
4. Acetonitrile 10 mg in 70 ml Very slightly soluble 
5. Acetone 10 mg in 20 ml Very slightly soluble 
6. Benzene More than 100 ml Insoluble 
7. Chloroform 10 mg in 7 ml Slightly soluble 
8. Carbon tetra chloride More than 100 ml Insoluble 
9. Cyclohexane More than 100 ml Insoluble 
10. Dimethyl formamide 10 mg in 0.85 ml Sparingly soluble 
11. Diethylamine 10 mg in 0.06 ml Practically insoluble 
12. Dichloromethane 10 mg in 0.550 ml Freely soluble 
13. Ethanol 10 mg in 30 ml Very slightly soluble 
14. Isopropyl alcohol More than 100 ml Insoluble 
15. Methanol 10 mg in 8 ml Slightly soluble 
16. N-Butanol 10 mg in 60 ml Very slightly soluble 
17. N-Hexane More than 100 ml Practically insoluble 
18. Petrolium Spirit More than 100 ml Practically insoluble 
19. Pyridine 10 mg in 0.3 ml Soluble 
20. Acid Phathale buffer pH3.0 More than 100 ml Practically insoluble 
21. Acid Phathale buffer pH4.0 More than 100 ml Practically insoluble 
22. Phosphate buffer pH 7.0 More than 100 ml Practically insoluble 
23 Phosphate buffer pH 8.0 More than 100 ml Practically insoluble 
24 Alkaline borate buffer pH 8.0 More than100 ml Practically insoluble 
25 Alkaline borate buffer pH 9.0 More than 100 ml Practically insoluble 
26 Alkaline borate buffer pH 10 More than 100ml Practically insoluble 
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Table 2 
SOLUBILITY PROFILE OF CHLORTHALIDONE 
S.NO SOLVENT EXTENT OF 
SOLUBILTY 
CATEGORY 
1. Distilled water More than 100 ml Practically insoluble 
2. 0.1 M NaOH 10 mg in 0.35ml Sparingly soluble 
3. 0.1 M HCL More than 100 ml Insoluble 
4. Acetonitrile 10 mg in 3 ml Slightly soluble 
5. Acetone 10 mg in 0.06 ml Freely  soluble 
6. Benzene More than 100 ml Insoluble 
7. Chloroform More than 7 ml Slightly soluble 
8. Carbon tetra chloride More than 100 ml Insoluble 
9. Cyclohexane More than 100 ml Insoluble 
10. Dimethyl formamide 10 mg in 0.850 ml Freely soluble 
11. Diethylamine 10 mg in 0.06 ml Freely soluble 
12. Dichloromethane 10 mg in 0.550 ml Sparingly soluble 
13. Ethanol 10 mg in 0.6 ml Sparingly soluble 
14. Isopropyl alcohol 10 mg in 20 ml Very slightly soluble 
15. Methanol 10 mg in 0.08 ml Freely soluble 
16. N-butanol 10 mg in 8 ml Slightly soluble 
17. N-Hexane More than 100 ml Practically insoluble 
18. Petroleum Spirit More than 100 ml Practically insoluble 
19. Pyridine 10 mg in 0.08 ml Freely soluble 
20. Acid Phathale buffer pH3.0 More than 100 ml Practically insoluble 
21. Acid Phathale buffer pH4.0 More than 100 ml Practically insoluble 
22. Phosphate buffer pH 7.0 More than 100 ml Practically insoluble 
23 Phosphate buffer pH 8.0 More than 100 ml Practically insoluble 
24 Alkaline borate buffer pH 8.0 More than100 ml Practically insoluble 
25 Alkaline borate buffer pH 9.0 More than 100 ml Practically insoluble 
26 Alkaline borate buffer pH 10 More than 100ml Practically insoluble 
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Table 3 
OPTICAL PARAMETER OF TELMISARTAN 
(FIRST ORDER DERIVATIVE SPECTROPHOTOMETRY) 
PARAMETERS AT 311 nm* 
Beers law limit  (μg/ ml) 5 – 40 
Molar absorptivity (L mol
-1
cm
-1
) 932.003 
Sandell‟s sensitivity (μg/cm2/0.001 A.U) 0.5733 
Correlation coefficient (r) 0.9999 
Regression equation (Y=mx+c) Y = 0.001744x +0.000667 
Slope (m) 0.001744 
Intercept (c) 0.0006672 
LOD (μg/ ml) 0.037716 
LOQ (μg/ ml) 0.11429 
Standard Error 0.0005218 
(*Mean of six observations) 
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Table 4 
OPTICAL PARAMETER OF CHLORTHALIDONE 
      (FIRST ORDER DERIVATIVE SPECTROPHOTOMETRY) 
PARAMETERS AT 251 nm* 
Beers law limit  (μg/ ml) 2 – 24 
Molar absorptivity (L mol
-1
cm
-1
) 345.923 
Sandell‟s sensitivity (μg/cm2/0.001 A.U) 0.981964 
Correlation coefficient (r) 0.9999 
Regression equation (Y=mx+c) Y = 0.0010184x+ (-) 0.0000266 
Slope (m) 0.0010184 
Intercept (c) 0.0000266 
LOD (μg/ ml) 0.03393 
LOQ (μg/ ml) 0.10283 
Standard Error 0.0001267 
(*Mean of six observations) 
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Table 5 
ANALYSIS OF SYNTHETIC MIXTURE   
    (FIRST ORDER DERIVATIVE SPECTROPHOTOMETRY) 
Drug 
Theoretical 
concentration 
 
Experimental 
value 
(µg/ml)
* 
Percentage 
Obtained
* 
 
Mean 
 
 
 S.D 
% RSD SE 
TEL 
 
5 
10 
15 
20 
25 
30 
35 
5.0255 
10.0035 
15.1631 
19.9596 
25.3390 
30.6228 
35.2091 
100.50 
100.03 
101.08 
99.80 
101.35 
102.07 
100.60 
100.77 
 
 
 
 
0.7866 
0.7806 0.0160 
CHL 
 
 
2 
4 
8 
12 
16 
20 
24 
1.9704 
3.9014 
7.8125 
11.8546 
15.8149 
19.7915 
23.8499 
98.51 
97.54 
97.62 
98.76 
98.84 
98.95 
99.36 
98.51 
 
 
 
 0.6856 
0.6959 0.01399 
(* Mean of six observations) 
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Table 6 
QUANTIFICATION OF FORMULATION (ERITEL - CH 40) 
      (FIRST ORDER DERIVATIVE SPECTROPHOTOMETRY) 
Drug 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)
* 
Percentage 
Obtained
* 
 
Average 
(%)  
 
 
 
S.D % RSD SE 
 
 
CI
 
TEL 
 
40 
40 
40 
40 
40 
40 
 
40.7522 
40.0355 
40.1550 
39.8444 
40.0594 
39.9639 
 
101.88 
100.08 
100.38 
99.61 
100.15 
99.91 
 
100.33 
 
 
 
 
  0.7993 
0.7966 0.0222 
 
99.01 to 
101.64 
CHL 
 
 
12.5 
12.5 
12.5 
12.5 
12.5 
12.5 
 
12.5337 
12.5746 
12.4927 
12.4927 
12.4270  
12.4928 
 
100.26 
100.60 
99.94 
99.94 
99.98 
99.94 
 
99.99 
 
 
 
 0.4373 
0.4304 0.0121 
99.27 to 
100.70 
 
(*Mean of six observations) 
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Table 7 
INTRADAY AND INTER DAY ANALYSIS OF FORMULATION 
 (FIRST ORDER DERIVATIVE SPECTROPHOTOMETRY) 
Drug 
Amount   
labeled 
(mg/tab) 
Percentage 
Obtained* 
SD %RSD 
Intra 
day 
Inter 
day 
Intra 
day 
Inter 
day 
Intra 
day 
Inter 
day 
TEL 
40 
40 
40 
 
101.29 
99.73 
100.03 
 
101.94 
99.43 
101.59 
 
0.9540 
0.7260 
1.1191 
 
1.0209 
0.6168 
0.9056 
 
0.9418    
0.7280 
1.1186 
 
1.0015    
0.6203 
0.9056 
 
CHL 
12.5 
12.5 
12.5 
 
99.95 
100.12 
100.29 
 
100.28 
99.43 
101.59 
1.4785 
1.1471 
1.0095 
1.0209 
1.4661 
1.0662 
1.4792 
1.1457 
1.0067 
1.0093 
1.4667 
1.0597 
(*Mean of six observations) 
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Table 8 
RUGGEDNESS STUDY 
(FIRST ORDER DERIVATIVE SPECTROPHOTOMETRY) 
(*Mean of six observations) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PARAMETER PERCENTAGE AMOUNT 
FOUND 
SD %RSD 
TEL CHL TEL CHL TEL CHL 
DIFFERENT 
ANALYST 
99.80 99.93 0.7627 0.42763 0.7643 0.4279 
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Table 9 
RECOVERY ANALYSIS OF FORMULATION (ERITEL – CH 40) 
(FIRST ORDER DERIVATIVE SPECTROSCOPY) 
Drug 
Amount 
Present 
(µg/tab) 
Amount 
Added 
(µg/tab)* 
Amount 
Estimated 
(µg/tab)* 
Amount 
Recovered 
(µg/tab)* 
Percentage 
Recovered* 
SD %RSD SE 
TEL 
16.1567 
16.1567 
16.1567 
 
13.2549 
16.8176 
19.6671 
 
29.2672 
33.1006 
36.3588 
 
13.0105 
16.9439 
20.2021 
99.13 
100.75 
102.72 
1.7978 1.7823 0.1997 
Mean 
 
100.62 
 
CI = 100.26 to 102.77 
CHL 
 
4.9977 
4.9977 
4.9977 
 
 
 
4.2288 
4.9817 
5.9637 
 
 
 
9.2253 
9.9781 
11.0855 
 
 
 
4.2276 
4.9804 
6.0551 
99.98 
99.97 
101.52 
1.1207 1.1152 0.01384 
Mean 100.49 CI = 98.85 to 102.87 
(* Mean of three observation 
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TABLE – 10 
SYSTEM SUITABILITY PARAMETR 
PARAMETERS TELMISARTAN CHLORTHALIDONE 
Retention time 2.915 4.637 
Tailing factor 1.176 1.133 
Asymmetrical factor 1.146 1.119 
Theoretical plates 3826 2130 
Capacity factor 1.2083 2.5128 
Resolution Between TEL and CHL 9.187 
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Table 11 
OPTICAL PARAMETER OF TELMISARTAN AND CHLORTHALIDONE BY RP-
HPLC 
PARAMETERS TELMISARTAN* CHLORTHALIDONE* 
max (nm) 229nm 229nm 
Beers law limit (μg mL-1) 5-25 2-16 
Correlation coefficient (r) 0.9994 0.9996 
Régression équation 
(y=mx+c) 
Y= (83176)x+6710.61 Y=(75502)x-(6399.85) 
Slope (m) 83176 75502 
Intercept (c) 6710.61 6399.85 
LOD (μg mL-1) 0.17426 0.101042 
LOQ (μg mL-1) 0.5280 0.30621 
Standard Error 28090.69 11229.25 
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FIGURE -12 
QUANTIFICATION OF FORMULATION (ERITEL-CH 40)  
BY RP – HPLC 
Drug 
Sample 
No. 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg) 
Percentage 
Obtained * 
Average 
(%) 
S.D 
% 
R.S.D. 
S.E. 
 
 
 
TEL 
 
 
 
1 
2 
3 
4 
5 
6 
 
40 
40 
40 
40 
40 
40 
 
40.7148 
40.4804 
40.5334 
40.4825 
40.5081 
40.1978 
 
101.79 
101.20 
101.33 
101.20 
101.27 
102.99 
 
 
 
 
101.63 
 
 
 
 
 
 
0.7025 
 
 
 
0.69122 
 
 
 
0.0195 
 
CI=100.89 to 102.36 
 
 
 
CHL 
 
 
 
 
1 
2 
3 
4 
5 
6 
 
 
12.5 
12.5 
12.5 
12.5 
12.5 
12.5 
 
12.6410 
12.5592 
12.7512 
12.6016 
12.6897 
12.7360 
 
101.12 
100.47 
102.00 
100.81 
101.59 
101.51 
 
 
 
 
101.46 
 
 
 
 
 
0.4449 
 
 
 
 
0.4379 
 
 
 
0.01236 
 
CI=100.72 to 102.19 
* Mean of Six Observations              
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TABLE – 13 
RECOVERY ANALYSIS OF FORMULATION (ERITEL-CH 40) BY  
RP – HPLC 
Drug 
Sample 
No. 
Amount 
present 
( g/ml) 
Amount 
added 
( g/ml) 
Amount 
estimated* 
( g/ml) 
Amount 
recovered 
( g/ml) 
% 
Recovery* 
S.D 
% 
R.S.D 
S.E. 
 
 
 
TEL 
 
 
 
1 
2 
3 
 
 
 
8.1306 
8.1306 
8.1306 
 
 
6.4 
8 
9.6 
 
 
14.5392 
16.0862 
17.9000 
 
 
 
6.4087 
7.9556 
9.7695 
 
 
100.14 
99.45 
101.76 
100.45 
 
 
1.6042 
0.6238 
0.5861 
 
 
1.6019 
0.6273 
0.5760 
 
 
0.1782 
0.0693 
0.0651 
Mean 
 
 
 
 
CHL 
 
 
 
 
 
1 
2 
3 
 
 
 
 
2.5326 
2.5326 
2.5326 
 
 
 
2 
2.5 
3 
 
 
4.5727 
5.0097 
5.5860 
 
 
2.0401 
2.4771 
3.0542 
 
 
102.01 
99.08 
101.80 
 
 
0.4501 
0.2775 
0.3592 
 
 
0.4412 
0.2801 
0.3528 
 
 
0.0500 
0.0308 
0.0399 
Mean 100.96 
* Mean of Six Observations 
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TABLE- 14 
 
OPTICAL CHARACTERISTICS OF TELMISARTAN AND CHLORTHALIDONE 
BY HPTLC 
 
PARAMETERS TELMISARTAN CHLORTHALIDONE 
Detection 
wavelength 
229 nm 229 nm 
Linearity range 
(ng/ l) 
100 – 800 50 – 400 
Correlation 
Coefficient (r) 
0.9992 0.9989 
Regression 
Equation (y=mx+c) 
Y=2.1182 +(-16.9111) Y = 7.06113x+80.8474 
Slope (m) 2.1182 7.06113 
Intercept (c) -16.9111 80.8474 
LOD (ng/ l) 0.22446 0.5206 
LOQ (ng/ l) 0.68019 1.5775 
Standard Error 2.47903 4.7374 
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TABLE – 15 
QUANTIFICATION OF FORMULATION (ERITEL – CH 40)  
BY HPTLC 
Drug 
Sample 
No. 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)
* 
Percentage 
Obtained
* 
 
Average 
(%)  ± 
SD 
 
% 
RSD. 
SE 
 
 
CI
 
 
TEL 
 
1 
2 
3 
4 
5 
6 
40 
40 
40 
40 
40 
40 
40.8965 
40.3105 
40.7179 
40.9714 
40.8532 
40.2397 
102.24 
100.77 
101.77 
101.42 
102.13 
100.59 
101.66 
± 
0.7853 
0.7725 0.0218 
 
 
100.36 to 
102.95 
 
 
CHL 
 
 
1 
2 
3 
4 
5 
6 
12.5 
12.5 
12.5 
12.5 
12.5 
12.5 
12.7264 
12.7538 
12.6086 
12.7166 
12.4776 
12.6989 
101.81 
102.05 
101.73 
100.86 
99.82 
101.59 
101.31 
± 
0.8336 
0.8228 0.02319 
 
99.94 
 to 
102.68 
 
TEL = Telmisartan,  CHL=Chlorthalidone,  
*Mean of six observations 
CI
@
 = confidence interval (95 %) 
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TABLE – 16 
RECOVERY ANALYSIS OF FORMULATION (ERITEL-CH 40) BY  
RP – HPTLC 
Drug 
Sample 
No. 
Amount 
present 
(ng/ l) 
Amount 
added 
(ng/ l 
Amount 
estimated* 
(ng/ l 
Amount 
recovered* 
(ng/ l 
% 
Recovery 
S.D 
% 
R.S.D 
S.E. 
 
 
 
TEL 
 
 
 
1 
2 
3 
 
 
 
325.30 
325.30 
325.30 
 
 
256 
320 
384 
 
 
578.78 
642.83 
705.86 
 
 
253.43 
317.53 
380.56 
 
 
98.99 
99.23 
99.10 
99.10 
 
 
 
0.1201 
 
 
 
0.1212 
 
 
 
0.0133 
Mean 
 
CI = 98.90 to 99.29 
 
 
 
CHL 
 
 
 
 
 
1 
2 
3 
 
 
 
 
101.31 
101.31 
101.31 
 
 
80 
100 
120 
 
 
183.22 
202.96 
222.65 
 
 
81.9116 
101.6535 
121.3388 
 
 
102.38 
101.65 
101.16 
 
 
 
0.6319 
 
 
 
0.6034 
 
 
 
0.0682 
Mean 101.73 CI = 100.68 to 102.77 
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